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Thesis summary 
This thesis explores the use of aminobromomaleimide and dithiomaleimide 
functionalities to probe their environment. These fluorescent functionalities were 
incorporated into responsive polymeric nanostructures allowing their behaviour to 
be read-out upon external stimuli. 
 
Chapter 1 gives a brief introduction on nanoparticles formation and the 
polymerisation techniques used throughout the thesis. The properties of bromo- 
and thio-maleimides and their use in protein and polymer chemistry were also 
introduced. 
 
Chapter 2 describes a morphology transition simultaneously with a fluorescence 
on-to-off switch as a result of the modification of the dithiomaleimide substituent.  
 
Chapter 3 presents the synthesis of a library of aminomaleimides and explores their 
fluorescent properties. 
 
In Chapter 4, the fluorescent properties of aminobromomaleimide were 
incorporated into CO2-responsive polymeric nanoparticles for a built-in read-out of 
the CO2-response. 
 
Chapter 5 explores the possibility of using the fluorescent properties of 
aminobromomaleimide to read-out the behaviour of glutathione-responsive 
particles. 
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1.1. Abstract 
With work in this thesis focusing on the development of fluorescent nanoparticles, 
this introduction will provide a brief overview first into nanoparticles, focussing on 
different synthetic methods. Then it will cover maleimide based fluorophores, 
initially looking at their biological applications, and secondly providing an 
introduction to their fluorescent properties.  
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1.2. Polymeric nanoparticles 
Polymeric nanoparticles have been widely developed for many applications 
including nanomedicine, drug/gene delivery, imaging and nanomaterials.1-9 There 
are a variety of polymeric particle architectures (Figure 1.1), such as micelles, 
liposomes, nanoparticles, dendrimers, and latexes, which can be prepared using 
different techniques.10-18 In particular, there is a great interest in responsive and 
fluorescent nanoparticles, especially for nanomedicine and bio-imaging 
applications.4,13,19-28  
 
Figure 1.1. Examples of nanostructures developed for drug and gene delivery. 
Reproduced from reference.8 
 
1.2.1. Nanoparticles formation 
Different strategies can be used to form nanoparticles. In this thesis, two techniques 
have been utilised: first, emulsion polymerisation, which is a free radical 
polymerisation process,29 and second, the self-assembly of well-defined polymers 
synthesised via controlled polymerisation processes.17  
1.2.1.1. Emulsion polymerisations  
Emulsion polymerisation has several advantages over other methods including the 
facile nature of the process, the large range of compatible monomers and 
polymerisations can often be taken to high conversion.29,30 Moreover, the size of 
particles synthesised by emulsion polymerisation can be tuned between 0.05-5 µm 
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in diameter. Most emulsion polymerisations are performed in aqueous media, but 
inverse emulsion polymerisations are also possible, depending on the solvent used 
to disperse the insoluble monomer. In the case of an aqueous emulsion 
polymerisation, the initiator has to be water soluble, and a surfactant is necessary to 
stabilise the monomer in micelles. Hence, the concentration of the surfactant needs 
to be above its critical micellar concentration (CMC).  
 
Firstly during polymerisation, initiation occurs in solution with subsequent reaction 
with the initiating species and monomer producing an initial growing chain (Figure 
1.2, labelled z-mer). When the growing chain reaches a critical length, the oligomer 
becomes insoluble in solution and is stabilised by penetrating a surfactant micelle 
(Figure 1.2, labelled monomer swollen micelle). The propagation of the chains 
continues inside the micelle consuming the monomer in the droplets. This process 
continues until all of the growing chains are stabilised, at which point the remaining 
 
Figure 1.2. Schematic representation of the emulsion polymerisation process. 
Reproduced from reference.29 
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surfactant from surfactant stabilised monomer micelles (Figure 1.2, labelled non-
nucleated micelles) is sequestered to stabilise the growing particles. The propagation 
ends once all the monomer is consumed and the conversion approaches 100%. 
Emulsion polymerisation can also be performed with the incorporation of a cross-
linker, which “locks” the structure through crosslinking either the core or the shell 
of the nanoparticles or both. This increases the particle stability to changes in its 
environment (solvent, temperature, pH or concentration).  
The polymerisation process employed in emulsion polymerisation is a free radical 
process. Free radical polymerisation presents many advantages, with most vinyl 
monomers able to be used, and it can be carried out in a variety of media: in solution, 
as a dispersion, as a suspension, in an emulsion or in bulk. The free radical 
polymerisation mechanism consists of three main stages: initiation, propagation and 
termination (combination or radical disproportionation) (Scheme 1.1). Owing to 
termination being significantly faster than propagation (ktc/td > kp), chains terminate 
before complete monomer conversion. Moreover, as a consequence of the high 
reactivity of radical species, the rate of initiation is slower than the rate of 
propagation (ki<kp) resulting in some chains having grown significantly before other 
chains have initiated. As a result of these two effects, conventional free radical 
polymerisation doesn't allow good control over molecular weight or dispersity. 
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Scheme 1.1. General free radical polymerisation mechanism. 
 
1.2.1.2. Polymer self-assembly 
Whilst emulsion polymerisation provides an easy method for the production of 
spherical nanoparticles, other morphologies can be obtained through copolymer 
self-assembly. The driving force to form these self-assembled structures depends on 
the solvophobicity of each block of the copolymer. Indeed, the solvent needs to be 
a good solvent for one of the blocks and the second block should be insoluble in that 
solvent. The morphology obtained (spherical micelles, cylindrical micelles or 
polymersomes, Figure 1.3) depends on the amphiphilic balance between the blocks 
(represented in red and blue in Figure 1.3), and also on the polymer packing ability 
and therefore the polymer chain curvature: for higher curvatures, where the packing 
parameter is < 1/3 (Figure 1.3), smaller structures are obtained. The packing 
parameter can be determined from the volume (v) and the length of the hydrophobic 
segment (lc), and the head group area (a0).10,18  
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Figure 1.3. Schematic representation of different morphologies adopted in 
solution depending on the amphiphilic balance of the polymer, where p = 
packing parameter, v = volume, ao = head group area and lc = the length of the 
hydrophobic segment. Reproduced from reference.18  
 
In order to form these nanostructures, it is necessary to synthesise copolymers in a 
controlled manner with a low dispersity to ensure a targeted amphiphilic balance 
and block ratios.18 In order to produce copolymers in a controlled manner, different 
polymerisation techniques can be utilised, including reversible addition-
fragmentation chain transfer (RAFT) polymerisation, atom-transfer radical-
polymerization (ATRP), nitroxide-mediated polymerization (NMP) and ring 
opening polymerisation (ROP).  
1.2.1.2.1. Reversible addition-fragmentation chain transfer (RAFT) polymerisation 
RAFT polymerisation is a reversible-deactivation radical polymerisation (RDRP) 
mechanism, allowing for the synthesis of polymers with control over the molecular 
weight and therefore with a narrow molecular weight distribution. A large range of 
monomers can be used for RAFT polymerisation, as RAFT polymerisation is tolerant 
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of a wide range of functional groups. A RAFT polymerisation is composed of a radical 
source, a RAFT chain transfer agent (CTA), and a monomer; a solvent is also often 
used. The RAFT polymerisation mechanism consists of several steps: initiation, 
reversible chain transfer, reinitiation, chain equilibrium and termination. The RAFT 
CTA is necessary for exerting control over the polymerisation, producing a dormant 
form of the polymer chains (Scheme 1.2, compound 4), in equilibrium with the active 
chains (Scheme 1.2, compound 3), in a process known as chain equilibrium. The 
rapid exchange between the dormant and growing polymer chains ensures an equal 
probability for chain growth of any of the polymer chains, therefore resulting in 
polymers with narrow dispersities. Commonly, the RAFT CTA can be a dithioester, 
a trithiocarbonate or a dithiocarbamate, with the RAFT CTA chosen depending on 
the reactivity of monomer class being polymerised. 
 
 
Scheme 1.2. Mechanism of RAFT polymerisation.  
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1.2.1.2.2. Ring opening polymerisation (ROP) 
Ring opening polymerisation consists of the ring opening and polymerisation of a 
cyclic monomer, catalysed by a metal-based catalyst (e.g. Zn, Ca, or Al complexes31) 
or an organocatalyst (e.g. thiourea-amine32, 4-(dimethylamino)pyridine33, or N-
heterocyclic carbenes34), to obtain a linear polymer. Developments in organic 
catalysts allowed for the synthesis of well-defined polymers with narrow 
dispersities.33-35 A wide range of cyclic monomers can be polymerised by ROP, 
including lactones,36,37 lactams,38 carbonates,39 and ethers.40 In the polymerisation 
of lactide catalysed by a thiourea-amine combination, the lactide carbonyl becomes 
more electrophilic through the activation from the thiourea, and the alcohol 
becomes more nucleophilic through the activation by the tertiary amine, (Scheme 
1.3). This catalytic system was also shown to be very selective for polymerisation 
relative to transesterification. 
 
 
Scheme 1.3. Example of the polymerisation of lactide in the presence of a 
thiourea-amine catalyst. Adapted from reference.32 
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Pratt et al. tested different thiourea-amine catalysts for the polymerisation of 
lactide.32 The most efficient catalyst combination to polymerise rac-lactide with 
thiourea was found to be (-)-sparteine (Figure 1.4). The polymerisation reached 99% 
conversion in only 2 h, which is significantly shorter than polymerisations with other 
catalytic systems (e.g. a in Figure 1.4) that often take 48 to 72 h. Moreover, the 
polydispersity of the polymer obtained was very low even at high conversion; for 
example, polymerisation of rac-lactide produced a polymer (Mn = 20700 g·mol-1) 
with a polydispersity of 1.05 at high monomer conversion (99%).  
 
 
Figure 1.4. Activation of lactide and alcohol initiator with (a) bifunctional 
thiourea-tertiary amine, vs. (b) thiourea and (-)-sparteine. 
 
1.2.2. Responsive polymers and nanoparticles 
There is a great interest in responsive polymers, as they are readily employed in a 
variety of applications such as drug-delivery and sensing.1,41-47 The key feature of 
responsive polymers is their ability to respond to their environment, changing their 
physical or chemical properties in response to a physical, chemical and/or biological 
stimulus, e.g. temperature,41,48,49 light,50-52 pH,53-55 carbon dioxide,56-58 or a redox 
reaction.46,59,60  
The most studied and understood class of responsive polymers are 
thermoresponsive, the most widely studied of which is poly(N-isopropylacrylamide) 
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(PNIPAM), which exhibits a lower critical solution temperature (LCST). When in 
solution at a temperature below the LCST, the polymer is hydrophilic as it forms 
hydrogen bonds with water. However, when in solution at a temperature above the 
LCST, the polymer becomes hydrophobic and therefore rendered insoluble in water. 
Such an effect has been reported by Moughton et al., who synthesised a 
thermoresponsive block copolymer with methyl acrylate (MA) and N-
isopropylacrylamide (NIPAM), the latter forming the responsive block.61 The 
copolymer was synthesised by RAFT polymerisation utilising a quaternary amine 
functionalised RAFT agent, which formed a permanent hydrophilic ‘headgroup’. 
Below the LCST, the copolymer self-assembled into spherical micelles, but when the 
temperature was increased above the LCST a morphology transition occurred from 
spherical micelles to vesicles. The morphology transition was a result of the 
interfacial curvature variation controlled by the response of the NIPAM segment 
located between the hydrophilic head and the hydrophobic segment, Figure 1.5. 
 
 
Figure 1.5. Schematic representation of a morphology transition induced by 
temperature. Reproduced from reference.61  
 
Similarly, Feng et al. reported a dual-responsive PNIPAM and poly(N,N’-
(diethylamino)ethyl methacrylate) (PDEAEMA) copolymer, which self-assembled 
into vesicles (Figure 1.6). PNIPAM was utilised to add thermoresponsive properties 
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to the copolymer, facilitating a change of the vesicle size and also the reversible self-
assembly of the copolymer into spherical micelles. Moreover, with the copolymer 
second block composed of PDEAEMA, which is pH/CO2-responsive through the 
protonation of the amine in acidic environment, a change of the environment 
triggered a reversible disassembly of the vesicles (Figure 1.6.)  
 
As demonstrated in the previous example by Feng et al., pH/CO2-responsive 
polymers can be synthesised from amines; however, amidines and guanidines can 
also be used, see Figure 1.7. Upon pH cycling, these different functionalities can 
alternate between protonated and non-protonated states. The advantage of utilising 
CO2, compared to alternating addition of acid and base, is that it does not 
contaminate the solution with the formation of salts.  
 
Figure 1.6. Schematic example of dual-responsive vesicles and the transitions 
upon changes in temperature or pH/CO2. Reproduced from reference.62 
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Redox-responsive particles have also received attention, especially for drug-delivery 
applications.59,60 The most commonly studied redox system involves the application 
of glutathione (GSH/GSSH), as it has been shown to be present at higher 
concentrations intracellularly (ca. 1-10 mM) than extracellularly (ca. 1-10 µM).63,64 
Moreover, it has been reported that cancer cells have a significantly higher GSH 
concentration compared to normal cells,65,66 with the intracellular GSH 
concentration able to trigger a thiol-disulfide exchange. Indeed, Ryu et al. presented 
the synthesis of an amphiphilic copolymer in which a disulfide bridge links the 
hydrophobic tail. Depending on the GSH concentration, the micelle disassembled, 
releasing the drug, see Figure 1.8.67  
 
 
Figure 1.8. Schematic example of drug release through GSH-responsive self-
assembled amphiphilic copolymer disassembly. Reproduced from reference.67 
 
 
Figure 1.7. pH/CO2-responsive functionalities and their response to CO2. 
Reproduced from reference.56 
 
Chapter 1 
14 
 
Li et al. reported another example of a glutathione responsive system, involving the 
crosslinking of nanoparticles upon addition of a catalytic amount of dithiothreitol 
(DTT), see Figure 1.9. When penetrating the cells, the presence of glutathione 
induces a disulfide-thiol exchange, resulting in de-crosslinking of the particle core, 
resulting in the release of doxorubicin.68  
 
 
Figure 1.9. Schematic representation of the reversible cross-linking of dextran-
lipoic acid anhydride nanoparticles using DTT, and the release of doxorubicin 
(DOX) in cells. Reproduced from reference.68  
 
These different responses can also be combined into one system to produce multi-
stimuli responsive materials.19,51,69-72 The aforementioned dual pH and temperature 
responsive vesicles by Feng et al. is one example of multi-responsive polymer self-
assembly.62 Extending the concept, Klaikherd et al. presented the synthesis of a 
temperature, pH and redox responsive polymer, see Figure 1.10. Consisting of a 
tetrahydropyran protected poly(2-hydroxyethyl methacrylate) (PHEMA) block, and 
a PNIPAM block, with the two blocks linked by a disulfide bond.73 As mentioned 
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previously, PNIPAM exhibits an LCST, while the deprotection of the HEMA block in 
acidic conditions will change the block from hydrophobic to hydrophilic. With the 
disulfide bond sensitive to addition of reducing agents such as DTT, this polymer is 
triply responsive.  
 
 
Figure 1.10. Schematic example of a multi-responsive polymer. Reproduced from 
reference.73  
 
1.2.3. Fluorescently labelled nanoparticles 
Fluorescent polymer nanoparticles are of great interest for imaging 
applications.5,7,24,27 Currently, the most popular fluorescent dyes for polymer 
functionalisation are small molecules, but these can have problems, for example low 
emission caused by photobleaching, and/or their toxicity can prevent biomedical 
applications.74-76 The incorporation of fluorophores into polymeric particles can 
overcome these problems, rendering them more applicable for biomedical 
applications. Different methods to incorporate fluorophores into polymeric particles 
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have been reported, including direct polymerisation of the fluorophore, and 
entrapment during self-assembly, emulsion or nanoprecipitation.7,77,78  
One commonly applied practice is to synthesise a fluorescent monomer from a 
fluorescent dye;79 this technique allows the dye to be covalently linked to the 
polymeric nanostructure. Indeed, Cova et al. presented such an approach, 
synthesising biocompatible fluorescent nanoparticles for bioimaging.80 In this work, 
a Rhodamine B functionalised 2-hydroxyethyl methacrylate (HEMA-RhB) was 
synthesised to form a fluorescent macromonomer. This macromonomer was used 
to synthesise nanoparticles via emulsion polymerisation with methyl methacrylate 
(MMA). The resultant particles were shown to be successfully internalised by stem 
cells allowing efficient labelling and tracking of the cells in vitro and in vivo.  
Another technique to obtain fluorescent nanoparticles is to encapsulate an organic 
dye into polymeric nanoparticles. Indeed, Wang et al. showed the synthesis of 
polymeric nanoparticles using this approach, demonstrating two different routes to 
incorporate the fluorescent dye into the particles, see Figure 1.11.81  
 
 
Figure 1.11. Schematic representation for two different routes to encapsulate an 
organic dye. Reproduced from reference.81 
 
These nanoparticles were synthesised via emulsion polymerisation; in the first case, 
the dye was embedded in the particles during the polymerisation, and in the second 
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case, the dye was adsorbed into the nanoparticles post-polymerisation. It was found 
that the embedded nanoparticles exhibited higher luminescent properties 
compared to the adsorbed nanoparticles. It was hypothesised that the difference in 
luminescence was a consequence of the dye incorporation process. The dye could 
be incorporated at a higher concentration in the inner core of the embedded 
nanoparticles, than can be adsorbed into the nanoparticles. 
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1.3. Dibromomaleimides and dithiomaleimides  
Maleimides, important building blocks in synthetic organic chemistry, consist of a 
cyclic unsaturated imide, of the generic structure indicated in Figure 1.12.  
 
Figure 1.12. Generic structure of maleimides.  
 
1.3.1. For protein modification and disulfide bridging  
For many years, there has been a growing interest in maleimides, mainly for protein 
modification using the amino acid cysteine,82 but also for thiol detection.83 The 
maleimide is often used as it is selective towards cysteine and has a fast rate of the 
reaction. Moreover, the irreversibility of the modification is also advantageous, 
though in certain situations may be unwanted. Maleimide has also been utilised as 
a linker for fluorophores: Baker and co-workers have reported optimised protein 
modifications and disulfide bridging using dibromomaleimides and 
dithiomaleimides (Figure 1.12, where R1 = H, R2 = R3 = Br for the former, and R1 = H, 
R2 = R3 = SR for the latter, respectively).82,84-86 Indeed, reversible protein 
modification using bromomaleimide instead of maleimide was demonstrated.84 By 
incorporating a leaving group on the maleimide double bond, the reaction with 
cysteine would produce a thiomaleimide in which the double bond is preserved, see 
Scheme 1.4 (product 7). 
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 Scheme 1.4. Reaction of thiol with maleimide or bromomaleimide. Adapted 
from reference.87 
 
Furthermore, by reacting both bromomaleimide and maleimide with cysteine, it was 
confirmed that the reaction of a thiol with bromomaleimide was faster than with 
unsubstituted maleimide, obtaining a 70:30 mixture of 7 and 6 (Scheme 1.4). 
Competition between other nucleophiles and cysteine to react with 
bromomaleimide was also evaluated, by adding propylamine to the mixture of 
bromomaleimide and cysteine. The results showed a clear selectivity for 
bromomaleimide towards cysteine over amines. Moreover, the reversibility of the 
reaction of bromomaleimide with cysteine was demonstrated by reacting the 
reducing agent tris(2-carboxyethyl)phosphine (TCEP), with the cysteine-maleimide 
conjugate, which results in the cleavage of the thiomaleimide and release of the 
cysteine, with a 98% yield, see Scheme 1.5.84  
 
 
Scheme 1.5. Cleavage of the thiomaleimide with TCEP. Adapted from 
reference.84 
 
The usage of bromomaleimide for protein modification and disulfide bridging was 
further investigated by the same research group.82 It was noted that, if 
dibromomaleimide can be used instead of bromomaleimide, the second bromine 
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can be substituted by another thiol such as glutathione or thioglucose to obtain a 
di-substituted maleimide. Moreover, they showed that in the presence of a large 
excess of another thiol such as mercaptoethanol or glutathione, the free unmodified 
protein can be fully recovered from either mono-substituted maleimide or di-
substituted maleimides, see Scheme 1.6. 
 
Scheme 1.6. Schematic representation of the reversible modification of cysteine 
with maleimides. Adapted from reference.82 
 
In order to get one step closer to potential drug-delivery applications, the ability of 
substituted dithiomaleimide (13 in Scheme 1.6) to be cleaved by glutathione present 
in the cytoplasm of cells was evaluated. Unmodified free protein 10 (Scheme 1.6) was 
successfully recovered after treatment of 13 with intracellular-like conditions, 
confirming cleavage of the maleimide substituted protein.82 Afterward, cleavability 
of maleimide conjugates in mammalian cells was tested on different rhodamine-
Green Fluorescent Protein-maleimide conjugates. It was found that maleimide 
conjugates were successfully cleaved in vitro at different cleavage rates depending 
on the structure.88 The cleavage of the maleimide conjugates was also successful in 
HeLa cells showing the potential of thiomaleimide in drug-delivery systems. 
Chapter 1 
21 
 
Baker, Caddick and co-workers also investigated the possibility of using 
dibromomaleimide to modify disulfide bonds in somatostatin (a disulfide bridge 
containing peptide playing a role in hormone regulation). The protein was treated 
with TCEP to break the disulfide bond, which was subsequently reacted with 
dibromomaleimide, see Scheme 1.7. As previously demonstrated for cysteine 
(Scheme 1.6), the modification of somatostatin was reversible upon a similar 
treatment with an excess of mercaptoethanol, see Scheme 1.7. Moreover, it was 
demonstrated that the modification of somatostatin could be achieved utilising 
dithiomaleimide instead of dibromomaleimide, preventing some cross reactivity 
with TCEP.85 
 
Inspired from the commercially available fluorescein-maleimide (commonly used in 
protein labelling), the ability of dibromomaleimide to have three points of 
attachment was tested through the synthesis of a fluorescently labelled 
dibromomaleimide, see Scheme 1.8.82 The reversible modification of somatostatin 
with fluorescein-dibromomaleimide was performed using the same protocol 
previously used with dibromomaleimide. Comparison of the emission of the 
different precursors (fluorescein-dibromomaleimide, fluorescein-amine, and 
somatostatin) and product of the modification indicated successful labelling of the 
protein. However, no comparison was made with the maleimide-somatostatin 
conjugate 14 in Scheme 1.7.  
 
Scheme 1.7. Reversible modification of somatostatin. Adapted from reference.82 
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Scheme 1.8. Synthesis of the fluorescein labelled dibromomaleimide, and 
reversible modification of the somatostatin disulfide bridge with fluorescein-
dibromomaleimide. Adapted from reference.82  
 
The demonstration of successful three point functionalisation of dibromomaleimide 
to produce the somatostatin-maleimide-fluorescein conjugate, and the observation 
that intracellular-like conditions can reduce the disulfide bridge, opened the path 
to applications in drug-delivery, imaging and detection.  
Dibromomaleimide was also functionalized by the attachment of polyethylene 
glycol (PEG) polymer chains for subsequent conjugation to somatostatin. The PEG-
dibromomaleimide and PEG-dithiomaleimide were synthesised via a Mitsunobu 
reaction, with a higher yield obtained when using dithiomaleimide (73%) compared 
to dibromomaleimide (13%, Scheme 1.6). PEG-dibromomaleimide was tested with 
sequential addition of TCEP and somatostatin, whereas PEG-
dithiophenolmaleimide was tested with in situ conditions, see Scheme 1.9.  
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Scheme 1.9. Synthesis of PEG-maleimide and PEGylation of somatostatin via a 
stepwise protocol (a) or in situ protocol (b). Adapted from reference.85 
 
1.3.2. For antibody drug conjugation  
Following the development of dibromomaleimide/dithiomaleimide disulfide 
bridging, Caddick and Baker extended the area of study to antibody fragment 
conjugation.89-91 PEG-dibromomaleimide and fluorescein-dibromomaleimide 
antibody conjugates were successfully synthesised via similar methods to the ones 
developed for protein disulfide bridging. The antibody was also labelled with a spin 
label for EPR-based detection to potentially monitor antibody-antigen interactions 
(Figure 1.13).89  
  
 
Figure 1.13. Schematic concept of functionalisation of the antibody and the 
antibody-antigen interaction detection by EPR-sensing. Reproduced from 
reference.89 
Further investigations were carried out into the use of dithiomaleimide for antibody 
drug conjugates. Initially, an anti-cancer drug (monomethyl auristatin E, MMAE) 
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was coupled to dithiophenolmaleimide. The product was successfully conjugated to 
an antibody (IgG1 trastuzumab) via re-bridging the interchain disulfide bonds 
(Figure 1.14). Post hydrolysis, the antibody drug conjugate was shown to be stable in 
blood serum, selectively targeting and killing cancer cells.90,91  
 
 
Figure 1.14. Schematic example of an antibody drug conjugate synthesised 
through utilisation of dithiomaleimide. Reproduced from reference.91 
 
 
1.3.3. For polymers functionalisation 
Following their work on the conjugation of PEG and somatostatin with maleimide 
derivatives, Caddick, Baker and co-workers collaborated with Gibson, Haddleton 
and co-workers to develop dibromomaleimide functionalised polymers synthesised 
by atom transfer radical polymerisation (ATRP), a form of reversible-deactivation 
radical polymerisation, for application in protein disulfide bridging.92 In this case, 
salmon calcitonin (a disulfide bridge containing hormone) was targeted for disulfide 
bridging with the maleimide species. Whilst the same approach as mentioned above 
(functionalisation of PEG with dibromomaleimide via the Mitsunobu reaction, see 
Scheme 1.9) successfully produced a PEG-dibromomaleimide conjugate, the 
efficiency and the reaction yield were low, and the product required additional 
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purification via column chromatography. Moreover, the initial test of performing 
ATRP of oligo(ethylene glycol) methyl ether 
Methacrylate (OEGMA) in the presence of dibromomaleimide led to inhibition of 
the polymerisation under the conditions evaluated. To circumvent this ATRP 
inhibition, other indirect synthetic routes were tested to obtain dibromomaleimide 
functionalised PEG. In these alternative routes, dibromomaleimide was successfully 
added onto PEG via post-polymerisation modification. The conjugation of the 
resulting dibromomaleimide-PEG was evaluated using the disulfide rebridging of 
the salmon calcitonin, with successful polymer-peptide conjugation reported. 
Investigations using a dibromomaleimide functionalised ATRP initiator were 
further pursued through the synthesis of two dibromomaleimide functionalised 
ATRP initiators.93 Both initiators were tested for the ATRP polymerisation of MA 
and tertbutyl acrylate (tBA). Unlike the earlier results, the polymerisations did not 
seem to be inhibited, although a loss of control was noticed via size exclusion 
chromatography (SEC) analysis of polymerisation samples, showing bimodal SEC 
traces. The possibility of using a maleimide ATRP initiator was further investigated. 
As previously observed, dibromomaleimide was more sensitive to TCEP than 
dithiomaleimide85, therefore it was hypothesised that a dithiomaleimide 
functionalised ATRP initiator would be more tolerant to the reaction conditions. 
Indeed, oligo(ethylene glycol) methyl ether methacrylates (OEGMA) was 
successfully polymerised with good control using a dithiomaleimide initiator, and 
conjugated to salmon calcitonin.94  
Following the successful polymerisation using a dithiomaleimide ATRP initiator and 
the conjugation with salmon calcitonin, Haddleton and co-workers developed an 
oxytocin PEG conjugate via disulfide bridging of the oxytocin cysteines and an 
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α-dithiomaleimide PEG (Scheme 1.10).95 The formation of this conjugate, reversible 
in situ, significantly reduced the drug degradation. 
 
 
Scheme 1.10. Synthesis of an oxytocin PEG conjugate using a dithiomaleimide 
functionalised ATRP initiator. Adapted from reference.95 
 
The possibility of using RAFT polymerisation was also investigated. Inspired by 
Caddick, Baker and co-workers, Robin et al. synthesised a RAFT CTA containing the 
dibromomaleimide functionality.93 The synthesis of the trithiocarbonate-based CTA 
(21 in Scheme 1.11) was reported by Petzetakis et al.,96 and the functionalisation with 
dibromomaleimide was performed following a procedure reported by Weinreb.97  
 
 
Scheme 1.11. Synthesis of the DBM RAFT agent. Adapted from reference.93 
 
Using the dibromomaleimide RAFT CTA, different RAFT polymerisation conditions 
were tested to polymerise tBA, MA, triethylene glycol acrylate (TEGA), and NIPAM. 
The resultant polymers were compared to polymers synthesised with the 
benzylbromine analogue of the dibromomaleimide and its precursor (22 and 21 in 
Scheme 1.11, respectively). Polymerisation of tBA, MA and TEGA with CTA 23 
proceeded to high conversion with good control (low dispersity); however, a 40 
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minutes induction period was observed. Moreover, polymerisation of acrylic 
monomers seemed to be significantly slower than expected. The post polymerisation 
modification of the dibromomaleimide terminated polymers was also tested and 
optimised to form monothiomaleimide and dithiomaleimide via addition of 
thiophenol with catalytic imidazole. In the presence of imidazole, the reaction 
occurred rapidly, achieving high conversion after only 15 minutes (monosubstituted 
product still present) and total conversion after 60 minutes.93 
1.3.4. Fluorescent properties 
Following the successful RAFT polymerisations, the DBM containing RAFT initiator 
(23) was functionalised with mercaptoethanol (24 in Scheme 1.12), in order to 
initiate the polymerisation of rac-lactide (LA) via ROP, allowing for the synthesis of 
a block copolymer, see Scheme 1.12.  
 
Scheme 1.12. Synthesis of a block copolymer using a novel RAFT/ROP initiator. 
Adapted from reference.98 
 
Interestingly, the block copolymer (25 in Scheme 1.12) showed luminescent 
properties, under a UV lamp, see Figure 1.15. It was also noted that the PLA precursor 
and RAFT/ROP initiator exhibited similar properties.  
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Figure 1.15. Picture of the copolymer 25 at 1mg·mL-1 in chloroform under a UV 
lamp (λ = 345 nm). 
 
To further investigate this phenomenon, Robin et al. synthesised a range of 
dithiomaleimide small molecules via the addition-elimination reaction of 
dibromomaleimide with different thiols, see Scheme 1.13.  
 
 
Scheme 1.13. Synthesis of different dithiomaleimide small molecules. Adapted 
from reference.99 
 
Dithiomaleimide 26, synthesised from dibromomaleimide and butanethiol showed 
an emission spectrum in chloroform with a maximum at 520 nm, and excitation 
maxima at 265 nm and 415 nm. Dithiomaleimides 27 (mercaptoethanol substituted) 
and 24 (N-substituted with RAFT agent) showed similar fluorescence spectra. The 
fluorescence properties of RAFT CTA 24 explained the luminescence observed with 
the aforementioned block copolymer 25 in Scheme 1.12, the same CTA (24) was used 
to synthesise the copolymer.  
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These observations are consistent with a patent published in 1987 reporting the use 
of dibromomaleimide and dichloromaleimide to detect thiol and amine 
functionalities.100 The halogenated maleimide stain was used to detect the presence 
of proteins via the direct addition of the stain to the protein sample; fluorescence 
could be observed within 15 minutes with a UV light source. However, it was 
observed that when dibromomaleimide was conjugated with an aromatic ring such 
as 28 (thiophenol substituent) and 29 (N-phenyl substituent), the fluorescence 
emission was drastically decreased, see Figure 1.16.  
As a consequence of dithiomaleimides being previously used for cysteine 
PEGylation, and disulfide re-bridging in somatostatin and salmon calcitonin 
proteins,82,84,85 Robin et al. tested whether the fluorescent properties of 
dithiomaleimide were retained when conjugated to proteins. Following a procedure 
previously developed by Caddick and co-workers, it was successfully demonstrated 
that dibromomaleimide conjugated with glutathione formed a fluorescent product, 
as did the dibromomaleimide functionalised cysteine. Similarly, disulfide 
re-bridging of salmon calcitonin also resulted in the incorporation of fluorescent 
properties. However, when monocysteine was added to dibromomaleimide, 
producing a thiobromomaleimide, the product showed fluorescent properties but 
with considerably reduced intensity, see Figure 1.16.  
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Figure 1.16. Emission and excitation spectra of 26, 28, and 29 at 0.1 mM in 
chloroform. Adapted from reference.99 
 
Alongside the study on the fluorescence properties of dithiomaleimides, Robin et al. 
investigated the RAFT polymerisation of different monomers (tBA, TEGA, Styrene 
and NIPAM) utilising the fluorescent dithiomaleimide RAFT agent (24 in Scheme 
1.13). The polymerisation of these monomers by RAFT polymerisation was previously 
tested using a dibromomaleimide RAFT agent, where styrene and NIPAM 
polymerisations were found to be inhibited. However, when using the 
mercaptoethanol-derived dithiomaleimide RAFT agent (24 in Scheme 1.13), RAFT 
polymerisations of the different classes of monomers evaluated were successful, and 
all the polymers exhibited fluorescent properties similar to the RAFT agent.  
As mentioned above, the amphiphilic block copolymer synthesised with the dual 
RAFT/ROP initiator containing dithiomaleimide (see Scheme 1.12) exhibited 
luminescent properties, with a fluorescence emission spectrum showing an emission 
maximum at 522 nm and an excitation maximum at 403 nm in methanol.98 The 
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polymer emission intensity also showed a low concentration dependence between 
200 nM and 200 µM. It was also found that this amphiphilic block copolymer self-
assembled into spherical micelles of 20 nm diameter in water. The small size of the 
dithiomaleimide functionality presumably located at the hydrophilic/hydrophobic 
interface did not disrupt the copolymer self-assembly, and the block copolymer 
appeared to retain fluorescence when self-assembled. The fluorescent behaviour of 
these fluorescent micelles in in vitro conditions was also tested. It was observed that 
three different forms of micelle and their degraded products could be found in 
different parts of rat vascular tissue and that these species could be differentiated by 
their respective fluorescence life-time as determined by fluorescence lifetime 
imaging microscopy (FLIM), see Figure 1.17.98 These results showed the potential of 
dithiomaleimide functional group to be used in self-reporting materials for 
nanomedicine.  
 
 
Figure 1.17. Fluorescence lifetime imaging microscopy (FLIM) of fluorescent 
micelles in a rat hippocampal tissue (A) clotting regions, (B) vascular tissue, (C) 
blood cells. Reproduced from reference.98 
 
 
  
Chapter 1 
32 
 
The aforementioned copolymer 25 was able to self-assemble into spherical micelles 
in aqueous media. These micelles were further developed (RM2) as a potential 
nanovehicle for neural stem cells modulation and compared to a fluorescently 
labelled NIPAM based nanogels (RM1).101 It was reported that both micelles (RM2) 
and nanogels (RM1) were successfully internalised by stem cells, which could be 
observed by fluorescence microscopy, see Figure 1.18. The toxicity of RM1 and RM2 
was also assessed and it was found that these fluorescent micelles were not toxic at 
a concentration equal or below 150 µg·mL-1. However, the loading of a drug (retinoic 
acid) was tested and showed a low loading capacity of the micelles RM2 as a result 
of the packed nature of the core.  
 
 
Figure 1.18. Internalisation of nanoparticles RM1 and RM2. (a-f) Confocal 
microscopy images of cells at 70 and 150 µg·mL-1 after 4 h and 24 h. (g-h) 
Proliferation assays at different concentration. Reproduced from reference.101  
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1.4. Summary 
The introduction has mainly been focused, in the first part, on polymeric 
nanoparticles. There is a large variety of nanoparticles with different properties for 
a myriad of applications. Specifically, fluorescent responsive particles are of 
particular interest for biomedical applications, as they can combine drug-delivery, 
targeting and imaging properties. Concepts involving responsive nanoparticles are 
utilised in Chapter 2 (self-assembled micelles responsive to an excess of thiophenol), 
in Chapter 4 (CO2-responsive fluorescent nanoparticles), and in Chapter 5 
(glutathione-responsive fluorescent nanoparticles).  
The second part of this introduction has focused on the development of the 
dibromomaleimide and dithiomaleimide chemistries, which led to the discovery of 
their fluorescent properties. The dithiomaleimide fluorescent properties introduced 
have been explored in Chapter 2, with work focussing on a fluorescence emissive 
on-to-off switch. The fluorescent properties have further been exploited within this 
Thesis, with the development of another fluorophore derivative in Chapter 3, and 
subsequent applications in Chapter 4 and 5 allowing for a read-out of the state of 
the particles, rendering them self-reporting. 
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Chapter 2   
Dithiomaleimide containing polymeric 
micelles: on-to-off fluorescence emission 
switch with simultaneous morphology 
transition  
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2.1. Abstract 
This chapter discusses changes in the morphology and fluorescence of self-
assembled polymers containing dithiomaleimide moieties. These changes are shown 
to be the result of an addition-elimination reaction taking place upon addition of an 
aromatic thiol that dramatically alters the fluorescence emission properties of 
dithiomaleimide while the morphology transition is attributed to the change of the 
polymer polarity. These phenomena are the result of an addition-elimination 
reaction that occurs on the dithiomaleimide, present at the core-shell interface, in 
the presence of an excess of an aromatic thiol.*  
 
 
Figure 2.1. Schematic representation summarising the concept of this chapter: 
morphology transition along with fluorescence intensity decrease, triggered by 
the addition of thiophenol onto the maleimide and elimination of the PLA-SH. 
PTEGA-b-PLA2: poly(triethylene glycol monomethyl ether acrylate)]-b-
[poly(D,L-lactide)2. Figure reproduced from reference.1 
 
  
                                                     
* The synthesis of most materials presented in this chapter was carried out by the author in 
the context of her master’s degree however the study of the properties of the materials was 
mainly carried out during the course of this PhD. 
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2.2. Introduction 
The precise control over self-assembled polymer morphologies in solution is 
currently of great interest to the research community. Various morphologies such 
as spherical micelles, cylinders, rods, and vesicles or polymersomes can be formed 
through the self-assembly of amphiphilic block copolymers in selective solvents.2 
The morphology adopted in solution by the amphiphiles is determined by the block 
copolymer composition and properties. Conventional self-assembled 
nanostructures are based on hydrophilic-hydrophobic repulsive interactions,3 and 
their morphology can be rationalised with the variation of the packing parameter p, 
which is defined in terms of optimal interface a0, volume occupied by the 
hydrophobic chain v and the maximum length of the amphiphile lc. Depending on 
the value of the packing parameter, which is related to the curvature of the 
amphiphilic polymer: for high curvature or p ≤ ⅓, the polymer self-assembles into 
spherical micelles; for medium curvature or ⅓ ≤ p ≤ ½, cylindrical micelles are 
formed; and for low curvature or ½ ≤ p ≤ 1, hollow vesicles or polymersomes are 
formed, see Figure 2.2.3,4 Self-assembled nanostructures formed from stimuli-
responsive polymers are able to undergo morphology transitions induced by 
external stimuli such as pH, temperature and light.5-11 The incorporation of a stimuli-
responsive polymer into a block copolymer can, upon a specific stimulus, trigger a 
disruption in the hydrophilic-hydrophobic balance of the copolymer and potentially 
affect its self-assembly properties to form a different nanostructure. These 
morphology transition properties can, for example, be utilised for applications in 
nanotechnology and/or drug delivery.12-17  
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Previously, Baker et al. have shown that the conversion of dibromomaleimide (DBM) 
to dithiomaleimide (DTM) is highly efficient. They showed that cysteine present in 
a protein domain can be modified by addition of DBM, which forms a 
monothiomaleimide (MTM), the addition of 1 equivalent of thioglucose or 
glutathione can further functionalise the maleimide group to obtain a DTM. 
Moreover, the addition of a large excess (100 equivalents) of another thiol, in this 
case 2-mercaptoethanol, glutathione or tris(2-carboxyethyl)phosphine (TCEP) can 
lead to a full recovery of the free unmodified protein.18  
 
 
Figure 2.3. Schematic representation of the reversible modification of a protein 
with DBM. Figure reproduced from reference.18 
 
Figure 2.2. Schematic representation of different morphology adopted in 
solution depending on the amphiphilic balance of the polymer. Figure 
reproduced from reference.4  
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The addition-elimination reaction to obtain a DTM from a DBM or to change the 
DTM substituents has been shown to be more efficient in the presence of a base 
catalyst such as triethylamine,19,20 imidazole 21,22 or sodium acetate. 19,23,24 
When DTMs were found to be fluorescent emissive groups, the investigation of the 
substituent’s nature effect on the DTM’s emission led to the conclusions that DTMs 
functionalised with alkyl thiols are highly fluorescent whilst those with aromatic 
substituents show a significant decrease in fluorescence emission.19  
Previously, Robin et al. presented the incorporation of the DTM functionality into 
polymeric self-assembled nanostructure.20 The DTM functionality was first 
incorporated into a polymer via the synthesis of a DBM containing chain transfer 
agent (CTA) for reversible addition-fragmentation chain transfer (RAFT) 
polymerisation followed by a post-polymerisation modification with the addition of 
thiol.21 Orthogonal functional groups could be attached on either side of the 
maleimide group, resulting in a potentially cleavable linkage. Subsequently, the 
DTM functional group was incorporated into an amphiphilic block copolymer at the 
hydrophilic-hydrophobic interface via a similar method as mentioned above; 
utilising a DTM labelled dual initiator for ring opening polymerisation (ROP) and 
RAFT polymerisation.20 The aqueous solution-state self-assembly of this 
amphiphilic block copolymer results in the incorporation of the DTM functionality 
at the core-shell interface of spherical micelles.20  
Fluorescent labelling functionalities are often large hydrophobic groups that can 
affect the scaffold size and stability.17 The small size of the DTM functionality does 
not affect the micelles’ self-assembly as the hydrophilic-hydrophobic balance is not 
perturb; therefore allows to access fluorescently labelled micelles with very similar 
properties to the unmodified micelles. Moreover, nanostructures with fluorescence 
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properties have been of key interest owing their potential use in nanomedicine 
applications, such as sensing, imaging, and labelling for drug-deliery.25-27  
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2.3. Results and discussion 
 Synthesis of dithiomaleimide-containing polymers 
 Synthesis of the PTEGA-b-PLA2 copolymer (poly(triethylene glycol 
monomethyl ether acrylate)]-b-[poly(D,L-lactide)2)  
As mentioned in the previous section, efforts towards stimuli responsive self-
assemblies has intensified over the past decade, however only few reports tackle the 
simultaneous change of morphology and luminescence of such polymer assemblies. 
Thus, the incorporation of DTM in an amphiphilic polymer was instigated as it 
would result in highly fluorescent micelles (depending on the polymer chemistry) 
which would then be tuned through chemical stimulation. Previously, Robin et al. 
reported the preparation of spherical micelles from an amphiphilic dye-containing 
block copolymer, which was synthesised via sequential ROP28 and RAFT 
polymerisation29 utilising a dual RAFT chain transfer agent (CTA)/ROP initiator.19,20 
The design of this species ensured the location of the DTM group between the 
hydrophobic and the hydrophilic blocks, allowing the addition-elimination reaction 
to be coupled with a fluorescence emission on-to-off switch simultaneous with a 
morphology transition as a result of the change in volume fractions of the 
amphiphile components. The structure and properties of the amphiphilic copolymer 
were carefully chosen to enable a significant modification of the 
hydrophilic-hydrophobic balance along with a fluorescence emission decrease by 
changing the nature of the hydrophobic segment. Being connected to the DTM 
motif as thiol ligands, the hydrophobic segments were eliminated through 
subsequent addition-elimination with another thiol.  
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The DTM-containing ROP/RAFT dual initiator was synthesised from a 2,3-DBM-
functionalised RAFT CTA.21 Reaction with mercaptoethanol and triethylamine gave 
a fluorescent DTM-functionalised ROP/RAFT dual initiator with two hydroxyl 
groups that served as the initiating species for the ROP of rac-lactide.30  
The ROP was chosen to be performed first as it requires dry conditions and it was 
estimated that the initiator would be easier to dry than the hydrophilic PTEGA. The 
polymerisation was performed using a thiourea/(-)-sparteine catalyst, which has 
been reported to allow good control over the polymerisation with narrow molecular 
weight distribution.28 The low dispersity expected was confirmed by size exclusion 
chromatography (SEC) analysis (Ɖ = 1.13). The resulting polymer was characterised 
by 1H NMR spectroscopy (see Figure 2.4) and SEC analysis (Figure 2.5), (Mn,NMR = 6.7 
kg·mol-1, Mn,SEC = 8.1 kg·mol-1).† Fluorescence spectroscopy confirmed the presence 
of the DTM functional group in the PLA2 polymer, by showing a similar emission 
spectrum as for the initiator, see Figure 2.6. The shift in emission could be attributed 
to the difference in polarity of the solvents utilised for the measurements. 
                                                     
† Synthesis and characterisation of materials previously reported during Master’s degree 
project are marked with this symbol (†). 
 
Scheme 2.1. Synthesis of the amphiphilic block copolymer, PTEGA-b-PLA2. 
TEGA: triethylene glycol monomethyl ether acrylate , 
AIBN: azobisisobutyronitrile. 
 
Chapter 2 
48 
 
 
Figure 2.4. 1H NMR (CDCl3, 400 MHz) spectrum of PLA2.† 
 
 
Figure 2.5. Molecular weight distribution of PLA2. SEC in THF, PS calibration. † 
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initiator 
 
PLA2 
 
Figure 2.6. Fluorescence emission (green) and excitation (black) spectra of PLA2 
in chloroform at 1 mg·mL-1 (λex = 410 nm and λem = 520 nm); insert: emission 
spectrum of the initiator in methanol (λex = 450 nm); pictures of initiator and 
PLA2 under UV lamp. † 
 
The PLA2 polymer was then chain-extended to afford the diblock copolymer 
[poly(triethylene glycol monomethyl ether acrylate)]-b-[poly(rac-lactide)]2, PTEGA-
b-PLA2, see Scheme 2.1. The polymerisation was performed utilising 1 equivalent of 
initiator for 0.25 equivalents of AIBN, 110 equivalents of TEGA in chloroform for 16 
hours. The product was purified by dialysis against water. 1H NMR (Figure 2.7) and 
SEC analysis (Figure 2.8) confirmed the chain extension by showing the presence of 
both PLA and PTEGA characteristic chemical shifts, the increased molecular weight 
compare to the PLA2 precursor, and the low dispersity of the copolymer (Mn,NMR 
= 25.7 kg·mol-1, Mn,SEC = 19.5 kg·mol-1, Ɖ = 1.21). †  
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Figure 2.8. Molecular weight distribution of PTEGA-b-PLA2. SEC in THF, PS 
calibration. † 
 
  
 
Figure 2.7. 1H NMR (CDCl3, 400 MHz) spectrum of PTEGA-b-PLA2.† 
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Figure 2.9. Fluorescence emission (green) and excitation (black) spectra of 
PTEGA-b-PLA2 in chloroform at 1 mg·mL-1; λex = 410 nm and λem = 520 nm. † 
 
The presence of a fluorescence emission peak in the same region as the initiator 
further confirmed the presence of the DTM moiety in the polymer.  
 Synthesis of the PTEGA homopolymer 
 
 
Scheme 2.2. Synthesis of the PTEGA homopolymer 
 
A PTEGA homopolymer was synthesised for the comparison of the addition-
elimination reaction on both PTEGA-b-PLA2 block copolymer and PTEGA 
homopolymer, and the comparison of the properties of the respective products. The 
initiator of the block copolymer synthesis was also utilised to synthesise a PTEGA 
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homopolymer by RAFT polymerisation with 0.1 equivalent of AIBN for 1 equivalent 
of initiator and 110 equivalents of TEGA. The resulting polymer was purified by 
dialysis against water and analysed by 1H NMR (Figure 2.10), and SEC (Figure 2.11). 
The polymer was found to be of a similar DP = 75 as the PTEGA block in the block 
copolymer presented above (DP = 87), and of a low molecular weight dispersity (Ɖ 
= 1.19). Mn,NMR = 16.2 kg·mol-1, Mn,SEC = 13.5 kg·mol-1.† 
 
 
Figure 2.10. 1H NMR spectrum of PTEGA (CDCl3, 400 MHz). 
 
Figure 2.11. Molecular weight distribution of PTEGA. SEC in THF, PS calibration. 
 
Chapter 2 
53 
 
  
Figure 2.12. Fluorescence emission and excitation spectra of PTEGA in water at 
1 mg·mL;  
λex = 415 nm and λem = 535 nm. 
 
The comparative PTEGA was successfully synthesised with a similar DP as the 
PTEGA block in block copolymer PTEGA-b-PLA2. The emission spectrum confirmed 
the presence of the DTM moiety with an emission maximum at 535 nm, which is 
similar to the initiator emission maximum (see insert in Figure 2.6). However, the 
emission intensity was low, in order to detect the emission the sensitivity of the 
instrument was increased (intensities of different fluorescence emission spectra 
cannot be compared unless the instrument parameters are kept constant).  
 Self-assembly of PTEGA-b-PLA2 
After confirming that the polymers were successfully synthesised with the DTM 
intact in between the two blocks, we instigated its self-assembly in water, as the 
polymer was composed of a hydrophilic PTEGA and two hydrophobic PLAs. It was 
anticipated that the DTM would reside at the interface of the hydrophilic and 
hydrophobic regions of the self-assembly. The copolymer self-assembly was 
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achieved via direct dissolution of the copolymer in 18.2 MΩ.cm water at a 
concentration of 1 mg·mL-1, see Scheme 2.3. 
 
 
Scheme 2.3. Self-assembly of the PTEGA-b-PLA2 amphiphilic block copolymer in 
water at 1 mg·mL-1. 
 
2.3.1.3.1. Fluorescence characterisation 
The fluorescence excitation spectrum of the self-assembled polymer in 18.2 MΩ.cm 
water showed an excitation maximum at 405 nm, and an emission maximum at 
510 nm as shown in Figure 2.13, these are similar to previously reported DTM 
polymer systems.  
 
 
Figure 2.13. (left) Fluorescence emission and excitation spectra of micelles in 
water at 1 mg·mL-1, λex = 405 nm and λem = 510 nm; (right) picture of a solution of 
micelles in water at 1 mg·mL-1, λlamp = 365 nm. 
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The presence of a fluorescence emission peak at a wavelength that corresponds to 
the emission wavelength of the copolymer confirmed the fluorescence properties of 
the self-assembly in water.  
2.3.1.3.2. Size and morphology characterisation 
The size and morphology of the self-assembled polymers in water was investigated 
by light scattering and microscopy analysis. Initially, DLS measurements were 
performed at angles from 80° to 140° for a sample of PTEGA-b-PLA2 micelles at 
1 mg·mL-1 to evaluate the angular dependence of the apparent diffusion coefficient 
Dapp, see Figure 2.14. From the slope of the plot τ-1 vs. q² (Figure 2.14) Dapp was 
calculated and found to be 6.13⨯10-15 m²ms-1, a value that according to the Stokes-
Einstein equation (section 2.5.1) corresponds to a hard sphere with a hydrodynamic 
radius of 26 nm.  
  
 
Figure 2.14. Light scattering results from the self-assembly of PTEGA-b-PLA2 in 
water at 1 mg·mL-1; Plot of τ-1 vs. q². 
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Figure 2.15. Light scattering results from the self-assembly of PTEGA-b-PLA2 in 
water at 1 mg·mL-1; Plot of τ-1q-2 vs. q². 
 
The same sample was then subjected to SLS measurements to further characterise 
the self-assembled polymer. The plot of Kc/Rθ vs. q² (Figure 2.15), showed an angular 
independence of Kc/Rθ within the 10% error applied to laser light scattering 
measurements.31 A slight slope could be observed which was attributed to the fact 
that the size of the particles is close to the detection limits of the setup: for spherical 
particles with a radius smaller than λ/20 (i.e. 30 nm) there is a negligible phase 
difference between light emitted from various scattering centres within the particle. 
Thus, the scattering intensity is independent of the angle of observation, and is only 
dependent on the mass of the particle; in this case, a reliable radius of gyration could 
not be determined.  
The spherical morphology of the micelles was further analysed via synchrotron small 
angle X-ray scattering (SAXS) experiments.‡ Analysis of the SAXS curves were fitted 
to a Guinier-Porod plot (Figure 2.16) confirmed the spherical morphology with an 
Rg value of 10.2 nm, such a difference with light scattering results could be explained 
                                                     
‡ SAXS experiment and analysis performed by Dr Anaïs Pitto-Barry. 
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by the hydration of the PTEGA shell, and thus the radius visible by SAXS would 
correspond to the radius of the core and a partial layer of the shell, the one which is 
denser and near the core. 
 
Figure 2.16. SAXS profile and Guinier-Porod fit of the solution of micelles in 
water at 1 mg·mL-1.  
 
Transmission electron microscopy (TEM) was also employed to determine the 
morphology of the assembled polymers. To achieve this, a droplet of the solution 
used for light scattering measurements was allowed to dry on a graphene oxide TEM 
grid, which owing to its low thickness allows stain-free observation of the sample 
(Figure 2.17).32  
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Figure 2.17. Representative TEM image of the self-assembled polymer 
PTEGA-b-PLA2 on GO grids (scale bar = 50 nm) and size distribution of the 
observed particles. § 
 
The average diameter of the observed particles (ca. 26 nm) was smaller than the 
hydrodynamic diameter determined from dynamic light scattering (ca. 52 nm). This 
could be attributed to fact that in dry conditions, the volume of the hydrophilic layer 
is reduced by the absence of water, which in DLS analysis contributes to the size of 
the self-assembly.  
 Reactions of the dithiomaleimide-containing polymers with 
thiophenol 
 Optimisation of the reaction 
Depending on the nature of the thiol conjugated to the maleimide, the resulting 
DTM can be highly emissive or not, e.g. the fluorescence emission is drastically 
decreased when maleimides are directly conjugated to an aromatic ring.19 In order 
to induce a dual response through one stimulus for the polymer self-assemblies, 
thiophenol was chosen as the chemical stimulus, as upon thiol exchange with the 
thio-poly(lactide) hydrophobic segment, the fluorescence was expected to be 
                                                     
§ TEM image was acquired by Dr Anaïs Pitto-Barry. 
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reduced and the amphiphilic character of the polymer changed. The reaction 
conditions were first optimised utilising an analogous small molecule model system: 
di(thioethanol)maleimide in lieu of the polymer. The first conditions tested for this 
reaction were inspired from the DTM syntheses presented by Muus et al.22 and 
Robin et al. 21 The first conditions utilised were 1:2:2 (DTM, thiophenol, imidazole) 
in THF but no conversion was observed over the 15 hours of monitoring by TLC, 
which could be attributed to the lack of excess of reagents. Then, the ratio were 
increased (1:5:5, 1:10:10) to push the reaction toward the product, but even with 
1:10:10, no conversion was observed. Since the polymer was self-assembled in water, 
the reaction was also tested in water with a 1:10:10 ratio, some product was observed 
by HPLC but the conversion was too low to be isolated. The same reaction was tested 
without the imidazole catalyst to confirm its effect and the product was obtained 
with the same conversion, so the following attempts were performed without the 
imidazole catalyst. The ratios were further increased to 1:20 and 1:50 (DTM: 
thiophenol), and a drastic increase in conversion was observed.  
The conclusions of these optimisation experiments were that the reaction can occur 
in the absence of imidazole, water seems to be a good solvent for the reaction and 
the optimum number of molar equivalents of thiophenol is 20 for 1 equivalent of 
DTM. Moreover, the reaction was monitored by HPLC and a complete consumption 
of the starting material (1) was observed 10 min after the addition. The different 
peaks were identified utilising purified solution of each compound, the starting 
material was also detectable by the HPLC fluorescence detector. 
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Figure 2.18. HPLC traces of the reaction mixture before the reaction and 10 min 
later; 1 is the starting material, 2 is thiophenol, 3 is the mono-substituted 
product, and 4 is the di-substituted product.†  
 
 Reaction of PTEGA-b-PLA2 micelles with thiophenol 
Based on the results obtained from the reaction of thiophenol with the small DTM 
model compound it was hypothesised that the optimised conditions, i.e. water, 20 
equivalents of thiophenol, were suitable for the reaction of thiophenol with the DTM 
derivative of the micelles. The PTEGA-b-PLA2 micelle solution was treated with 20 
equivalents of thiophenol, and then purified by exhaustive dialysis (MWCO = 1 kDa) 
against water. It was anticipated that the addition of thiophenol to the micelle 
solution would result in the addition of thiophenol to the maleimide and 
synchronous elimination of two thiol terminated PLAs. 
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Scheme 2.4. Reaction of PTEGA-b-PLA2 copolymer in water at 1 mg·mL-1 with 
thiophenol.  
 
When the reaction was performed in water, a precipitate was observed; it was 
assumed this precipitate is the water-insoluble PLA. Despite the results observed 
with the model reaction (section 2.3.2.1), a small amount of organic solvent 
(dioxane, THF) was added in an attempt to improve the solubility of the detached 
PLA in the reaction mixture. The percentage of organic solvent in water was 
increased up to 20 vol%, but in all cases the PLA-SH residue was found to be 
insoluble in the reaction mixture. Further increase of the organic solvent ratio was 
found to interfere with the formation of micelles as a consequence of the increased 
solubility of the two blocks in the medium, thus preventing segregation and 
subsequent self-assembly. Therefore, the reaction was performed in water and the 
resultant heterogeneous solution was centrifuged to remove the precipitate which 
was confirmed by 1H NMR spectroscopy to be mainly composed of PLA (Figure 2.19). 
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Figure 2.19. 1H NMR (400 MHz, CDCl3) spectrum of the PLA-SH, obtained after 
separation following the addition-elimination reaction compared to 1H NMR 
spectrum of the starting block copolymer PTEGA-b-PLA2. The characteristic 
signal of the PLA protons is highlighted at 5.2 ppm while the absence of the 
characteristic TEGA proton signals at 4.2 ppm is also indicated. 
 
In order to further confirm the successful scission of the block copolymer into the 
corresponding homopolymers, SEC characterisation was employed to compare the 
chromatograms of the parent copolymer with the two isolated polymers, i.e. the 
dissolved polymer and the precipitate.  
Chapter 2 
63 
 
 
Figure 2.20. Molecular weight distributions of PLA2, PTEGA-b-PLA2, PTEGA-
SPh, and PLA-SH. SEC in THF, PS calibration. 
  
Sample Mn,SEC (kg·mol-1) 
PLA2 8.1 
PTEGA-b-PLA2 19.5 
PTEGA-SPh 10 
 
The SEC chromatograms showed a clear decrease of the molecular weight upon 
exposure to thiophenol (PTEGA-b-PLA2 vs. PTEGA-SPh). The SEC chromatogram of 
the PTEGA-SPh exhibiting a tailing could correspond to residual cleaved PLA-SH. 
The trace of the isolated PLA precipitate showed a double peak, corresponding to 
half of the PLA2 molecular weight and also an equivalent molecular weight of PLA2, 
these could be attributed to the cleaved PLA-SH and possibly a disulfide bridging 
between two PLA-SH chains. 
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It was shown that the reaction of thiophenol with the DTM moiety present at the 
interface between the PTEGA block and the PLA2 block was successful and the 
majority of the PLA residue could be removed from the reaction mixture.  
2.3.2.2.1. Characterisation of the fluorescence emission upon exposure to thiophenol  
Along with a structure modification, the purpose of the addition of thiophenol was 
also to alter the fluorescence emission of the polymer. The fluorescence emission 
was monitored via steady state fluorescence spectroscopy and time-resolved 
fluorescence spectroscopy.  
The examination of the emission spectrum of the resultant solution of PTEGA-SPh 
indicated a drastic decrease of the fluorescence as a result of the modification at the 
DTM reactive centre. At the same excitation wavelength, the comparison of the 
emission spectra of the solution before and after the reaction (measured at the same 
concentration) showed a decrease in the intensity of the maxima (510 nm) from 730 
to 30 a.u, see Figure 2.21. 
 
Figure 2.21. Fluorescence emission spectra before (dash line) and after the 
reaction (solid line) in water at 1 mg·mL-1, with an excitation wavelength of 405 
nm. 
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The decrease in fluorescence emission intensity was also monitored over time, after 
the addition of thiophenol, a drastic intensity decrease can be observed in less than 
10 min, see Figure 2.22.  
 
Figure 2.22. Variation of fluorescence emission maxima at 510 nm over time 
before and after addition of thiophenol to micelles in water at 1 mg·mL-1; 
excitation wavelength 405nm. 
 
The results obtained confirmed the expectation of a quick fluorescence switch off 
upon reaction of the copolymer PTEGA-b-PLA2 with thiophenol.  
2.3.2.2.2. Morphology transition characterisation 
The expected result of the reaction was to simultaneously quench the fluorescence 
emission and induce the micelles’ disassembly as a result of the disruption of the 
hydrophilic/hydrophobic balance of the self-assembled nanostructure. Instead of 
the expected disassembled micelles, another nanostructure was observed. This 
nanostructure appeared to be of a larger diameter than the starting spherical 
micelles. Although the structural modification was not expected, the fluorescence 
emission switch off occurred simultaneously. 
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(i) Analysis by DLS/SLS 
The morphology of the assemblies obtained following the reaction of micelles with 
thiophenol was characterised via multi-angle laser light scattering.  
From the DLS data, the hydrodynamic radius Rh was found to be 56 nm, see Figure 
2.23.c. The angular independence of the apparent diffusion coefficient showed in 
Figure 2.23 (a, b).  
 
Figure 2.23. Light scattering results from the self-assembly of PTEGA-SPh in 
water at 2 mg·mL-1; (a) Plot of τ-1 vs. q²; (b) Plot of Kc/Rθ vs. q². 
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Interpretation of the data collected in static light scattering (SLS) mode, using 
CONTIN analysis, allowed to plot Kc/Rθ vs. q² (see Figure 2.23.d), which showed an 
angular dependence of Kc/Rθ. The radius of gyration Rg can be determined from the 
slope (𝑎) of the linear regression of this plot, according to the Zimm equation: 
 𝑅𝑔 = √𝑎3𝑀W and it was found to be 51 nm.  
As previously mentioned, the ratio of Rg/Rh can give an indication on the 
nanostructure morphology, 0.775 indicating a solid spherical micelle and 1 
indicating a hollow vesicular structure.33 In this case, Rg/Rh was calculated to be 0.91, 
suggesting the formation of hollow vesicular nanostructures. 
It was proposed that the vesicles hydrophobic layer could be composed of both the 
substituted maleimide group (containing the –SPh ligands) and dodecyl end group 
(the RAFT agent Z-group). This was consistent with previous reports which have 
shown that hydrophilic polymers with hydrophobic aromatic and aliphatic end-
groups can self-assemble into nanoparticles, including vesicles.34-37 
(ii) Analysis by SAXS** 
To further probe the proposed micelle-to-vesicle transition upon thiophenol 
addition, synchrotron SAXS experiments were performed. The reaction was 
performed in the beamline and the in situ kinetics of the morphology transition were 
examined. Analysis of the SAXS curves over a 20 minutes time period indicated a 
change of morphology, see Figure 2.24. An increase in the size of the morphologies 
in solution happened promptly (less than 10 min) and after 18 minutes, the form 
factor fit indicated the formation of vesicles as well as the presence of random chains 
in solution (PLA in solution). 
                                                     
** All SAXS experiments and analyses were performed by Dr Anaïs Pitto-Barry. 
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At the beginning, a spherical morphology was observed, see Figure 2.25. The 
Guinier-Porod fit gave an Rg value of 12 nm, and the PolyCoreForm function†† 38,39 
used for this fit was considered as a uniform micelle with some dispersity (PD = 0.3), 
a radius of 14 nm was obtained, which fitted well with the Rg obtained with the 
Guinier-Porod plot. The scattering length density of the micelle was found slightly 
higher than usual for lactide, which suggested the incorporation of some PTEGA in 
this layer. 
                                                     
†† This function is used to calculate the form factor of polydisperse spherical particles with a 
core-shell scaffold.  
 
Figure 2.24. SAXS profiles for the in situ micelle-to-vesicle transition in water at 
1 mg·mL-1. 
 
 
Figure 2.25. SAXS profile and fits of the reaction mixture (in water at 1 mg·mL-1) 
at t = 3 min. 
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Figure 2.26. (top) SAXS profile and fits of the reaction mixture (in water at 
1 mg·mL-1) at t = 18 min; (bottom) SAXS data after 18 min showing the Sum 
model and the different contributions. 
After 18 minutes, the Guinier-Porod fit gave an Rg value of 20 nm (see Figure 2.26), 
which was lower than the value determined by LS. Again, the hydration of PTEGA 
does not allow for the polymer to be entirely visible by SAXS. A PolyCoreForm 
function with a core-shell structure was fitted to the experimental curve for q values 
below 0.025 Å-1, which suggested the presence of another morphology with poorly-
defined form factor in the solution. This correlates well with the presence of 
polylactide in solution. Polylactide being hydrophobic, it tends to form collapsed 
coils in water, which was confirmed by a Debye fit. To further confirm the presence 
of these two structures in solution, a linear combination of the PolyCoreForm 
function with a core-shell structure and Debye fits was performed. This Sum model 
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confirmed the structure of vesicles with a large dispersity on the core. These vesicles 
seemed to have a core full of water with a radius of 4 nm and a shell of PTEGA with 
a thickness of 19 nm. These values were similar to the ones obtained with the 
PolyCoreForm function for vesicle alone, and were in good agreement with the 
Guinier-Porod fit. The addition of random coil polymer allowed for a better fit for q 
values above 0.025 Å-1. The vesicle contribution was much more important at low q 
than the Debye one, for q above 0.015 Å, the two models contributed more equally, 
see Figure 2.26 (bottom). The evolution of SAXS curves and their fit at different 
times showed the transition, see Figure 2.27. A Guinier-Porod used for each curve 
provided general information on the shape and size of the sample in solution (see 
values in Table). The values followed a trend: bigger particles were obtained after 
the reaction, and they were more spherical than at the beginning of the reaction. A 
transition from spherical micelle to vesicle was confirmed by the change of shape of 
the raw data curves and the incorrect fit provided by the micelle model after 7 min.  
 
 
Figure 2.27. SAXS curves and fit at different time points during the reaction in 
water at 1 mg·mL-1. 
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(iii) TEM imaging 
Unfortunately, attempts to image the vesicles by dry-state TEM, were not possible 
as the nanostructures were not stable to dehydration and hence no structure were 
observed upon drying and TEM analysis. 
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 Model thiophenol-functional PTEGA 
To further probe the vesicle formation which was observed in the micelle-to-vesicle 
transition (see Scheme 2.5), the addition-elimination reaction was performed on a 
model homopolymer. 
 
2.3.2.3.1. Characterisation of the fluorescence emission intensity decrease 
The reaction of PTEGA with thiophenol would be expected to induce a fluorescence 
emission decrease. Indeed, the comparison of the emission spectra before and after 
the reaction showed the clear decrease in intensity, see Figure 2.28.  
 
Figure 2.28. Fluorescence emission spectra before (dash line) and after the 
reaction (solid line) in water at 1 mg·mL-1, excitation wavelength at 415 nm. 
 
Scheme 2.5. Schematic representation of the two different routes to obtain 
PTEGA vesicles. 
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As observed for the addition-elimination reaction with the micelles, the 
fluorescence emission of the homopolymer solution again underwent a fast on-to-
off switch (15 min by analysis of the 535 nm emission) during the reaction with 
thiophenol, see Figure 2.29.  
 
Figure 2.29. Variation of the fluorescence emission maxima at 535 nm over time 
before and after the reaction in water at 1 mg·mL-1; excitation wavelength 415 nm. 
 
Similarly to the reaction of PTEGA-b-PLA2 micelles with thiophenol, the reaction of 
the PTEGA homopolymer with thiophenol resulted in the same fluorescence 
emission decrease.  
2.3.2.3.2. Characterisation of the self-assembly 
The product of the reaction of PTEGA and thiophenol being the same as the product 
of the reaction of PTEGA-b-PLA2 with thiophenol, the potential formation of a 
nanostructure was also investigated. DLS analysis of aqueous solutions of the initial 
PTEGA homopolymer (which possesses α-diol and ω-dodecyl end-groups), 
indicated the presence of unimers in solution. However, after the addition-
elimination reaction between PTEGA and an excess of thiophenol, well-defined 
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nanostructures were observed, MA-LLS was performed, and values of Rg and Rh were 
extracted from the results.  
 
Figure 2.30. Light scattering results from the self-assembly of PTEGA-SPh in 
water at 1 mg·mL-1; (a) Plot of τ-1 vs. q², (b) Plot of Kc/Rθ vs. q². 
 
By interpreting the data collected in SLS mode (see Figure 2.30), Rg was found to be 
63 nm. From the DLS data, Rh was calculated utilising the Zimm equation and found 
to be 68 nm. Hence the Rg/Rh obtained was 0.93, which once again suggested that 
the nanostructures formed in this reaction were vesicles. Similarly to the vesicles 
previously observed, resulting from the reaction of the PTEGA-b-PLA2 micelles with 
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thiophenol, the reaction of the PTEGA homopolymer with thiophenol formed self-
assemblies of a similar size and morphology. This is understandable as the addition-
elimination reaction of PTEGA-b-PLA2 and PTEGA would be expected to give the 
same resultant homopolymer, namely PTEGA-SPh homopolymer with α-SPh and ω-
dodecyl end-groups, which would be expected to assembly into similar 
morphologies, as showed in Scheme 2.5. 
 
  
Chapter 2 
76 
 
2.4. Conclusions 
A fluorescence on-to-off emission switch simultaneously with a fast micelle-to-
vesicle morphology transition were presented. The transition’s triggering reaction 
was an addition-elimination: an excess of thiophenol reacting with the DTM present 
at the hydrophilic/hydrophobic interface; eliminating the hydrophobic block. The 
suggested driving force for the formation of vesicles was the combination of both 
end-groups hydrophobicity. A unimer-to-vesicle transition also occurred for a DTM 
group-containing homopolymer as the end-group was modified via the same 
triggering reaction. These experiments highlighted the high reactivity of the DTM 
functional group toward thiols present in its environment and the ability to switch 
the fluorescence emission depending on the DTM substituents. This versatile system 
could be tuned for utilisation of different aromatic thiol and could be used for 
release monitoring in self-assembled systems. Further investigation into tuning the 
system to obtain a fluorescence emission switch-on simultaneously with the 
disassembly of the vesicle could extend the potential of the system.  
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2.5. Experimental 
 Materials and methods 
Chemicals were used as received from Aldrich, Fluka and Acros. Dry solvents were 
obtained by passing over a column of activated alumina using an Innovative 
Technologies solvent purification system. TEGA was synthesised by Mathew Robin 
as previously reported and stored below 4 °C.40  
1H and 13C NMR spectra were recorded on a Bruker DPX-400 spectrometer in CDCl3. 
Chemical shifts are given in ppm downfield from the internal standard 
tetramethylsilane (TMS).  
Size exclusion chromatography (SEC) measurements were conducted using a Varian 
390-LC-Multi detector suite fitted with differential refractive index (DRI), light 
scattering (LS) and photodiode array (PDA) detectors equipped with a guard column 
(Varian Polymer Laboratories PLGel 5 μm, 50×7.5 mm) and two mixed D columns 
(Varian Polymer Laboratories PLGel 5 μm, 300×7.5 mm). The mobile phase was 
either tetrahydrofuran (THF) with 2% triethylamine (TEA) at 40 °C operating at a 
flow rate of 1.0 ml·min-1 and data was analysed using Cirrus v3.3 with calibration 
curves produced using Varian Polymer laboratories Easi-Vials linear poly(styrene) 
or poly(methyl)methacrylate standards.  
Multi-angle Laser Light Scattering (MA-LLS) measurements were performed at 
angles of observation ranging from 30° up to 150° with an ALV CGS3 setup operating 
at λ0 = 632 nm and at 25 ± 1 °C, the data was collected with 100 s run time in duplicate 
unless otherwise specified. Calibration was achieved with filtered toluene and the 
background was measured with 18.2 MΩ.cm water. Electric field autocorrelation 
functions (g1 (q,t)) were fitted with CONTIN. In DLS mode, the apparent diffusion 
coefficient of the particles (Dapp) is determined from the relaxation time (τ) for a 
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specific concentration (see equation 2.1). The hydrodynamic diameter Rh is 
calculated using the Stokes-Einstein equation (2.2), in which kB is the Boltzmann 
constant, T the temperature and η the viscosity. In SLS mode, the Zimm equation 
(2.3) allows determination of different parameters: the radius of gyration (Rg), the 
particle’s molecular weight (Mw) and the second virial coefficient (A2). 
 
𝜏−1 = 𝐷𝑎𝑝𝑝𝑞
2 (2.1) 
 
𝑅ℎ =
𝑘𝐵𝑇
6𝜋𝜂𝐷0
 (2.2) 
 𝐾𝑐
𝑅𝜃
=
𝑞2𝑅𝑔
2
3𝑀𝑊
+
1
𝑀𝑊
+ 2𝐴2𝑐 
(2.3) 
 
Synchrotron small-angle X-ray scattering (SAXS) measurements were carried on the 
SAXS/WAXS beamline at the Australian Synchrotron facility at a photon energy of 
11 keV. The samples in solution were run by using a 1.5 mm diameter quartz capillary. 
Temperature was held at 25 °C and controlled via a water bath connected to a brass 
block which is part of the sample holder. The measurements were collected at a 
sample to detector distance of 7.323 m to give a q range of 0.02 to 0.14 Å-1. All 
patterns were normalised to fixed transmitted flux using a quantitative beamstop 
detector. The scattering from a blank was measured in the same capillary and was 
subtracted for each measurement. The two-dimensional SAXS images were 
converted into one-dimensional SAXS profile (I(q) versus q) by circular averaging, 
where I(q) is the scattering intensity. The functions used for the fitting from the 
NIST SANS analysis package were “Guinier-Porod”,41,42 “Debye”43 and 
“PolyCoreForm”.38 ScatterBrain44 and Igor45 were used to plot and analyse the data. 
The scattering length density of the solvent and the monomers were calculated using 
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the “Scattering Length Density Calculator”46 provided by NIST Centre for Neutron 
Research. Limits for q range were applied for the fittings from 0.002 to 0.1 Å -1.  
Solutions of graphene oxide were synthesised as reported previously. Aqueous 
solutions of graphene oxide (0.10 mg.mL− 1) were sonicated for 30 s prior to use. 
Lacey carbon grids (400 Mesh, Cu) (Agar Scientific) were cleaned using air plasma 
from a glow-discharge system (2 min, 20 mA). The TEM grids were placed on a filter 
paper and one drop ( ≈ 0.08 mL) of the sonicated GO solution was deposited onto 
each grid from a height of ≈ 1 cm, allowing the filter paper to absorb the excess 
solution, and the grids were left to air-dry in a dessicator cabinet for ≈ 60 min. 4 μL 
of the nanoparticle dispersion (~20 ppm) was pipetted onto a GO grid and left to 
air-dry in a dessicator cabinet for ≈ 60 min. Bright field TEM images were captured 
with a transmission electron microscope (JEOL TEM-2011), operating at 200 kV.  
Fluorescence spectra were recorded using a Perkin-Elmer LS 55 Fluorescence 
Spectrometer. 
 Specific safety procedures 
All work with thiols was carried out in an efficient fume cupboard and on the 
smallest scale possible. Disposable gloves were used, changed regularly. All 
materials (gloves, paper towels, glassware) utilised to work with thiol were 
decontaminated with the thiol killing solution.47-49 
Sulfide Oxidiser (thiol killing solution): 
% by weight: 3% cyclohexane, 82% water, 5% sodium dodecyl sulfate, 10% 
butan-1-ol, 1 ml of sulfide in 15 ml of microemulsion. Add 5% aqueous sodium 
hypochlorite solution (undiluted bleach) in 2-fold excess. Takes approximately 15 
seconds to kill smell.  
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 Synthetic procedures 
 Dual RAFT/ROP initiator synthesis 
The synthesis of the initiator was concluded in four steps, the three first steps are 
based on procedures from the literature.19,21,50  
2.5.3.1.1. First step 
Synthesised as reported by Petzetakis et al.50 
 
For the first step, potassium phosphate (3.725 g, 17.5 mmol) was dissolved in acetone 
(300 mL) with carbon disulphide (3 mL, 49.5 mmol) and dodecanethiol (3.8 mL, 
15.9 mmol) and the reaction was stirred for 2 hours at room temperature. Then, 
4-(chloromethyl)benzyl alcohol (2.5 g, 15.9 mmol) was added to the mixture and 
stirred for 24 h at room temperature. The solvent was removed under vacuum and 
the solid was dissolved in DCM (200 mL). The organic layer wash washed with HCl 
(1M, 150 mL x 2), water (3 x 150 mL), brine (150 mL), dried with MgSO4 and filtered. 
The solvent was evaporated under vacuum. The crude product was a yellow solid 
which was washed with hexanes (200 mL x 3). The pure product is a yellow solid 
(3.49 g, 55 %). 1H NMR (400 MHz, CDCl3) δ 7.35-7.30 (4H, m, H8 & H9), 4.67 (2H, 
s, H11), 4.61 (2H, s, H6), 3.36 (2H, t, J = 7.5 Hz, H4), 1.73-1.66 (3H, m, H3 & H12), 
1.43-1.26 (18H, m, H2), 0.88 (3H, t, J = 7.0 Hz, H1).  
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2.5.3.1.2. Second step 
Synthesised as reported by Robin et al.21 
 
For the second step, the yellow solid (3.4 g, 8.53 mmol) was dissolved in dry diethyl 
ether (75mL) and dry dimethylformamide (15mL) at 0 °C, then was added 
phosphorous tribromide (0.8 mL, 8.53 mmol). The reaction was stirred under inert 
N2 atmosphere at room temperature for 3 hours. The crude product was added to 
diethyl ether (100 mL) and washed with sodium hydrocarbonate (3 x 100 mL), water 
(2 x 100 mL) and brine (100 mL). The organic layer was dried with MgSO4 and the 
solvent was removed in under vacuum. The crude product was purified via column 
chromatography (30:1 pet. ether : ethyl acetate). The pure product is a yellow solid 
(2.81 g, 71 %). Rf = 0.77. 1H NMR (300 MHz, CDCl3) δ 7.35-7.30 (4H, m, H8 & H9), 
4.60 (2H, s, H6), 4.47 (2H, s, H11), 3.37 (2H, t, 2J = 7.5 Hz, H4), 1.75-1.65 (2H, quin., 
2J = 7.5 Hz, H3), 1.43-1.26 (18H, m, H2), 0.88 (3H, t, J = 7.0 Hz, H1). 
2.5.3.1.3. Third step 
Synthesised as reported by Robin et al.21 
 
For the third step, the yellow solid from the second step (2.8 g, 6.1 mmol) was 
dissolved in acetone (45 mL), 2,3-dibromomaleimide (1.7 g, 6.7 mmol) and crushed 
anhydrous potassium carbonate (0.92 g, 6.7 mmol) were added to the mixture. The 
reaction was stirred at room temperature for 24 hours. The solvent was removed 
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under vacuum. The crude product was added to DCM (100 mL) and washed with 
water (3 x 100 mL) and brine (2 x 100 mL). The organic layer was dried with MgSO4 
and the solvent was removed under vacuum. The crude product was purified via a 
column chromatography (gradient 1:2 DCM: pet. ether then 2:3 DCM: pet. ether and 
finally 1:1 DCM: pet. ether). The pure product is a yellow solid (1.36 g, 35 %). 1H NMR 
(400 MHz, CDCl3) δ 7.33-7.28 (4H, m, H8 & H9), 4.72 (2H, s, H11), 4.58 (2H, s, H6), 
3.36 (2H, t, 2J = 7.5 Hz, H4), 1.73-1.65 (2H, quin., 2J = 7.5 Hz, H3), 1.41-1.26 (18H, m, 
H2), 0.88 (3H, t, J = 7.0 Hz, H1). 
2.5.3.1.4. Fourth step 
Synthesis as reported by Robin et al.19  
 
For the last step, the yellow solid from the third step (0.7 g, 1.1 mmol) was dissolved 
in THF (10 mL) and cooled to 0 °C. TEA (0.38 mL, 2.75 mmol) and mercaptoethanol 
(0.19 mL, 2.75 mmol) were added to the mixture. The reaction was stirred for 3 
hours, allowing to warm to room temperature. The solvent was removed under 
vacuum, the crude product was dissolved in DCM (150 mL) and washed with water 
(2 x 100 mL) and brine (100 mL). The product was purified via a column 
chromatography (1:2 pet. ether: ethyl acetate). The pure product is a yellow solid 
(0.25 g, 35 %). Rf = 0.47. 1H NMR (400 MHz, CDCl3) δ 7.30-7.28 (4H, m, H8 & H9), 
4.63 (2H, s, H11), 4.58 (2H, s, H6), 3.83 (4H, t, 2J = 6.0 Hz, H15), 3.47 (4H, t, 2J = 6.0 
Hz, H14), 3.36 (2H, t, 2J = 7.5 Hz, H4), 1.73-1.65 (2H, quin., 2J = 7.5 Hz, H3), 1.59 (2H, 
m, H16), 1.41-1.26 (18H, m, H2), 0.88 (3H, t, J = 7.0 Hz, H1) ; 13C NMR δ223.6 (C5), 
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166.2 (C12), 136.4 (C13), 135.4 (C7), 135.1 (C10), 129.6 (C8), 128.7 (C9), 62.1 (C15), 41.9 
(C11), 40.8 (C6), 37.1 (C4), 34.7 (C14), 32-22 (C2-3), 14.1 (C1) ; (MaXis) m/z found 
652.1688, calc. 652.1688 (M+Na, 100 %) ; FTIR ν3258 cm-1 (alcohol), 1763 cm-1 
(maleimide), 1700 cm-1 (maleimide), 1524 cm-1 (aromatic), 1466cm-1 (aromatic) ; 
Fluorescence in methanol λem = 545 nm, λex = 450 and 370 nm. 
 Polymer syntheses 
2.5.3.2.1. Polylactide block, PLA2 
The PLA was synthesised by ring opening polymerisation (ROP), this reaction has 
been set up in the glove-box to be free of water. A thiourea/sparteine co-catalyst 
system was used as previously reported.28 
The dual RAFT/ROP initiator (70 mg, 0.11 mmol) dissolved in dry DCM (2 mL) was 
added to a mixture of rac-lactide (0.641 g, 4.4 mmol) and thiourea catalyst (82.3 mg, 
0.22 mmol) in dry DCM (4.41 mL). Then (-)-sparteine (25.5 µL, 0.11 mmol) was 
added and the reaction was stirred at room temperature for 2 hours to a monomer 
conversion > 99%. Out of the glove-box, the resultant polymer was precipitated in 
hexane (200 mL) and filtered. The crude polymer was dissolved in CH2Cl2 and 
precipitated in hexane (200 mL). The polymer was purified via a prep GPC column 
(Bio-beads). The pure polymer is a yellow solid (0.5293 g, 74 %). Mn,SEC = 8.1 g·mol-1 
; Mn,NMR = 6.7 kg·mol-1; Ð = 1.13, see Table 2.1 for the details. Fluorescence in CHCl3 
λem = 520 nm, λex = 410 and 275 nm. 1H NMR spectrum shown in Figure 2.4, 
molecular weight distribution shown in Figure 2.5 and fluorescence spectra shown 
in Figure 2.6. 
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2.5.3.2.2. PTEGA-b-PLA2 block copolymer  
PLA2 (25 mg, 3.7 µmol, 1 eq.), TEGA (79.9 µL, 0.4 mmol, 110 eq.), AIBN (261 µg, 0.1 
eq.), CDCl3 (240 µL) were added to a polymerisation ampoule. The solution was 
degassed by three freeze-pump-thaw cycles, the ampoule was sealed under N2 and 
the reaction was stirred at 60 °C. A conversion sample was taken at the end of the 
reaction. The product as purified by dialysis (MWCO 6-8000 Da) against distilled 
water and dried by lyophilisation. The pure polymer is a yellow oil. Mn,NMR = 25.7 
kg·mol-1, Mn,SEC = 19.5 kg·mol-1, Ɖ = 1.21, see Table 2.1 for the details. 1H NMR 
spectrum shown in Figure 2.7, molecular weight distribution shown in Figure 2.8 
and fluorescence spectra shown in Figure 2.9. 
2.5.3.2.3. PTEGA homopolymer 
The initiator (10 mg, 1 eq.), TEGA (0,343 mL, 110 eq.), AIBN (261 µg, 0.1 eq.) were 
dissolved in CHCl3 and added to a polymerisation ampoule. The solution was 
degassed by three freeze-pump-thaw cycles, then sealed under N2 and the reaction 
was stirred at 60 °C for 16 hours. The polymer was purified by dialysis (MWCO 
6,000-8,000 Da) against DI water and dried by lyophilisation. The pure polymer is 
a yellow oil. Mn,NMR = 16.2 kg·mol-1, Mn,SEC = 13.5 kg·mol-1, Ɖ = 1.19, see Table 2.1 for 
the details. 1H NMR spectrum shown in Figure 2.10, molecular weight distribution 
shown in Figure 2.11 and fluorescence spectra shown in Figure 2.12. 
 
Table 2.1. Characteristic of the different polymers synthesised. 
polymer Conv. Mth (kg·mol-1) Mn,NMR (kg·mol-1) Mn,SEC (kg·mol-1) Đ DP 
PLA2 >99% 6.4 6.7 8.1 1.13 42 
PTEGA-
b-PLA2 
82% 33.1 25.7 19.5 1.21 
87-
42 
PTEGA 95% 24.6 16.2 13.5 1.19 75 
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 Reaction of the self-assembled PTEGA-b-PLA2 with thiophenol  
20 Equivalents of thiophenol were added to the solution of self-assembled PTEGA-
b-PLA2. The reaction was stirred at room temperature for 1 h. The mixture was 
purified via exhaustive dialysis (MWCO = 1000 Da) against 18.2 MΩ.cm water to 
remove the excess thiophenol, centrifuged to separate the precipitate PLA-SH and 
freeze-dried. The resultant solid PTEGA-SPh was re-suspended at 1 mg·mL-1 to give 
a solution of vesicles. 
 Reaction of the PTEGA homopolymer with thiophenol 
The PTEGA homopolymer was dissolved in 18.2 MΩ.cm water at 1 mg·mL-1 and 20 
equivalents of thiophenol were added to the solution. The reaction was stirred at 
room temperature for 1 h. The mixture was purified via exhaustive dialysis (MWCO 
= 1,000 Da) against 18.2 MΩ.cm water to remove the excess of thiophenol and 
freeze-dried. The resultant solid PTEGA-SPh was re-suspended at 1 mg·mL-1 to give 
a solution of vesicles. 
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2.6. Notes 
† This symbol was used to tag materials synthesised and characterised during 
Master’s degree project.  
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3.1. Abstract 
This chapter presents the synthesis of a library of amino-substituted maleimides: a 
new class of highly emissive compounds, with large Stokes shifts (>100 nm) and high 
fluorescence quantum yields (up to ~60%). The emission of this dye is responsive to 
its environment with both a red-shift, and quenching, observed in protic polar 
solvents. These compounds can easily be functionalised and provide a versatile 
fluorescent probe. This new class of fluorophore can be divided in two main 
subcategories, the monoaminomaleimides (MAMs) and the 
aminobromomaleimides (ABMs), depending on the precursor utilised, see Figure 
3.1.* 
 
 
Figure 3.1. Schematic representation of the synthesis of aminomaleimide and 
pictures of the reagent and product.1 
 
 
  
                                                     
* MAMs were synthesised and analysed by Dr Mathew Robin. 
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3.2. Introduction 
Fluorophores play an important role as probes in biological systems, for imaging, 
and for the study of dynamic processes.2-8 These choices of application result from 
the high sensitivity and ease of measurement for fluorescence emission, and the 
responsiveness of dyes to the physical nature of their environment – for example 
solvatochromism. A solvatochromic shift is observed when the absorption and 
emission wavelengths shift depending on the solvent polarity.9 The response of 
fluorophores to chemical stimuli is also highly desirable, and is frequently utilised 
in the study of conjugation to biological macromolecules.10 One mechanism for 
response is the conversion of a latent quenched fluorophore to an emissive 
fluorophore upon the application of the desired chemical stimulus.11,12 Quenching 
occurs both with direct conjugation of maleimide to fluorophore (as a consequence 
of maleimide’s low lying nπ* state providing a non-radiative pathway for excited 
state decay13-15) and also where maleimide and fluorophore are joined by a spacer 
group (as a consequence of photo-induced electron transfer (PET) to the C=C double 
bond).16-18 By this process, N-fluorophore maleimides have been used as fluorescent 
probes for the detection of thiols such as cysteine, homocysteine and glutathione. 
Bis-maleimides have been used to allow detection of bis-thiols (including reduced 
disulfides),19-21 and maleimide-functional probes have been used for protein 
labelling22 and both single and two-photon imaging of cells where they allow 
detection of thiol functional peptides.19,21,23-26 Response to chemical stimuli can also 
be achieved when the reaction of two non-fluorescent species leads to the 
generation of a fluorophore. For example the highly efficient tetrazole-
alkene/azirine-alkene cycloaddition results in an emissive pyrazoline product.27 This 
cycloaddition reaction has been used to fluorescently label proteins both in vitro and 
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within live cells,28-30 and for the construction of labelled polymer conjugates with 
silicon and cellulose surfaces,31-33 and with proteins (PEGylation).34 
An alternative fluorophore-generating reaction was previously reported in our 
group, whereby the addition of two equivalents of an alkyl thiol to 
2,3-dibromomaleimide (DBM) generates the dithiomaleimide (DTM) fluorophore, 
see Scheme 3.1.35 In these compounds rather than quenching emission, the 
maleimide forms the fluorophoric centre. This off-to-on emission switch upon thiol 
addition has been used in protein labelling (including disulfide bridging),35 polymer 
and polymer nanoparticle labelling,35-39 and the formation of polymer-protein 
conjugates.35 Furthermore, as a consequence of the reversibility of thiol addition to 
DBM40 the alkyl thiols of emissive DTMs can be replaced with aromatic thiols, the 
result being the formation of a non-emissive DTM. This on-to-off switch has been 
used as an indicator of polymer nanostructure morphology transition.37 
Previous reports have shown that incorporation of the maleimide group into 
extended π-systems gives a range of dyes with fluorescence quantum yields (Φf) of 
up to 100%, emission maxima ranging from 460-680 nm, and often large Stokes 
shifts (> 100 nm).41-46 There are also scattered reports of emissive maleimides with 
heteroatom substitutions,47-49 although a thorough investigation has been lacking.  
The ability to form a fluorophore by amino-substitution of a bromomaleimide is of 
particular interest as a consequence of the prevalence and availability of amine 
groups in biological substrates. 
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3.3. Results and discussion 
3.3.1. Synthesis of aminomaleimides 
A library of monoaminomaleimides (MAMs) and aminobromomaleimides (ABMs) 
was constructed. These compounds were synthesised through an addition-
elimination reaction with monobromomaleimide (MBM) or 2,3-dibromomaleimide 
(DBM), see Scheme 3.1.  
 
 
Scheme 3.1. Reaction of DBM or MTM with thiols or amines to obtain DTM, 
MTM, ABM, or MAM.  
 
The first objective was to compare the previously reported dithiomaleimide 
fluorophore with the novel aminomaleimide compounds. The thiomaleimides used 
for the purpose of this comparison were dithiobutylmaleimide (DTM-1) and 
monothiobutylmaleimide (MTM-1), see Figure 3.2 for structures. Four model 
compounds were synthesised with different substituents, including butylamine 
(ABM-1 and MAM-1), which allowed a direct comparison with the DTM compounds; 
and diethylamine, (ABM-2 and MAM-2), to observe the difference between a 
secondary amine and a tertiary amine product (see Figure 3.2 for structures).  
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Figure 3.2. Summary of the different aminobromomaleimides (ABMs) 
synthesised, their monoaminomaleimide (MAM) homologues, and 
thiomaleimides (dithiomaleimide (DTM), and monothiomaleimide (MTM)). 
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Awuah and Capretta developed a method to synthesise a library of substituted 
maleimides including amino-substituted maleimides.50 They demonstrated that 
under mild conditions with an excess of amine, only the monoaminated maleimide 
can be formed (with microwave irradiation required to achieve a second 
substitution). Therefore, as the maleimide undergoes a single amine substitution 
only, the second substituent of the C=C double bond can be retained; bromine or 
hydrogen depending on the reactant used (DBM or MBM), see Scheme 3.1, and 
Scheme 3.2 for an example mechanism. 
 
All reactions were performed in tetrahydrofuran at room temperature with a small 
excess of amine, and sodium carbonate as a base. Reactions were completed within 
0.5-2 hours. The resultant mixture was washed and purified via column 
chromatography on silica gel. The product was obtained with a yield ranging from 
11% to 79%. The structures were confirmed by 1H NMR spectroscopy, 13C NMR 
spectroscopy, mass spectrometry and IR spectroscopy, see Experimental, 
section 3.5.3.  
  
 
Scheme 3.2. Example of an ABM synthesis mechanism (DBM and 
isopropylamine) to obtain ABM-3. 
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3.3.2. Spectroscopic properties of aminomaleimides compared to 
thiomaleimides  
In order to compare spectroscopic properties, absorption, excitation and emission 
spectra were recorded, the extinction coefficient and the fluorescence quantum 
yield were calculated, and the brightness (being a function of both fluorescence 
quantum yield and extinction coefficient: B = Фf × ε) was then deduced.  
The fluorescence quantum yield (Φf) is one of the most important parameters to 
compare fluorophores. It allows calculation of the efficiency of the conversion of 
absorbed photons into emitted photons. The quantum yields quoted below were 
determined following the protocol presented by Resch-Genger and co-workers.51 
The use of a standard, which has a known quantum yield under specific conditions, 
is necessary to determine fluorescent quantum yields. The standard is chosen 
depending on its absorption and emission wavelength range, which should 
respectively correspond to the sample’s absorption and emission wavelengths. In the 
case of aminomaleimides and thiomaleimides, the most appropriate standard was 
quinine sulfate dihydrate in solution in 0.105 M perchloric acid, with a quantum 
yield of 59%.  
3.3.2.1. Thiomaleimide models 
The thiomaleimides DTM-1 and MTM-1 (see Figure 3.2 for structures) had different 
spectroscopic properties. DTM-1 showed an emission maximum at 504 nm for 
excitation maxima at 262 nm and 405 nm in 1,4-dioxane, see Figure 3.3. Peaks at 
λex = λem are the result of Rayleigh scattering from the sample solution. An increase 
of the solvent polarity also generated a red-shifting of the fluorescence emission 
maximum, from 486 nm in cyclohexane to 504 nm in 1,4-dioxane and 546 nm in 
methanol.  
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Figure 3.3. a) Excitation, emission and absorption spectra of DTM-1 in 
1,4-dioxane at 10 µM; b) 3D excitation-emission spectra (with a 5 nm step) of 
DTM-1 in 1,4-dioxane at 10 µM.  
 
The polarity of the solvent had an effect on the fluorescence of DTM-1: a decrease 
in fluorescent quantum yield could be observed for solvents with a higher polarity. 
Φf was calculated to be 28% in cyclohexane, 10% in 1,4-dioxane and 0.4% in 
methanol. The molar extinction coefficient (εmax) varied less significantly with 
solvent: between 4900-5500 M-1·cm-1.  
Interestingly, while DTM-1 is emissive with a Φf of 10% in 1,4-dioxane, MTM-1 is 
non-emissive, having a Φf < 0.05% in both 1,4-dioxane and methanol. 
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3.3.2.1.  Aminomaleimide models 
Spectroscopic properties were investigated first for four model compounds ABM-1, 
ABM-2, MAM-1 and MAM-2, the measurements were performed in cyclohexane, 
1,4-dioxane, methanol and water (where solubility allowed) to examine the effect of 
solvent polarity on the emission.  
3.3.2.1.1. Aminobromomaleimides 
In 1,4-dioxane, ABM-1 showed excitation maxima at 233 nm and 363 nm, with both 
excitation wavelengths corresponding to the same emission maximum at 469 nm, 
see Figure 3.4. Stokes shifts for these excitation wavelengths were respectively 
236 nm and 106 nm. This good spectral separation of excitation and emission is 
important for potential application in FRET experiments.52 ABM-1 also showed a 
solvatochromic emission with a red-shift upon increasing solvent polarity, see 
Figure 3.5. 
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Figure 3.4. a) Excitation, emission and absorption spectra of ABM-1 in 
1,4-dioxane at 10 µM, b) 3D excitation-emission spectra (with a 5 nm step) of 
ABM-1 in 1,4-dioxane at 10 µM. 
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Figure 3.5. Emission spectra of ABM-1 at 10 µM in cyclohexane (λex = 354 nm), 
dioxane (λex = 363 nm), and methanol (λex = 370 nm). These spectra were 
normalised to their maxima to help the wavelength maxima comparison. 
 
The fluorescent quantum yield for ABM-1 was calculated to be 31% in cyclohexane, 
38% in 1,4-dioxane, and 1.1% in methanol, see Figure 3.6. A significant decrease in Φf 
was observed in the protic polar solvents methanol and water. The molar extinction 
coefficient in 1,4-dioxane was found to be 4500 M-1·cm-1 and the brightness was 
calculated to be 1700 M-1·cm-1. In comparison with quinine, a well-known 
fluorophore emitting in a similar region (and the standard used for the fluorescent 
quantum yield), exhibiting a brightness of 3000 M-1·cm-1,53 ABM-1 has a lower 
brightness. However, these measurements illustrated that the aminomaleimide 
fluorophores were significantly brighter than the previously reported DTM 
fluorophores.39 A further advantage for the aminobromomaleimides is that these 
fluorophores were generated by single substitution of the maleimide, whereas for 
thiomaleimide fluorophores intense emission is only observed for di-substitution.35 
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This property would be particularly beneficial for sterically demanding substituted 
products.  
Interestingly, ABM synthesised with a secondary amine produced a non-emissive 
compound (ABM-2), with Φf < 0.2% in all solvents (see Figure 3.6), suggesting 
perhaps that the inductive effects of the diethylamine perturbs the electronic 
structure. 
 
Figure 3.6. Relative fluorescence quantum yield for the ABM models in different 
solvents compared to DTM, MTM models. 
 
3.3.2.1.2. Monoaminomaleimides 
The MAM with an n-butylamine substituent (MAM-1) showed a very similar 
excitation and emission spectral profile to the corresponding ABM (ABM-1). For 
example in 1,4-dioxane MAM-1 displayed a slight blue shift in the absorption 
(233 nm, 346 nm), excitation (236 nm, 346 nm) and emission (450 nm) maxima 
relative to ABM-1, see Figure 3.7, and Figure 3.8 for the comparison of emission 
spectra of MAM-1, ABM-1 with DTM-1. Similarly to DTM-1 and ABM-1, MAM-1 
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showed a solvatochromic emission with a red-shift upon increasing solvent polarity, 
see Figure 3.9. 
 
Figure 3.7. a) Excitation, emission and absorption spectra of MAM-1 in 
1,4-dioxane at 10 µM; b) 3D excitation-emission spectra (with a 5 nm step) of 
MAM-1 in 1,4-dioxane at 10 µM. 
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Figure 3.8. Emission spectra of ABM-1 (λex = 363 nm) and MAM-1 (λex = 346 nm) 
compared to DTM-1 (λex = 405 nm). All spectra were recorded in 1,4-dioxane at 
10 µM. 
  
 
Figure 3.9. Emission spectra of MAM-1 at 10 µM in cyclohexane (λex = 334 nm), 
dioxane (λex = 346 nm), methanol (λex = 355 nm) and water (λex = 365 nm). 
 
The extinction coefficient for MAM-1 (4900 M-1·cm-1) was comparable to ABM-1, 
while Φf, and therefore the brightness (Φf × εmax), were significantly higher at 59% 
Chapter 3 
104 
 
and 2900 M-1·cm-1 respectively, see Figure 3.10. A significant decrease in Φf was also 
observed in the protic polar solvents methanol and water. 
Similarly to the non-emissive tertiary ABM-2, the equivalent MAM-2 with a 
diethylamine substituent displayed Φf < 0.5% in all solvents, see Figure 3.10. 
 
 
Figure 3.10. Relative fluorescence quantum yield for the MAM models in 
different solvents compared to DTM, MTM and ABM models. 
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3.3.2.2. Additional aminomaleimides 
In order to compare the effect of amino-substituents on fluorescence emission, a 
range of amines were selected for the addition-elimination reaction with 
2,3-dibromomaleimide in addition to the six model systems studied. Different 
primary amines were utilised; isopropylamine, benzylamine and aniline, see Figure 
3.2, the latter aromatic amine being included to illustrate the effect of conjugation 
of the maleimide with an aromatic ring. All further spectroscopy measurements 
were performed in 1,4-dioxane. This solvent was chosen for giving the brightest 
emission for one of the model compounds (MAM-1), and the better solubility of 
aminomaleimides in 1,4-dioxane than in cyclohexane.  
Interestingly, DBM substituted with different primary amines such as 
isopropylamine (ABM-3) and benzylamine (ABM-4) showed similar fluorescence 
properties to ABM-1 (n-butylamine substituent) in 1,4-dioxane with absorption 
maxima at 233 nm and 364 nm and emission maxima at 467 nm, see Figure 3.11 for 
ABM-3 and Figure 3.12 for ABM-4. Fluorescent quantum yields for ABM-3 and 
ABM-4 in 1,4-dioxane were calculated to be respectively 35% and 34%, which are 
similar to ABM-1 with Φf = 38%.  
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Figure 3.11. a) Excitation, emission and absorption spectra of ABM-3 in 
1,4-dioxane at 10 µM; b) 3D excitation-emission spectra (with a 5 nm step) of 
ABM-3 in 1,4-dioxane at 10 µM. 
  
Chapter 3 
107 
 
 
Figure 3.12. a) Excitation, emission and absorption spectra of ABM-4 in 
1,4-dioxane at 10 µM; b) 3D excitation-emission spectra (with a 5 nm step) of 
ABM-4 in 1,4-dioxane at 10 µM. 
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The possibility of using different primary amines as substituents demonstrated the 
versatility of the ABM fluorophores to further functionalisation, as the emission was 
invariant to the groups attached to the primary amine. However, when the 
maleimide was directly conjugated with a phenyl group (ABM-5) the product was 
non-emissive with Φf = 0.05%. This result was consistent with our previous reports 
of emission quenching where DTM was directly conjugated to aromatic rings.35,37,38 
A similar result was obtained for MAM with an aniline substituent (MAM-3), which 
was also quenched, having Φf = 0.02%. 
In addition to the introduction of functionality to these aminomaleimide 
fluorophores through choice of the amine substituent, further functionality can also 
be easily incorporated at the maleimide nitrogen.54,55 The effect on emission of 
N-functionalisation of the maleimide was investigated by synthesising an N-methyl 
ABM with an n-butylamine substituent (ABM-6). Incorporation of an alkyl group at 
the maleimide nitrogen produced a fluorescent compound (ABM-6) with an 
emission maximum at 486 nm for the excitation maxima at 244 nm and 374 nm, see 
Figure 3.13. However, a reduction in fluorescent quantum yield was observed: 20% 
for ABM-6 compared to a similar compound that did not have an N-substituent (see 
Figure 3.2 for structures), ABM-1 with Φf = 38%.  
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Figure 3.13. a) Excitation, emission and absorption spectra of ABM-6 in 
1,4-dioxane at 10 µM; b) 3D excitation-emission spectra (with a 5 nm step) of 
ABM-6 in 1,4-dioxane at 10 µM. 
 
This did however confirm that N-functionalisation is possible, which gives the 
aminomaleimide fluorophores the versatility to be used as a fluorescent tag through 
either nitrogen, or as a fluorescent linker group between two species of interest.37,39 
A phenyl group could also be directly conjugated to the maleimide through the 
maleimide nitrogen, however this had the same effect on fluorescence intensity as 
the conjugation through the amine: fluorescence quenching was observed for 
ABM-7, ABM-8 and MAM-4. 
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3.4. Conclusions 
In conclusion, a library of novel aminomaleimide fluorophores was synthesised. 
MAMs and ABMs were shown to be highly emissive in the range 400-500 nm with 
large Stokes shifts (> 100 nm). The fluorescent properties of aminomaleimides were 
found to depend on the fluorophore’s structure: a red-shift was observed for MAMs 
compared to ABMs, and the fluorescence of aminomaleimides was quenched by the 
direct conjugation of aromatic rings to the maleimide group. Moreover, the 
fluorophores’ emission wavelength and fluorescence quantum yield showed a 
dependence on the solvent polarity, and significant red-shifts of the emission 
maxima and higher quantum yield were observed in aprotic solvents. The consistent 
lower fluorescent emission observed in protic solvent was attributed to hydrogen 
bonding between the solvent and the maleimide’s carbonyl, altering the electronic 
structure. This effect could be countered through intramolecular hydrogen bonding, 
allowing the fluorescent emission of an aminomaleimide in protic environment.  
The potential of ABM fluorophores in polymer and nanostructure labelling and its 
solvent emission dependence is further developed in the following chapters. 
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3.5. Experimental 
3.5.1. Materials and methods 
Spectroscopy grade 1,4-dioxane, cyclohexane, and methanol were purchased from 
VWR. Water for spectroscopy was purified to a resistivity of 18.2 MΩ·cm using a 
Millipore Simplicity Ultrapure water system. 3,4-Dibromo-1-phenyl-2,5-dihydro-1H-
pyrrole-2,5-dione† was synthesised according to the procedure of Muus et al.56 
3-Bromo-2,5-dihydro-1H-pyrrole-2,5-dione† was synthesised according to the 
procedure of Vanel et al.57 3-Bromo-1-phenyl-2,5-dihydro-1H-pyrrole-2,5-dione† was 
synthesised according to the procedure of Martinez-Ariza et al.58 2,3-
Dibutylthiomaleimide (DTM-1) was synthesised as previously reported.35 All other 
chemicals were purchased from Aldrich, Fluka or Acros and used as received. 
1H and 13C NMR spectra were recorded on a Bruker DPX-400, or AV500 
spectrometer at room temperature unless otherwise stated. Chemical shifts are 
given in ppm downfield from the internal standard tetramethylsilane (TMS).  
Infrared spectra were recorded (neat) on a PerkinElmer, Spectrum 100 FT-IR 
Spectrometer.  
High Resolution Mass Spectrometry (HR-MS) was conducted on a Bruker UHR-Q-
ToF MaXis with electrospray ionisation.  
Fluorescence spectra were recorded using an Agilent Cary Eclipse Fluorescence 
spectrophotometer. UV-vis spectroscopy was carried out on a Perkin Elmer Lambda 
35 UV/vis spectrometer or an Agilent Cary 60 UV-Vis Spectrophotometer. Quartz 
cells with screw caps and four polished sides (Starna) were used for fluorescence and 
UV-vis measurements. 
                                                     
† Synthesised by Dr Mathew Robin 
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3.5.2. Specific safety procedures 
All work with thiols was carried out in an efficient fume cupboard and on the 
smallest scale possible. Disposable gloves were used, changed regularly. All 
materials (gloves, paper towels, glassware) utilised to work with thiol were 
decontaminated with the thiol killing solution.59-61 
Sulfide Oxidiser (thiol killing solution): 
% by weight: 3% cyclohexane, 82% water, 5% sodium dodecyl sulfate, 10% 
butan-1-ol, 1 ml of sulfide in 15 ml of microemulsion. Add 5% aqueous sodium 
hypochlorite solution (undiluted bleach) in 2-fold excess. Takes approximately 15 
seconds to kill smell.  
3.5.3. Synthetic procedures  
3.5.3.1. Aminobromomaleimides (ABMs) 
General procedure for the synthesis of ABMs 
Reactions were performed according to the protocol established by Awuah and 
Capretta.50 All reactions were performed in THF (20 mL) at room temperature with 
2,3-dibromomaleimide (1 eq.), sodium carbonate (2.5 eq.) and a small excess of 
amine (1.05-1.1 eq.). Consumption of 2,3-dibromomaleimide was monitored by TLC, 
and was complete within 0.5-2 h. The solvent was then evaporated under reduced 
pressure and the residue was taken up with CH2Cl2 (150 mL). The resultant mixture 
was washed with water (2 × 150 mL), dried with magnesium sulfate and purified via 
column chromatography on silica gel with petroleum ether/ethyl acetate. 
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3.5.3.1.1. 3-Bromo-4-(butylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (ABM-1)  
In this case, 2,3-dibromomaleimide (500 mg, 1.96 mmol) and n-butylamine (151 mg, 
2.06 mmol) were used in the general procedure described above. The product was 
obtained as a yellow powder (274 mg, 1.11 mmol, 57%) after purification by column 
chromatography on silica gel using a mixture of 5:1 petroleum ether and ethyl 
acetate. 1H NMR (CDCl3, 500 MHz) δ 7.75 (br, 1H), 5.51 (br, 1H), 3.65 (q, 3J = 8 Hz, 
2H), 1.65 (quin, 3J = 8 Hz, 2H), 1.42 (sex, 3J = 8 Hz, 2H), 0.97 (t, 3J = 8 Hz, 3H); 
13C NMR (CDCl3, 125 MHz) δ 167.6, 165.8, 143.7, 69.6, 42.7, 35.6, 19.6, 13.7; FTIR 
(neat) νmax / cm-1 3336 (H-N of amine), 3145 (H-N of maleimide) 1761 and 1708 (C=O 
of maleimide), 1630 (C=C of maleimide); HR-MS (MaXis) m/z found 268.9892, calc. 
268.9896 ([C8H11BrN2O2+Na]+, 100%). 
 
3.5.3.1.2. 3-Bromo-4-(diethylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (ABM-2)  
In this case, 2,3-dibromomaleimide (3.00 g, 11.8 mmol) and diethylamine (0.95 g, 
12.9 mmol) were used in the general procedure described above. The product was 
obtained as a yellow powder (2.11 g, 8.55 mmol, 72%) after purification by column 
chromatography on silica gel using a gradient from 6:1 to 4:1 of petroleum ether and 
ethyl acetate. 1H NMR (CDCl3, 400 MHz) δ 7.56 (br, 1H), 3.76 (q, 3J = 7 Hz, 4H), 1.28 
(t, 3J = 7 Hz, 6H); 13C NMR (CDCl3, 100 MHz) δ 166.6, 165.5, 144.0, 78.2, 45.8, 14.6; 
FTIR (neat) νmax / cm-1 3228 (H-N of maleimide) 1756 and 1707 (C=O of maleimide), 
1616 (C=C of maleimide); HR-MS (MaXis) m/z found 268.9895, calc. 268.9896 
([C8H11BrN2O2+Na]+, 100%). 
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3.5.3.1.3. 3-Bromo-4-(isopropylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (ABM-3)  
In this case, 2,3-dibromomaleimide (500 mg, 1.96 mmol) and isopropylamine 
(122 mg, 2.06 mmol) were used in the general procedure described above. The 
product was obtained as an orange powder (176 mg, 0.76 mmol, 39%) after 
purification by column chromatography on silica gel using a mixture of 5:1 
petroleum ether and ethyl acetate. 1H NMR (CDCl3, 500 MHz) δ 7.86 (br, 1H), 5.33 
(br, 1H), 4.41 (m, 1H), 1.30 (d, 3J = 5 Hz, 6H); 13C NMR (CDCl3, 125 MHz) δ 167.8, 
166.0, 142.8, 69.6, 44.7, 23.6; FTIR (neat) νmax / cm-1 3322 (H-N amine), 3189 (H-N of 
maleimide), 1764 and 1708 (C=O of maleimide), 1639 (C=C of maleimide); HR-MS 
(MaXis) m/z found 254.9738, calc. 254.9740 ([C7H9BrN2O2+Na]+, 100%). 
3.5.3.1.4. 3-Bromo-4-(benzylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (ABM-4)  
In this case, 2,3-dibromomaleimide (500 mg, 1.96 mmol) and benzylamine (221 mg, 
2.06 mmol) were used in the general procedure described above. The product was 
obtained as an orange powder (61 mg, 0.22 mmol, 11%) after purification by column 
chromatography on silica gel using a mixture of 5:1 petroleum ether and ethyl 
acetate. 1H NMR (CDCl3, 400 MHz) δ 7.36 (m, 5H), 7.11 (br, 1H), 5.60 (br, 1H), 4.86 
(d, 3J = 8 Hz, 2H); 13C NMR (CD3OD, 125 MHz) δ 169.3, 166.5, 157.3, 138.7, 128.3, 127.1, 
126.7, 103.22, 45.2; FTIR (neat) νmax / cm-1 3325 (H-N of amine), 3157 (H-N of 
maleimide) 1772 and 1714 (C=O of maleimide), 1645 (C=C of maleimide); HR-MS 
(MaXis) m/z found 302.9749, calc. 302.9740 ([C11H9BrN2O2+Na]+, 100%). 
3.5.3.1.5. 3-Bromo-4-(phenylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (ABM-5)  
In this case, 2,3-dibromomaleimide (500 mg, 1.96 mmol) and aniline (192 mg, 
2.06 mmol) were used in the general procedure described above. The product was 
obtained as an orange powder (103 mg, 0.39 mmol, 19%) after purification by 
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column chromatography on silica gel using a mixture of 5:1 petroleum ether and 
ethyl acetate. 1H NMR (CD3OD, 500 MHz) δ 7.38 (m, 4H), 7.23 (m, 6H); 13C NMR 
(CD3OD, 125 MHz) δ 169.3, 166.9, 141.7, 136.3, 128.0, 125.4, 124.6, 79.9; FTIR (neat) 
νmax / cm-1 3303 (H-N of amine), 3188 (H-N of maleimide) 1766 and 1706 (C=O of 
maleimide), 1636 (C=C of maleimide); HR-MS (MaXis) m/z found 288.9596, calc. 
288.9583 ([C10H7BrN2O2+Na]+, 100%). 
3.5.3.1.6. 3-Bromo-4-(butylamino)-1-methyl-2,5-dihydro-1H-pyrrole-2,5-dione 
(ABM-6)  
In this case, 2,3-dibromo-N-methylmaleimide (750 mg, 2.79 mmol) and 
n-butylamine (214 mg, 2.93 mmol) were used in the general procedure described 
above. The product was obtained as a yellow-orange powder (448 mg, 1.72 mmol, 
62%) after purification by column chromatography on silica gel using a mixture of 
5:1 petroleum ether and ethyl acetate. 1H NMR (CDCl3, 500 MHz) δ 5.46 (br, 1H), 
3.63 (q, 3J = 8 Hz, 2H), 3.02 (s, 3H), 1.63 (quin, 3J = 8 Hz, 2H), 1.42 (sex, 3J = 8 Hz, 
2H), 0.97 (t, 3J = 8 Hz, 3H); 13C NMR (CDCl3, 125 MHz) δ 168.1, 166.2, 143.3, 69.6, 
42.8, 32.7, 24.4, 19.6, 13.7; FTIR (neat) νmax / cm-1 3342 (H-N of amine), 1769 and 1709 
(C=O of maleimide), 1647 (C=C of maleimide); HR-MS (MaXis) m/z found 
283.0048, calc. 283.0053 ([C9H13BrN2O2+Na]+, 100%). 
 
3.5.3.1.7. 3-Bromo-4-(butylamino)-1-phenyl-2,5-dihydro-1H-pyrrole-2,5-dione 
(ABM-7)  
In this case, 3,4-dibromo-1-phenyl-2,5-dihydro-1H-pyrrole-2,5-dione (150 mg, 
0.46 mmol) and n-butylamine (35 mg, 0.48 mmol) were used in the general 
procedure described above. The product was obtained as a yellow-orange powder 
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(26 mg, 0.08 mmol, 25%) after purification by column chromatography on silica gel 
using a mixture of 5:1 petroleum ether and ethyl acetate. 1H NMR (CDCl3, 400 MHz) 
δ 7.44 (m, 2H), 7.34 (m, 3H), 5.57 (br, 1H), 3.70 (q, 3J = 8 Hz, 2H), 1.69 (quin, 3J = 8 
Hz, 2H), 1.45 (sex, 3J = 8 Hz, 2H), 0.99 (t, 3J = 8 Hz, 3H); ); 13C NMR (CD3OD, 125 
MHz) δ 167.4, 164.5, 144.2, 132.0, 131.6, 128.5, 127.4, 127.2, 126.0, 120.4, 42.1, 32.9, 
19.3, 12.8; FTIR (neat) νmax / cm-1 3321 (H-N of amine), 1770 and 1712 (C=O of 
maleimide), 1649 (C=C of maleimide); HR-MS (MaXis) m/z found 345.0207, calc. 
345.0209 ([C14H15BrN2O2+Na]+, 100%). 
3.5.3.1.8. 3-Bromo-1-phenyl-4-(phenylamino)-1H-pyrrole-2,5-dione (ABM-8)  
In this case, 3,4-dibromo-1-phenyl-2,5-dihydro-1H-pyrrole-2,5-dione (150 mg, 
0.46 mmol) and aniline (45 mg, 0.48 mmol) were used in the general procedure 
described above. The product was obtained as a yellow powder (66 mg, 0.19 mmol, 
42%) after purification by column chromatography on silica gel using a mixture of 
5:1 petroleum ether and ethyl acetate. 1H NMR (CD3OD, 400 MHz) δ 7.47 (m, 2H), 
7.40 (m, 5H), 7.28 (m, 3H); 13C NMR (CDCl3, 125 MHz) δ 166.6, 165.6, 139.9, 135.1, 
131.5, 129.2, 128.8, 127.9, 126.6, 125.8, 124.7, 81.2; FTIR (neat) νmax / cm-1 3309 (H-N 
of amine), 1769 and 1706 (C=O of maleimide), 1647 (C=C of maleimide); HR-MS 
(MaXis) m/z found 364.9905, calc. 364.9896 ([C16H11BrN2O2+Na]+, 100%). 
3.5.3.2. Monoaminomaleimides (MAMs)‡ 
General procedure for the synthesis of MAMs 
All reactions were performed in THF (20 mL) at room temperature with 
bromomaleimide (1 eq.), sodium carbonate (2.5 eq.) and a small excess of amine 
(1.05-1.1 eq.). Consumption of bromomaleimide was monitored by TLC and was 
                                                     
‡ Synthesised and characterised by Dr Mathew Robin 
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complete within 0.5-2 h. The reaction mixture was filtered, the filtrate collected and 
the solvent removed under reduced pressure. The resultant residue was then 
purified via column chromatography on silica gel with petroleum ether/ethyl 
acetate. 
3.5.3.2.1. 3-(Butylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (MAM-1)  
In this case, monobromomaleimide (500 mg, 2.84 mmol) and n-butylamine 
(218 mg, 2.98 mmol) were used in the general procedure described above. The 
product was obtained as a yellow powder (354 mg, 2.11 mmol, 74%) after purification 
by column chromatography on silica gel using a mixture of 5:1 petroleum ether and 
ethyl acetate. 1H NMR (CDCl3, 400 MHz) δ 7.07 (br, 1H), 5.37 (br, 1H), 4.81 (s, 1H), 
3.18 (q, 3J = 7 Hz, 2H), 1.63 (m, 2H), 1.41 (m, 2H), 0.96 (t, 3J = 7 Hz); 13C NMR (CDCl3, 
100 MHz) δ 172.7, 167.9, 149.9, 85.0, 44.1, 30.5, 20.0, 13.7; FTIR (neat) νmax / cm-1 3311 
(H-N of amine), 3187 (H-N of maleimide), 1760 and 1702 (C=O of maleimide), 1624 
(C=C of maleimide); HR-MS (MaXis) m/z found 191.0789, calc. 191.0791 
([C8H12N2O2+Na]+, 100%). 
3.5.3.2.2. 3-(Diethylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (MAM-2)  
In this case, monobromomaleimide (500 mg, 2.84 mmol) and diethylamine (218 mg, 
2.98 mmol) were used in the general procedure described above. The product was 
obtained as a yellow powder (375 mg, 2.23 mmol, 79%) after purification by column 
chromatography on silica gel using a mixture of 3:1 petroleum ether and ethyl 
acetate. 1H NMR (CDCl3, 500 MHz) δ 7.68 (br, 1H), 4.80 (d, 5J = 2 Hz, 1H), 3.84 (q, 
3J = 7 Hz, 2H), 3.26 (q, 3J = 7 Hz, 2H), 1.23 (t, 3J = 7 Hz, 6H); 13C NMR (CDCl3, 125 
MHz) δ 172.3, 167.5, 149.6, 86.8, 47.4, 44.4, 14.8, 11.0; FTIR (neat) νmax / cm-1 3111 (H-
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N of maleimide), 1750 and 1681 (C=O of maleimide), 1602 (C=C of maleimide); HR-
MS (MaXis) m/z found 191.0790, calc. 191.0791 ([C8H12N2O2+Na]+, 100%). 
3.5.3.2.3. 3-(Phenylamino)-2,5-dihydro-1H-pyrrole-2,5-dione (MAM-3)  
This compound was synthesised according to the procedure of Bowler et al.62 
1H NMR (CDCl3, 400 MHz) δ 7.1 (br m, 5H), 5.53 (s, 1H); 13C NMR (CD3OD, 
100 MHz) δ 176.4, 170.4, 145.9, 140.8, 130.5, 125.3, 120.6, 90.0; FTIR (neat) νmax / cm-1 
3251 (H-N of aniline), 1769 and 1688 (C=O of maleimide), 1619 (C=C of maleimide); 
HR-MS (MaXis) m/z found 211.0478, calc. 211.0476 ([C10H8N2O2+Na]+, 100%). 
3.5.3.2.4. 3-(Butylamino)-1-phenyl-2,5-dihydro-1H-pyrrole-2,5-dione (MAM-4)  
In this case, 3-bromo-1-phenyl-2,5-dihydro-1H-pyrrole-2,5-dione (400 mg, 
1.59 mmol) and n-butylamine (232 mg, 3.17 mmol) were used in the general 
procedure described above. The product was obtained as a yellow-green powder 
(258 mg, 1.06 mmol, 66%) after purification by column chromatography on silica 
gel using a mixture of 5:1 petroleum ether and ethyl acetate. 1H NMR (CDCl3, 
400 MHz) δ 7.44 (t, 3J = 8 Hz, 2H), 7.36 (m, 2H), 7.32 (t, 3J = 7 Hz, 1H), 5.50 (br, 1H), 
4.97 (s, 1H), 3.24 (q, 3J = 7 Hz, 2H), 1.67 (m, 2H), 1.44 (m, 2H), 0.98 (t, 3J = 7 Hz, 3H); 
13C NMR (CDCl3, 100 MHz) δ 171.1, 166.3, 149.1, 131.9, 128.9, 127.2, 125.8, 84.1, 44.1, 
30.1, 20.0, 13.6; FTIR (neat) νmax / cm-1 3253 (H-N of amine), 1763 and 1698 (C=O of 
maleimide), 1648 (C=C of maleimide); HR-MS (MaXis) m/z found 267.1105, calc. 
267.1104 ([C14H16N2O2+Na]+, 100%). 
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3.5.3.3. Monothiomaleimide§ 
3.5.3.3.1. 3-(Butylsulfanyl)-2,5-dihydro-1H-pyrrole-2,5-dione (MTM-1) 
To a solution of monobromomaleimide (400 mg, 2.27 mmol) in methanol (8 mL) 
was added dropwise a solution of sodium acetate (186 mg, 2.27 mmol) and 
n-butanethiol (204 mg, 2.27 mmol) in methanol (8 mL). After 2 h the solvent was 
removed under reduced pressure, and the resultant residue dissolved in ethyl 
acetate and filtered and the filtrate concentrated under reduced pressure. The 
product was obtained as a yellow powder (317 mg, 1.71 mmol, 75%) after purification 
by column chromatography on silica gel using a mixture of 4:1 petroleum ether and 
ethyl acetate. 1H NMR (CDCl3, 400 MHz) δ 7.34 (br, 1H), 6.05 (s, 1H), 2.92 (t, 3J = 
7 Hz), 1.75 (m, 2H), 1.49 (m, 2H), 0.97 (t, 3J = 7 Hz); 13C NMR (CD3OD, 100 MHz) 
δ 168.8, 167.3, 152.0, 117.5, 31.0, 29.0, 21.4, 12.9; FTIR (neat) νmax / cm-1 3179 (H-N of 
maleimide), 1768 and 1694 (C=O of maleimide), 1548 (C=C of maleimide); HR-MS 
(MaXis) m/z found 208.0404, calc. 208.0403 ([C8H11NO2S+Na]+, 100%). 
  
                                                     
§ Synthesised and characterised by Dr Mathew Robin 
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3.5.4. Fluorophore properties 
Quantum yields (Фf,x) were determined according to a protocol by Resch-Genger and 
co-workers51, utilising quinine sulfate dihydrate as a standard in solution in 0.105 M 
perchloric acid, with a quantum yield of 59% (Фf,st). Ideally, the solutions (standard 
and sample) used to measure the quantum yield have an absorbance of 0.1. First, the 
optimal excitation wavelength is determined and corresponds to the intersect of the 
sample and standard absorption spectra. The emission spectra of both standard and 
sample are obtained using the exact same parameters, and the area under the peaks 
are respectively measured (Fst, Fx).  
 
 
(3.1) 
In the equation above, nx and nst correspond to the refractive indices of the solvent 
of respectively the sample and the standard solutions; fx and fst are calculated using 
the equation below, A(λex) being the exact absorbance at the excitation wavelength.  
 
 
(3.2) 
 
The extinction coefficients (εmax) were determined by measuring the absorbance (A) 
of solutions at different concentrations (c) and with the Beer-Lambert law: A = ε∙l∙c, 
(l is the length of the cuvette), the slope of the plot A vs. c correspond to the 
extinction coefficient. 
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Table 3.1. Fluorescence spectroscopy data for ABMs, MAMs, DTM and MTM 
molecule solvent Фf εmax λabs,max λex,max λem,max 
  % 103·M-1cm-1 nm nm nm 
DTM-1 
Cyclohexane 28 5.8 230, 407 232, 405 486 
Dioxane 10 4.9 250, 402 262, 405 504 
Methanol 0.43 4.7 251, 402 250, 402 546 
Water Not soluble at 0.2 mM 
MTM-1 
Cyclohexane Not soluble at 0.2 mM 
Dioxane 0.043 4.7 247, 339 n/a n/a 
Methanol 0.011 4.6 244, 337 n/a n/a 
Water Not soluble at 0.2 mM 
ABM-1 
Cyclohexane 31 3.7 225, 357 235, 354 442 
Dioxane 38 4.5 229, 367 233, 363 469 
Methanol 1.1 5.5 229, 373 233, 370 514 
Water Not soluble at 0.2 mM 
ABM-2 
Cyclohexane 0.16 7.3 224, 380 232, 379 442 
Dioxane 0.15 6.6 234, 386 233, 381 474 
Methanol 0.054 6.5 236, 392 245, 396 515 
Water 0.037 5.7 231, 410 232, 409 567 
ABM-3 Dioxane 35 5.0 229, 364 233, 363 468 
ABM-4 Dioxane 34 3.3 231, 362 232, 364 466 
ABM-5 Dioxane 0.052 6.7 231, 375 n/a n/a 
ABM-6 Dioxane 20 3.7 240, 376 244, 374 486 
ABM-7 Dioxane 0.94 3.7 236, 378 241, 375 493 
ABM-8 Dioxane 0.13 4.8 245, 387 n/a n/a 
MAM-1 
Cyclohexane 52 5.0 231, 333 231, 334 412 
Dioxane 59 4.9 233, 346 236, 346 450 
Methanol 2.8 5.5 232, 357 233, 355 490 
Water 0.31 5.4 231, 369 231, 365 520 
MAM-2 
Cyclohexane Not soluble at 0.2 mM 
Dioxane 0.43 6.6 238, 367 233, 364 460 
Methanol 0.20 6.6 224, 374 233, 379 500 
Water 0.11 6.4 217, 391 232, 393 535 
MAM-3 Dioxane 0.017 9.9 
228, 240, 
366 
n/a n/a 
MAM-4 Dioxane 0.085 2.9 262, 360 n/a n/a 
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Chapter 4  
CO2/pH-responsive particles with built-in 
aminobromomaleimide for fluorescence 
read-out 
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4.1. Abstract 
A novel fluorescent monomer was synthesised to probe the state of CO2-responsive 
cross-linked polymer particles. The fluorescence emission of this 
aminobromomaleimide-bearing monomer, being sensitive to protic environments, 
can provide information on the core hydrophilicity of the particles and therefore 
indicates the swollen state and size of the particles. The core of the particles, 
synthesised from DEAEMA (N,N-diethylaminoethyl methacrylate), is responsive to 
CO2 through protonation of the tertiary amines of DEAEMA. The response is 
reversible and the fluorescence emission can be recovered by simply bubbling an 
inert gas into the particle solution. Alternate purges of CO2 and N2 into the solution 
of particles allow several on/off fluorescence emission cycles and simultaneous 
particle swelling/shrinking cycles. 
 
 
Figure 4.1. Schematic summary of the fluorescent responsive particles.1  
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4.2. Introduction 
Stimuli-responsive polymers have received great interest in recent years and have 
been developed for different applications such as nanotechnology, bio-materials and 
drug delivery.2-5 External stimuli such as temperature, pH, CO2 or light can be 
utilised to trigger a response and/or change in physical properties.6-10 Carbon 
dioxide, a naturally abundant gas and biocompatible, has been more and more 
recently used as a stimulus for responsive materials. The usage of CO2-responsive 
polymers is widely reported to trigger and control self-assembly morphology 
transitions.11-14 These responsive polymers are usually synthesised with monomers 
containing tertiary amine, amidine, guanidine or imidazole functional groups.15-17 
Such functional groups can all be protonated upon a decrease in pH which in turn 
can be induced by the presence of CO2. Tertiary amine-containing monomers such 
as DMAEMA (N,N-dimethylaminoethyl methacrylate), DEAEMA and DPAEMA 
(N,N-diisopropylaminoethyl methacrylate) exhibit a pH-responsive behaviour, as 
they can react with strong and weak acids.18,19  
 
 
Figure 4.2. Example of tertiary amine-containing monomer structures. 
 
These pH-responsive monomers are also responsive to CO2 in water, as CO2 partially 
dissolves in water to form an equilibrium with carbonic acid, which is a weak acid 
that can dissociate into HCO3-, CO32- and H+, which allows the protonation of the 
amine monomers, see Scheme 4.1. 
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Scheme 4.1. Protonation of a tertiary amine by CO2 bubbling in water. 
 
The CO2 response is a reversible process where reversal is carried out by simply 
bubbling an inert gas (nitrogen or argon) in the solution, which displaces carbonic 
acid and shifts the equilibrium toward the initial species in solution and thus the 
initial pH.20 CO2-responsive polymer assemblies can also be obtained via 
encapsulation of amine-bearing small molecules into non-responsive systems such 
as micelles.21 Further examples of CO2-responsive materials include the use of 
CO2/pH responsive latexes as Pickering emulsifiers, reported by Morse and co-
workers for example.22 The cross-linked latexes were synthesised from DEAEMA, 
DVB (divinylbenzene) and PEGMA (polyethylene glycol methacrylate) and showed 
a reversible diameter increase from 230 nm to 590 nm using HCl/KOH or CO2/N2 
gas purges to change the pH, see Figure 4.3.  
 
The protonation of the DEAEMA cross-linked core, using HCl or CO2, increases the 
core hydrophilicity, which induces a swelling effect. The deprotonation of DEAEMA 
 
Figure 4.3. CO2 responsiveness of PEGMA-DEAEMA latexes. Reproduced from 
reference. 22  
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via N2 purging or with addition of KOH decreases the hydrophilicity of the core and 
results in a reduction of the particle diameter to its original size. 
Recently, Chen and co-workers also reported the preparation of CO2-responsive 
polymeric microgels which are composed of a DEAEMA core covalently stabilised 
with PEGA (polyethylene glycol acrylate), cross-linked with EGDMA (ethylene 
glycol dimethacrylate) or BIS (methylene bis(acrylamide)).23 The different microgels 
obtained showed a reversible size increase upon CO2 and argon bubbling. 
Depending on the CO2 concentration, these microgels can reversibly swell, or swell 
then collapse.  
Fluorescent dyes are of key interest owing to their potential use in drug delivery 
systems.24-26 Liang and co-workers presented the advantages of a responsive and 
fluorescence combination for bio-medical applications with the preparation of 
polymeric nanoparticles that are fluorescent, pH-responsive, and biocompatible for 
intracellular imaging and drug delivery.27 We previously reported the synthesis of 
fluorescently labelled proteins and polymers with a dithiomaleimide moiety; a small 
functional group that does not affect the polymer or protein scaffold.28 This 
fluorescent functional group was also incorporated into an amphiphilic block 
copolymer which self-assembled into spherical micelles and can be used in 
nanomedicine.29 A one-pot emulsion polymerisation synthesis of fluorescent 
nanogels that were covalently dyed using a dithiomaleimide methacrylate monomer 
was also reported in our group, see Figure 4.4.30,31  
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Figure 4.4. Schematic representation of the synthesis of the dithiomaleimide 
labelled nanogels. Reproduced from reference.31  
 
It was also demonstrated these particles do not exhibit self-quenching at high 
concentration unlike commonly used fluorophores such as Phloxine B. 
Dithiomaleimides have been previously demonstrated to be highly fluorescent when 
the maleimide unit is conjugated to an alkyl thiol32 although dithiomaleimides in 
the presence of an excess of thiol can undergo substitution, which may result in loss 
of fluorescence emission properties if substituted with an aromatic thiol.28,33 To 
counter this substitution effect and thus the loss of fluorescence, a new class of 
highly emissive fluorophores, the aminobromomaleimides (ABM), was developed .34 
Their fluorescence properties are environment dependent; in protic solvents a loss 
of fluorescence can be observed.  
This chapter reports the synthesis of fluorescent CO2-responsive polymeric particles 
by emulsion polymerisation. A novel ABM functional fluorescent monomer, 
copolymerised in the particle core, was utilised as a probe of the core 
hydrophobicity. By simple CO2 bubbling, the particles become swollen and, as a 
consequence of the increased hydrophilicity of the particles, their fluorescence 
drastically decreases. This swelling is reversible by purging the solution with 
nitrogen and on/off cycles of fluorescence are reproducible with successive CO2/N2 
purges.  
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4.3. Results and discussion 
4.3.1. Synthesis and characterisation of the monomer 
The fluorescent ABM functional group was incorporated into the polymeric particles 
via a novel ABM-functionalised methacrylate monomer. The fluorescent monomer 
containing the ABM functionality was synthesised in two steps, see Scheme 4.2. 
First, 2,3-dibromomaleimide methacrylate (DBMMA) was synthesised by alkylation 
of 2-hydroxyethyl 2-methylprop-2-enoate with 2,3-dibromomaleimide using a 
modified Mitsunobu reaction procedure reported by Walker.35 The DBMMA 
monomer was then functionalised via mono-substitution of the bromine with 
isopropylamine to obtain an aminobromomaleimide methacrylate (ABMMA) (see 
1H NMR spectrum in Figure 4.5), following a procedure similar to that used for the 
synthesis of a library of aminomaleimides, as detailed in chapter 3. Similarly to the 
small molecules presented in chapter 3, the monomer presents two excitation 
maxima (λ = 247 nm and λ = 372 nm) for emission maximum (λ = 482 nm) in 
1,4-dioxane, see Figure 4.6.  
 
  
 
Scheme 4.2. Synthesis of DBMMA and ABMMA. Conditions: (a) PPh3, 
diisopropyl azodicarboxylate, 2,2-dimethylpropan-1-ol in THF; (b) Na2CO3 in 
THF. 
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Figure 4.5. 1H NMR spectrum of ABMMA (CDCl3, 400 MHz). 
 
  
 
Figure 4.6. Fluorescence emission (green line) and excitation (black line) spectra 
of ABMMA in 1,4-dioxane at 10-5 M; λem = 486 nm and λex = 374 nm. 
 
As it would be expected, the emission and excitation wavelengths are within the 
same range as the small molecules detailed in chapter 3. For example, the ABM with 
isopropylamine substituent (ABM-3) exhibits excitation maxima at 233 nm and 363 
nm for an emission maximum at 468 nm and the ABM with a methyl substituent on 
the maleimide nitrogen (ABM-6) exhibits excitation maxima at 244 nm and 374 nm 
for an emission maximum at 486 nm.  
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4.3.2. Synthesis and characterisation of fluorescent responsive 
particles 
Fluorescent responsive particles (FRP) were designed with a tertiary amine-bearing 
monomer (DEAEMA) and the fluorescent ABMMA monomer, the former allowed a 
pH response while the latter monomer allowed a fluorescence read-out of the state 
of the particles. Particles were synthesised via emulsion polymerisation in water and 
the polymerisation was initiated using potassium persulfate (KPS) as the initiator, 
see Figure 4.7.  
  
 
 
Compound Variation 
DEAEMA 50 to 150 eq. (for 1 eq. of OEGMA360) 
EGDMA (cross-linker) 0.5 to 5 wt% 
ABMMA (fluorescent) 0 to 2 wt% 
KPS (initiator) 1 - 2 wt% 
Figure 4.7. Schematic representation of the typical synthesis of fluorescent 
responsive particles (FRP), and table of the variation of the quantities of 
co-monomers and initiator. 
 
The emulsion polymerisation procedure consists of emulsifying an insoluble 
monomer phase in water in the presence of a stabilising amphiphilic compound.  
In this case, the insoluble core-forming monomer DEAEMA, cross-linker EGDMA, 
and fluorophore ABMMA were stabilised with OEGMA. The droplets assembled this 
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way copolymerised to form covalently bound core/shell particles. The tertiary 
amines of the core-forming block allowed a CO2-responsive behaviour while the 
presence of the ABM allowed a built-in fluorescence read-out.  
The influence of different parameters such as the cross-linking density, the 
fluorophore loading, the molecular weight of the stabilising monomer, and the co-
monomers ratios were tested to optimise the synthesis of the particles, see Table 4.1. 
It was observed that the variation of the ratio of the different co-monomers and 
initiator can affect the formation of particles.  
Table 4.1. Different size particles obtained for different monomers and initiator 
ratios.  
OEGMA360 
(eq.) 
DEAEMA 
(eq.) 
EGDMA 
(wt%)  
KPS 
(wt%) 
ABMMA 
(wt%) 
Dh  
(nm) 
PD 
Batch 
numbers 
1 
150 1 
1 0 185 0.02 1 
2 0 160 0.02 2 
120 
0.5 1 0 530 0.16 3 
1 
1 
0 190 0.07 4 
1 230 0.01 5 
2 165 0.02 6 
4 220 0.03 7 
2 0 200 0.03 8 
5 0 170 0.04 9 
2 1 0 295 0.20 10 
5 1 2 175 0.19 11 
100 1 
1 0 185 0.02 12 
2 0 200 0.04 13 
85 1 1 0 200 0.02 14 
70 1 
1 0 260 0.20 15 
2 0 145 0.05 16 
50 1 
1 0 290 0.19 17 
2 0 155 0.10 18 
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The data in Table 4.1 showed that the incorporation of the fluorescent ABMMA 
monomer does not have a consistent impact on the size and dispersity; particles 4, 
5, 6, and 7 were of slightly different size but within a 10% error, the dispersity varied 
between 0.01 and 0.07 but was still low and did not proportionally vary with the 
quantity of ABMMA.  
The amount of initiator did not affect the size of the particles either, particles 4, 8, 
and 9 exhibited the same range of size and the dispersity, as well as particles 12 and 
13, or particles 1 and 2. A difference in size could be observed between particles 15 
and 16, and 17 and 18, but in these cases, the dispersity was also affected; a lower 
dispersity and smaller particles were obtained with 2 wt% of initiator.  
It was observed as expected that the cross-linking density affects the particles size 
and dispersity. For example, 0.5 wt% cross-linking was too low as it formed large 
and disperse particles (3) compared to particles with 1 wt% cross-linking particles 
(4); 2 and 5 wt% cross-linking (respectively 10 and 11) was too high as it formed 
particles with a high dispersity (PD > 0.150) in comparison with 1 wt% cross-linking 
particles (4). It seemed that the optimum percentage of cross-linker regarding size 
and dispersity is 1 wt%.  
Variation of the equivalents between DEAEMA and OEGMA360 did not affect the 
size and dispersity (ca. 185 nm, PD < 0.1) of particles synthesised with 150, 120 or 100 
equivalents of DEAEMA for 1 equivalent of OEGMA360 (respectively particles 1, 4, 
and 12). However, for lower number of equivalents (85, 70 or 50; respectively 
particles 14, 15, and 17) the diameter and the dispersity of the particles obtained were 
larger as the number of equivalents was smaller.  
The synthesis of these different particles (1-18) highlighted that intra-particles 
interactions (larger diameter and dispersity) could be generated by higher cross-
linking density, but also by higher OEGMA content (lower number of equivalent of 
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DEAEMA). However, for higher OEGMA content particles, the size and the 
dispersity of particles showed a dependence on the initiator amount.  
The effect of the OEGMA molecular weight (from 360 Da to 2000 Da) on the 
particles size and responsive character was also studied (Table 4.2). Changing the 
molecular weight of the shell monomer OEGMA and keeping the same molar ratio 
did not affect the particles diameter in a consistent manner. Therefore, it was 
hypothesised that the density of the shell of the particles changed. These particles 
were synthesised with 120 equivalents of DEAEMA for 1 equivalent of OEGMA, 1 
wt% EGDMA, 1 wt% KPS and 0-2 wt% ABMMA. The hydrodynamic diameter of the 
different particles in solution in deionised water was measured by dynamic light 
scattering (DLS) and it was found that the particles were all in the same size range, 
see Table 4.2 and Figure 4.8 for the DLS measurements of the different particles.  
Table 4.2. Characteristics of the different particles synthesised. 
Batch name a 
OEGMA MW 
(Da) 
Fluorescent? Dh (nm) PD 
RP-360 (4b) 360 No 190 0.04 
RP-500 500 No 240 0.02 
RP-950 950 No 230 0.04 
RP-2000 2000 No 210 0.02 
FRP-360 (7b) 360 Yes 225 0.03 
FRP-2000 2000 Yes 235 0.01 
 a Particle batches named FRP or RP followed by the molecular weight of the OEGMA used 
(e.g. FRP-360). RP and FRP stand respectively for Responsive Particles and Fluorescent 
Responsive Particles. 
b Batch numbers from Table 4.1. 
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RP-360 RP-500 
 
RP-950 
 
RP-2000 
 
FRP-360 
 
FRP-2000 
Figure 4.8. DLS data of the different particles synthesised at ca. 0.05 mg·mL-1.  
 
  
The variation of the OEGMA molecular weight or the incorporation of ABMMA did 
not affect the morphology of the particles and the size range. The different OEGMA 
utilised changed the density of the shell as the DP was kept the same and the 
Chapter 4 
139 
 
monomer increased in size. The size of fluorescent particles with different shells 
(FRP-360 and FRP-2000) was also confirmed by transmission electron microscopy 
(TEM), see Figure 4.9. The spherical morphology of the particles was confirmed and 
the average diameter was measured to be 260 nm for particles FRP-360 and 330 nm 
for particles FRP-2000. The difference between the DLS hydrodynamic diameter 
and the TEM average diameter could be attributed to the dry state of the TEM 
technique.36 Fluorescence spectroscopy was performed on particles containing the 
fluorescent monomer (FRP-360 and FRP-2000) in solution in deionised water. The 
particles both presented an emission maximum at 487 nm for an excitation 
maximum at 375 nm, see Figure 4.10 for emission and excitation spectra of particles 
FRP-2000. Compared to the monomer, only one of the two excitation maxima 
could be observed for the particles as a consequence of the presence of a scattering 
peak obscuring the excitation peak.  
 
 
 
 
  
Figure 4.9. TEM images of particles of FRP-360 and FRP-2000 stained with 
uranyl acetate, and the distribution of size observed.* 
                                                     
* TEM images were acquired by Dr Anaïs Pitto-Barry. 
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Figure 4.10. Fluorescence emission and excitation spectra for particles FRP-
2000 in water at ca. 0.05 mg·mL-1; λem = 487 nm and λex = 375 nm. 
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4.3.3. Responsiveness experiments 
 
 
Scheme 4.3. Reversible swelling of a fluorescent responsive particle (FRP).  
 
 Particle size monitoring  
 By DLS 
DLS was utilised to monitor changes in the particle diameter in response to bubbling 
with CO2. When CO2 was bubbled in the particles solution, the amines of PDEAEMA 
present in the core of the particles became protonated and therefore hydrophilic. 
Owing to their cross-linked structure, the particles swelled and increased in 
diameter instead of disassembling. A size increase upon CO2 bubbling for 15 minutes 
was observed for all the particles, see Figure 4.11. For example, the hydrodynamic 
diameter of particles RP-360 increased from 185 nm to 390 nm and particles RP-
2000 presented a diameter increase from 200 nm to 435 nm. As bubbling CO2 in 
water changes the pH of the solution, it would have been interesting to control the 
pH of the different solutions before and after the CO2 purge.  
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RP-360 RP-500 
RP-950 RP-2000 
FRP-360 FRP-2000 
Figure 4.11. DLS data (number distribution) of the particles in water at 
ca. 0.05 mg·mL-1, before (dash line) and after (solid line) CO2 bubbling. See 
Table 4.3 for the data details and Figure 4.12 for an example of auto correlation 
function (FRP-2000). 
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Table 4.3. Hydrodynamic diameter of particles before and after CO2 bubbling. 
 
Batch name 
Before CO2 bubbling After CO2 bubbling 
Dh (nm) PD Dh (nm) PD 
RP-360 190 0.04 405 0.05 
RP-500 240 0.02 445 0.10 
RP-950 230 0.04 450 0.08 
RP-2000 210 0.02 460 0.04 
FRP-360 225 0.03 450 0.03 
FRP-2000 235 0.01 490 0.02 
   
 
Figure 4.12. Example of auto correlation function for particles before (dash line) 
and after (solid line) CO2 bubbling (FRP-2000). 
 
 By SAXS† 
The size increase of the non-fluorescent particles with the small molecular weight 
OEGMA shell (RP-360) was also monitored by small-angle X-ray light scattering 
(SAXS) with an in situ CO2 purge, see Figure 4.13. The SAXS data showed an increase 
of the radius of gyration within minutes. Analysis of the SAXS curves over a period 
of 21 minutes indicated an increase of particle size as well as an increase of the 
                                                     
† SAXS experiments and analyses were performed by Dr Anaïs Pitto-Barry. 
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dispersity. The initial particles could be analysed as spherical micelles with really 
low core dispersity and some coils accounting for the outer hydrated shell.37,38 After 
bubbling CO2 the dispersity of the core slightly increased (as evidenced by the loss 
of oscillations in the raw SAXS profiles) and a more pronounced core-shell spherical 
morphology was observed with an increase of core radius, see Figure 4.13. An initial 
diameter of 180 nm was observed, and an increase of the diameter was observed 
upon time: after 2 min of bubbling, 255 nm and after 21 min, 280 nm. The in situ 
analysis was not performed for an extended time as the SAXS profile did not evolve 
between 10 min 30 s and 21 min, see Figure 4.13.  
 
 
Figure 4.13. In situ monitoring by SAXS of particles (RP-360) with bubbling CO2 
over 21 min. 
 Fluorescence emission monitoring  
As previously demonstrated by our group, the ABM functional group is sensitive to 
polar protic environments.34 Thus, the ABM bearing monomer should be able to 
probe the protonation of its environment. Therefore, the increasing hydrophilicity 
of the core upon CO2 bubbling should quench the fluorescence emission of the 
particles.  
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Fluorescence emission of the particles FRP-360 and FRP-2000 was measured 
before and after CO2 bubbling, a drastic decrease of the intensity was observed in 
both cases. At 487 nm, for FRP-360 the maximum decreased from 742 a.u. to 168 
a.u., see Figure 4.14, and for FRP-2000 the emission maximum decreased from 
810 a.u. to 50 a.u., see Figure 4.15. The decrease in fluorescence emission upon CO2 
bubbling was also observed under a UV lamp (λ = 345 nm), see Figure 4.16. 
 
Figure 4.14. Fluorescence emission spectra of particles FRP-360 in water at ca. 
0.05 mg·mL-1, before (dash line) and after (solid line) CO2 bubbling; 
λex = 375 nm. 
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Figure 4.15. Fluorescence emission spectra of particles FRP-2000 in water at ca. 
0.05 mg·mL-1, before (dash line) and after (solid line) CO2 bubbling; λex = 375 
nm. 
 
  
 
Figure 4.16. Pictures of particles (FRP-360) before and after CO2 bubbling 
observed under a UV lamp at 345 nm. 
 
 Reversibility of the system: CO2/N2 purge cycles 
To test the reversibility of the system, the particles solution was repeatedly purged 
with successive cycles of CO2 and N2 bubbling. Six purge cycles were monitored by 
DLS and fluorescence spectroscopy (2 extra cycles for fluorescence monitoring). The 
purging time was kept constant for the entire experiment, CO2 was bubbled for 15 
min and N2 was bubbled for 30 min. Purge cycles experiments were performed on 
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fluorescent particles with the denser OEGMA shell (FRP-2000). The hydrodynamic 
diameter and the fluorescence emission at 487 nm of the particles (FRP-2000) were 
measured after each CO2 or N2 purge. As shown in Figure 4.17, the size of the 
particles alternatively increased and decreased six times. The dispersity of the 
particles also varied upon the different gas purges, see Figure 4.18, however the 
variation was consistent with the cycles. When CO2 was bubbled into the particle 
solution, the particles shrunk and their dispersity decreased.  
 
 
Figure 4.17. Hydrodynamic diameter of the particles in water in water at ca. 0.05 
mg·mL-1, (FRP-2000) measured after each gas purge. Error bars based on 
standard deviation. Line as a guide for the eye. 
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Figure 4.19. Fluorescence emission intensity of the particles in water at ca. 0.05 
mg·mL-1, (FRP-2000) after each gas purge, measured at 487 nm. λex = 375 nm. 
Line as a guide for the eye.  
 
The fluorescence emission intensity was also monitored and was reversibly 
quenched eight times, see Figure 4.19. The progressive decrease of the maximum 
 
Figure 4.18. Variation of the polydispersity (PD) of the particles (FRP-2000) in 
water at ca. 0.05 mg·mL-1, after each gas purge. Line as a guide for the eye. 
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intensity could be explained by an equilibration of the hydration of the system 
through the first cycles and stays stable from cycle number 4. 
The reversibility of the system was also tested on particles with a less dense shell 
(RP-360, FRP-360, RP-500, and RP-950). Despite being able to swell, these 
particles were unable to collapse upon N2 bubbling and formed large aggregates. For 
example, particles RP-360 exhibited a hydrodynamic diameter of 380 nm after 
bubbling CO2, then formed large aggregates upon N2 bubbling. This solution was 
subsequently purged with CO2 and a single population of particles could be observed 
again with a diameter of 390 nm, see Figure 4.20.  
 
 
Figure 4.20. DLS data (number distribution) example of irreversible swelling for 
particles RP-360 in water at ca. 0.05 mg·mL-1. The third graphic shows repeat 
measurements. 
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It was hypothesised that the inability to recover the particles’ original size could be 
attributed to the low density of the shell that cannot counter the effect of some core 
chains irreversibly penetrating the shell during the first protonation. The presence 
of these hydrophobic chains trapped in the shell when the particles shrink promotes 
inter-particle interactions, which leads to the formation of uncontrolled large 
aggregates, see Figure 4.21. The formation of aggregates was significantly reduced 
with a denser shell made of OEGMA with a molecular weight of 2000 Da (compared 
to 360 Da used previously). This was also confirmed by the variation of the dispersity 
shown in Figure 4.18; while the interaction was reduced with the formation of a 
denser shell, the dispersity still increased upon N2 bubbling and was reduced when 
particles were stabilised with CO2 bubbling (reduction of the pH).  
 
 
Figure 4.21. Schematic of potential inter-particles interactions. 
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 Additional experiments 
 Zeta potential measurements with RP-360 
In the previous section (Figure 4.21), it was hypothesised that after CO2 bubbling, 
particles could be stabilised by charged chains from the core penetrating the shell. 
The zeta potential of the particles (RP-360) in solution was measured before and 
after bubbling CO2 and N2. It was observed that after CO2 bubbling, the zeta 
potential was around +30 mV.  
It is known that particles with a zeta potential between -30 and +30 mV are less 
stable than particles with a zeta potential higher than +30 mV or lower than -30 mV, 
and can form aggregates.39 One of the factor affecting the zeta potential is the pH of 
the solution, typically, particles will have a zeta potential higher than +30 mV or 
lower than -30 mV for low and high pH respectively.  
The results obtained were consistent with the theory: particles are more stable after 
CO2 bubbling and tend to aggregate after bubbling nitrogen.  
 
Figure 4.22. Zeta potential distribution for particles solutions in water at ca. 
0.05 mg·mL-1, before any bubbling, after CO2 bubbling, and after N2 bubbling. 
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 pH-response with RP-360 
As mentioned previously in this chapter, these FRP are CO2/pH-responsive as a 
consequence of the core composition being mainly DEAEMA. It was shown that 
particles are responsive to CO2 via monitoring of the particles size upon gas purges. 
In order to confirm that the response was a result of the protonation of the DEAEMA 
monomer induced by a change in pH through dissolution of CO2 in water, the size 
of the particles was directly measured upon pH change via addition of HCl/NaOH 
solutions (0.1 and 0.05 M). The experiment was realised in different conditions, the 
first set was performed via manual addition of acid/base (see Figure 4.23) and 
individual measurements of the hydrodynamic diameter, and the second set was 
obtained through an automated titrator combined with a DLS (see Figure 4.24). The 
automated system was utilised to refine the data obtained manually by measuring 
more data points but it required to perform separated measurements (different 
colour plots in Figure 4.24) for smaller range of pHs. 
 
Figure 4.23. Particles size measurements at different pHs (adjusted manually) in 
water at ca. 0.05 mg·mL-1. 
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Figure 4.24. Multiple series of particles size measurements at different pHs in 
water at ca. 0.05 mg·mL-1, (auto-titrator coupled to DLS). The different colour 
plots correspond to different measurements over different ranges of pH: orange 
and green for pH 2-5.5, purple pH 3-6.5 and red pH 6-7.5. 
 
For both sets of results, a clear change in particle size was observed around pH 5-
5.5. For the manual experiment, the diameter changed from 192 nm to 392 nm, and 
for the automated measurements, the diameter increased from 217 nm to 330nm. 
These results confirmed the pH-responsive nature of the particles.  
 Temperature-response with RP-360 
It has previously been shown that a PEGMA-DEAEMA copolymer can exhibit a 
temperature-responsive behaviour depending on the polymer composition.40 The 
particles were therefore tested for temperature response independently from any pH 
modification: the diameter of the particles was monitored over a range of 
temperatures from 20 to 90 °C, see Figure 4.25 below. This experiment was 
performed with particles  
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Figure 4.25. Particles size monitored over a range of temperatures 20-90 °C in 
water at ca. 0.05 mg·mL-1 (performed in duplicate). 
 
The graph showed the absence of a temperature response, the size of the particles 
stayed constant between 20 and 90 °C. The three data point around 90 °C could be 
attributed to bubbles as it is close to the boiling point of water.  
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4.4. Conclusions 
The synthesis of fluorescent responsive particles has been presented. These cross-
linked particles were composed of a responsive DEAEMA core cross-linked with 
EGDMA, and an OEGMA shell. Moreover, the core of these particles was labelled 
with a novel fluorescent monomer whose synthesis was also presented. This ABM 
containing methacrylate novel monomer was inspired by the ABM fluorophores 
presented in chapter 3. The synthesis of the particles via free-radical polymerisation 
allowed the formation of well-defined particles. These particles were analysed by 
DLS and fluorescence spectroscopy, and found to have a Rh ≈ 200nm and be 
emissive in solution in water.  
Upon CO2 bubbling, the DEAEMA got protonated and increased the hydrophilicity 
of the core, which generate the swelling of the particles (as a consequence of the 
presence of the cross-linker, the assembly was retained). The consequence of this 
local change in hydrophobicity was a drastic decrease of the fluorescence emission 
of the ABM. Thus, the fluorescence intensity could be used to probe the particle core 
hydrophobicity and particle size. The reversible aspect of this system was obtained 
after optimisation of the particles composition. It has been demonstrated that the 
density of the shell can affect the stability and favour aggregation for less dense shell 
or prevent aggregation for denser shells. 
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4.5. Experimental 
4.5.1. Materials and methods 
Dry solvents were obtained by passing over a column of activated alumina using an 
Innovative Technologies solvent purification system. DEAEMA was filtered through 
a plug of alumina prior to use and stored at 4 °C. All other chemicals were purchased 
from Aldrich, Fluka or Acros and used as received.  
1H and 13C NMR spectra were recorded on a Bruker DPX-400, or AV300 
spectrometer at room temperature unless otherwise stated. Chemical shifts are 
given in ppm downfield from the internal standard tetramethylsilane (TMS). 
Infrared spectra were recorded (neat) on a PerkinElmer, Spectrum 100 FT-IR 
Spectrometer.  
High Resolution Mass Spectrometry (HR-MS) was conducted on a Bruker UHR-Q-
ToF MaXis with electrospray ionisation.  
Fluorescence spectra were recorded using an Agilent Cary Eclipse Fluorescence 
spectrophotometer. UV-vis spectroscopy was carried out on a Perkin Elmer Lambda 
35 UV/vis spectrometer or an Agilent Cary 60 UV-Vis Spectrophotometer. Quartz 
cells with screw caps and four polished sides (Starna) were used for fluorescence and 
UV-vis measurements.  
Dynamic Light Scattering (DLS) measurements were performed with a Malvern 
Zetasizer Nano ZS instrument and analysed with Malvern Zetasizer Software 7.03. 
All measurements were made in triplicate (with 10 measurements recorded for each 
run). 
Synchrotron small-angle X-ray scattering (SAXS) measurements were carried by Dr 
Anaïs Pitto-Barry, on the SAXS/WAXS beamline at the Australian Synchrotron 
facility at a photon energy of 11 keV. The samples in solution were run by using a 1.5 
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mm diameter quartz capillary. Temperature was held at 25 °C and controlled via a 
water bath connected to a brass block which is part of the sample holder. The 
measurements were collected at a sample-to-detector distance of 7.323 m to give a 
q range of 0.02 to 0.14 Å-1.  
All patterns were normalised to fixed transmitted flux using a quantitative beamstop 
detector. The scattering from a blank was measured in the same capillary and was 
subtracted for each measurement. The two-dimensional SAXS images were 
converted in one-dimensional SAXS profile (I(q) vs q) by circular averaging, where 
I(q) is the scattering intensity. The functions used for the fitting from the NIST SANS 
analysis package were “Guinier-Porod”,41,42 “Debye”,43 “PolyCoreForm”.44 
ScatterBrain45 and Igor46 were used to plot and analyse the data. The scattering 
length density of the solvent and the monomers were calculated using the 
“Scattering Length Density Calculator” provided by NIST Center for Neutron 
Research. Limits for q range were applied for the fittings from 0.002 to 0.1 Å-1.  
The stained transmission electron microscopy (TEM) images were obtained using a 
JEOL 2000FX or a JEOL 2100 LaB6 instrument operated at 200 kV. TEM samples 
were negatively stained by a aqueous solution of uranyl acetate (UA, 2.5 wt%) on 
formvar/carbon grids (300 Mesh, Cu, Elektron Technology UK LTD). Typically, 
formvar/carbon grids were cleaned by air plasma from a glow-discharge system (2 
min, 20 mA) which also improved the hydrophobicity of the grids. 5 µL of particle 
solution was added onto the grid and the solution was left to air-dry for 3 h. 5 µL of 
a 2.5 wt% UA solution was then added onto the grid to stain the particles and was 
blotted away after 15 s before air-drying. 
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4.5.2. Synthetic procedures 
 Monomer synthesis 
 Synthesis of the dibromomaleimide methacrylate (DBMMA) 
 
 
To an oven-dried round-bottom flask under an inert nitrogen atmosphere was added 
triphenyl phosphine (1.03 g, 1 equiv.) and dry THF (35 mL). The mixture was cooled 
to -78 °C before the dropwise addition of diisopropyl azodicarboxylate (0.769 mL, 1 
equiv.). The mixture was stirred for 5 min before adding 2-hydroxyethyl 
2-methylprop-2-enoate (0.475 mL, 1 equiv.), stirred for a further 5 min before adding 
2,2 dimethylpropan-1-ol (0.170 g, 0.5 equiv.), and stirred a further 5 min before 
adding 2,3-dibromomaleimide (1.00 g, 1 equiv.). The reaction was allowed to warm 
to room temperature while stirring for 18 h. The solvent was removed in vacuo, and 
the crude mixture purified by column chromatography on silica gel using a 1:1 
mixture of petroleum ether and dichloromethane, to give the product as a white 
solid (1.037 g, 73 %). 1H NMR (300 MHz, CDCl3) δ 6.08 (1H, br, H1b), 5.59 (1H, br, 
H1a), 4.30 (2H, t, 3JH-H = 6.0 Hz, H5), 3.95 (2H, t, 3JH-H = 5.5 Hz, H6), 1.90 (3H, s, H3); 
13C NMR (75 MHz, CDCl3) δ 163.1 (C7), 136.2 (C8), 135.2 (C2), 128.9 (C4), 126.0 (C1), 
61.0 (C5), 38.0 (C6), 17.6 (C3); FTIR (neat) νmax / cm-1 1720 (C=O of ester), 1633 (C=O 
of maleimide), 1595 (C=C aromatic), 1170 (C-O of ester); HR-MS (MaXis) m/z found 
389.8770, calc. 389.8770 ([M+Na]+, 100 %). 
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 Synthesis of (isopropyl)aminobromomaleimide methacrylate (ABMMA) 
 
 
DBMMA (1.00 g, 1 equiv.) was dissolved in THF (50 mL). To the solution, sodium 
carbonate (0.720 g, 2.5 equiv.) was added and stirred. Isopropylamine (0.250 mL, 
1.05 equiv.) was added dropwise to the solution, whereby an immediate colour 
change of the solution from colourless to yellow and the formation of a white 
precipitate was observed. Upon complete addition of isopropylamine, the solution 
was left to stir for 2 h at room temperature. The solvent was removed in vacuo, the 
residue dissolved in CH2Cl2 (150 mL), washed with water (2 × 150 mL) and dried 
with MgSO4. The organic layer was concentrated in vacuo and the product purified 
by column chromatography on silica gel using a 10:1 mixture of petroleum ether and 
ethyl acetate to yield the product as a yellow-orange solid (0.88 g, 94 %). 1H NMR 
(400 MHz, CDCl3) δ 6.09 (1H, br, H1b), 5.58 (1H, br, H1a), 5.28 (1H, br, H10), 4.42 
(1H, m, H11), 4.27 (2H, t, 3JH-H = 5.0 Hz, H5), 3.84 (2H, t, 3JH-H = 6.0 Hz, H6), 1.91 (3H, 
s, H3), 1.30 (6H, d, 3JH-H = 6.5 Hz, H12); 13C NMR (75 MHz, CDCl3) δ 166.8 & 166.4 
(C4, C8), 165.4 (C7), 141.7 (C9), 135.2 (C2), 125.7 (C1), 61.3 (C5), 44.2 (C11), 36.8 (C6), 
23.1 (C12), 17.6 (C3); FTIR (neat) νmax / cm-1 3284 (H-N of isopropylamine), 1710 and 
1657 (C=O of maleimide), 1181 (C-O of ester); HR-MS (MaXis) m/z found 367.0267, 
calc. 367.0264 ([M+Na]+,100%); λex,max (10-5 M in 1,4-dioxane at r.t.) 247 nm and 372 
nm, λem,max (10-5 M in 1,4-dioxane at r.t.) 482 nm. 
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 Particles 
General procedure for the synthesis of fluorescent particles.  
Oligoethylene glycol methacrylate (OEGMA) (0.11 mmol) was first dissolved in 44 
mL of water and then ethylene glycol dimethacrylate (EGDMA) (0.126 mmol), and 
aminobromomaleimide methacrylate (ABMMA) (0.145 mmol) were dissolved in 
N,N-(diethylaminoethyl methacrylate) (DEAEMA) (13.5 mmol) and added dropwise 
to the solution. The mixture, whilst stirred, was purged with nitrogen for 30 min 
and further heated at 65 °C for 30 min. The initiator, potassium persulfate (KPS) 
(0.093 mmol), was dissolved in water (1 mL) and purged with nitrogen before being 
added to the reaction mixture. The reaction was stirred at 65 °C for 16 h under a 
nitrogen atmosphere. The particles were purified by exhaustive dialysis (MWCO 3.5 
kDa) against water. 
 Responsive and fluorescent responsive particles 1-18 
For all these different batches of particles, OEGMA, MW = 360 Da, Ω-end: OH, was 
used, and the different ratios between the monomers and initiator were detailed in 
Table 4.2.  
 Responsive particles with OEGMA360 (RP-360) 
In this case, OEGMA, MW = 360 Da, Ω-end: OH (0.04 g), DEAEMA (2.5 g), EGDMA 
(0.025 g) and KPS (0.025 g) were used in the general procedure.  
 Fluorescent responsive particles with OEGMA360 (FRP-360) 
In this case OEGMA, MW = 360 Da, Ω-end: OH (0.04 g), DEAEMA (2.5 g), EGDMA 
(0.025 g), KPS (0.025 g) and ABMMA (0.09 g) following the general procedure.  
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 Responsive particles with OEGMA500 (RP-500) 
In this case, OEGMA, MW = 500 Da, Ω-end: CH3 (0.055 g), DEAEMA (2.5 g), 
EGDMA (0.025 g) and KPS (0.025 g) were used in the general procedure.  
 Responsive particles with OEGMA950 (RP-950) 
In this case, OEGMA, MW = 950 Da, Ω-end: CH3 (0.105 g), DEAEMA (2.5 g), 
EGDMA (0.025 g) and KPS (0.025 g) were used in the general procedure.  
 Responsive particles with OEGMA2000 (RP-2000) 
In this case, OEGMA, MW = 2000 Da, Ω-end: CH3, 50 wt% solution in water (0.442 
g), DEAEMA (2.5 g), EGDMA (0.025 g) and KPS (0.025 g) were used in the general 
procedure.  
 Fluorescent responsive particles with OEGMA2000 (FRP-2000) 
In this case, OEGMA, MW = 2000 Da, Ω-end: CH3, received as 50 wt% solution in 
water (0.442 g), DEAEMA (2.5 g), EGDMA (0.025 g), KPS (0.025 g) and ABMMA 
(0.05 g) were used in the general procedure.  
 General procedure for CO2/N2 responsiveness experiments 
Carbon dioxide was bubbled into the solution of particles through a needle at a 
regular flow for 15 min. After characterisation of the solution post-CO2-bubbling, 
nitrogen was bubbled in the same solution for 30 min, and the resulting solution 
was characterised. For the different measurements, different solution 
concentrations were necessary, therefore cycles monitored by fluorescence and light 
scattering were performed with distinct samples.  
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5.1. Abstract 
In this chapter, the development of fluorescent responsive particles was further 
advanced to include a glutathione (GSH) responsive system. The incorporation of 
the aminobromomaleimide functionality in the particles’ core would allow a read-
out of the particles’ disassembly. The aminobromomaleimide monomer has been 
shown to be sensitive to its environment, in polar protic environments the 
fluorescence is quenched. The proposed particles were cross-linked with a disulfide-
based dimethacrylate (DSDMA), which is responsive to glutathione through the 
reduction of the disulfide bond. In the presence of glutathione, the cross-linked 
particles would disassemble and therefore the fluorescence of the 
aminobromomaleimide monomer would be quenched when exposed to the 
solution. 
  
 
Figure 5.1. Schematic representation of the concept of the project: synthesis of 
glutathione (GSH) responsive particles with fluorescent read-out. 
Chapter 5 
167 
 
5.2. Introduction 
Along with other responsive systems, redox-responsive polymers have been 
extensively investigated for drug-delivery applications.1-12 The natural abundance of 
the glutathione/glutathione disulfide redox couple in animal cells has encouraged 
the development of glutathione responsive polymers toward potential drug-delivery 
applications. In vivo studies showed that normal cells exhibit different intra-cellular 
(1-10 mM) and extra-cellular (1-10 µM) glutathione concentrations, the highest 
concentration being in the cell.13 This difference is more significant for cancer cells, 
which can exhibit a glutathione concentration up to seven-fold higher than normal 
cells.13  
Grayson and co-workers presented the synthesis of glutathione-responsive 
degradable hydrogels,14 synthesised from (hydroxyethyl)methacrylate (HEMA) and 
containing a disulfide-based dimethacrylate (DSDMA) cross-linking monomer via 
free radical polymerisation along with an analogous non-responsive nanogel. The 
DSDMA nanogels exhibited the quick release of a dye in the presence of glutathione 
at micro-molar concentration. However, when tested for in vitro experiments, it 
appeared that the micro-molar concentration of glutathione was too low to trigger 
drug release even over a seven day period.  
Yang and co-workers presented the synthesis of glutathione, pH, and temperature 
responsive microgels.15 Biodegradable poly(vinylcaprolactam) based microgels 
containing N,N-bis(acryloyl) cystamine (BAC) were synthesised with a disulfide 
containing responsive cross-linker. These microgels were able to encapsulate 
doxorubicin, and cytotoxicity assays showed the good biocompatibility of these 
microgels. Upon degradation, triggered by exposure to glutathione, the nanogels 
effectively released doxorubicin and a good inhibition effect against HeLa cells was 
observed. 
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More recently, Yang and co-workers reported a similar poly(oligo(ethylene 
glycol)methacrylate) (POEGMA) nanogel system utilising the same cystamine-
based responsive cross-linker (BAC), see Figure 5.2.16 These nanogels also exhibited 
minimal leakage of the doxorubicin, however in the presence of glutathione, 
effective release of doxorubicin and a good inhibition effect against the HeLA cells 
were observed.  
Whittaker and co-workers synthesised cross-linked star polymers for imaging 
applications.9 This polymer, containing 2,2,2-trifluoroethyl methacrylate, could 
provide a 19F signal for MRI and a disulfide cross-linker was incorporated into the 
stars to allow the degradation of the contrast agent. The nanogels were shown to 
degrade upon addition of tris(2-carboxyethyl)phosphine (TCEP), which confirmed 
the biodegradability of the contrast agent. 
These examples show the potential of glutathione-responsive materials for drug-
delivery applications. The different concentrations of glutathione inside and outside 
 
Figure 5.2. Schematic example of the synthesis and response of N,N-bis(acryloyl) 
cystamine containing nanogels; loading and release of doxorubicin. Reproduced 
from reference.16  
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the cells and especially with cancer cells provides a straightforward strategy for 
drug-delivery systems. The use of a glutathione-responsive cross-linker, allowing the 
disassembly of a polymeric structure upon exposure to high concentration of 
glutathione could lead to the release of an encapsulated drug. 
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5.3. Results and discussion 
The synthesis of responsive particles was inspired by the particles presented in 
Chapter 4,17 however, a different cross-linking monomer was employed. The 
objective was to utilise a responsive cross-linker that would cleave in the presence 
of a specific concentration range of glutathione, which would result in the 
disassembly of the particles and the potential release of an encapsulated drug. The 
fluorescent functionality present in the core of the particles (fluorescence quenched 
upon exposure to water) would probe the state of the particles (cross-linked or 
unimers), therefore give a read-out response on the release of the drug. To achieve 
this objective, additional parameters needed to be considered for the synthesis of 
these particles. Firstly, the size of the nanoparticles; to allow the cellular uptake of 
these particles, their diameter should be below 100 nm, and a low particle size 
dispersity (PD < 0.1) is necessary.18-21 Secondly, the particles’ response; the particles 
would have to be responsive and disassemble at an intra-cellular concentration (1 
mM) of glutathione, and non-responsive at an extra-cellular concentration (10 µM) 
of glutathione, allowing the particles to preserve their integrity until they penetrate 
the cells. 
5.3.1. Preliminary tests 
The synthesis of the first batch of particles (1) was inspired by CO2-responsive 
particles synthesised in the previous chapter. The cross-linked core/shell particles 
(1) were composed of oligo(ethylene glycol) methyl ether methacrylate 
(OEGMA2000, Mn ≈ 2000 g·mol-1, 1 equivalent) for the hydrophilic shell, N,N-
diethylaminoethyl methacrylate (DEAEMA, 120 equivalents) and DSDMA (1 wt%) 
for the cross-linked hydrophobic core, see Figure 5.3. These particles were 
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synthesised via emulsion polymerisation in water, initiated with potassium 
persulfate (KPS, 1 wt%) at 65 °C under nitrogen atmosphere.  
 
 
Figure 5.3. Schematic representation of the synthesis of the 
glutathione-responsive particles (1). 
 
The resulting size of these particles was larger than 100 nm, this was expected 
knowing that the particles synthesised in the previous chapter were 250 nm in 
diameter. These DSDMA-containing particles (1) were 400 nm in diameter with a 
low dispersity (PD = 0.056), see Figure 5.4.  
 
 
Figure 5.4. DLS data for glutathione-responsive particles (1) in water at 
ca. 0.05 mg·mL-1. 
 
As a preliminary test, despite their large diameter, the response of these particles to 
glutathione was tested. Control experiments with non-responsive particles (2, 
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Dh = 205 nm, PD = 0.03), prepared with the non-responsive cross-linking monomer 
ethylene glycol dimethacrylate (EGDMA), were also performed. The size of particles 
in both batches was measured before and after addition of glutathione. Two 
solutions of glutathione were prepared at 20 mM and 200 µM; when added to the 
particle samples, the final GSH concentrations of the samples were 1 mM and 10 µM. 
These concentrations correspond respectively to intra-cellular and extra-cellular 
concentrations.13 It was observed that for the 10 µM GSH sample, the particle size of 
the responsive particles did not change upon addition of GSH up to 6 days after the 
addition of GSH, see Figure 5.5 and Figure 5.6. However, for the 1 mM GSH sample, 
a change in particle diameter, from 400 nm to 18 nm, was observed for the 
responsive particles by DLS, which would correspond to the disassembly of the 
particles upon addition of GSH, see Figure 5.5 and Figure 5.6. This experiment 
confirmed that particles were responsive to GSH at a relevant intra-cellular similar 
concentration and non-responsive at an extra-cellular similar concentration. 
 
 
Figure 5.5. DLS data for the responsive particles (1) in water at ca. 0.05 mg·mL-1 
before and after the addition of the GSH solutions (1 mM and 10 µM) and 6 days 
later for 10 µM. 
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Figure 5.6. Correlation function corresponding to the DLS data for the 
responsive particles (1) in water at ca. 0.05 mg·mL-1 before and after the addition 
of the GSH solutions (1 mM and 10 µM). 
 
The equivalent control experiments with the non-responsive particles (2) showed, 
similarly to responsive particles (1), an absence of response with 10 µM glutathione, 
see Figure 5.7 and Figure 5.8. However, with 1 mM, an increase in size can be 
observed, which could correspond to particles aggregation, see Figure 5.7 and Figure 
5.8. These results confirmed that the disassembly observed with the responsive 
particles (1) occurred as a consequence of the presence of the disulphide cross-
linker. 
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Figure 5.7. DLS data for the non-responsive particles (2) in water at 
ca. 0.05 mg·mL-1 before and after the addition of the GSH solutions (1 mM and 
10 µM). 
   
 
Figure 5.8. Correlation function corresponding to the DLS data for the 
responsive particles (2) in water at ca. 0.05 mg·mL-1 before and after the 
addition of the GSH solutions (1 mM and 10 µM). 
 
These experiments confirmed the potential of this particles as GSH-responsive 
system, however, the size of these particles was too high to allow tests with living 
cells as the particles would not be able to penetrate the cells. The next objective was 
to optimise and reduce the size of the glutathione-responsive particles.  
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5.3.2. Synthesis of fluorescent glutathione-responsive particles 
5.3.2.1. Optimisation of the particles synthesis 
In order to optimise the size of the particles, different parameters were altered: 
including the use of different monomers for both the core and shell, and their ratio 
was varied. The monomers and their ratios were changed in order to increase the 
hydrophobicity of the core and vary density of the shell; these parameters could both 
have an effect on particles’ size and stability. The synthesis was tested with different 
percentages of initiator and cross-linker, and different types of stirring were also 
tested. In this optimisation study, the particles were synthesised without the 
fluorescent aminobromomaleimide monomer, as it was previously shown in Chapter 
4 that the incorporation of this fluorescent monomer does not affect the 
hydrodynamic diameter of the particles. The different core monomers tested were 
DEAEMA (as used in Chapter 4), ethyl methacrylate (EMA), and methyl 
methacrylate (MMA). Different monomers were also tested for the composition of 
the shell of the particles: oligo(ethylene glycol) methyl ether methacrylate Mn ≈ 
2000 g·mol-1 (OEGMA2000), oligo(ethylene glycol) methacrylate Mn ≈ 360 g·mol-1 
(OEGMA360), triethylene glycol methyl ether methacrylate (TEGMA), and 
di(ethylene glycol) methyl ether methacrylate (DEGMA). Regarding the nature of 
the cross-linker, the size of the particles was optimised utilising EGDMA instead of 
DSDMA in the synthesis, as a consequence of the cost difference between the two 
chemicals. The initiator, potassium persulfate (KPS), and the concentration of 
monomer in water were kept the constant.  
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Figure 5.9. Structures of the different monomers utilised in the synthesis of the 
particles. 
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Table 5.1. Composition of the different particles presented in this chapter 
shell (eq.) core (eq.) 
cross-linker   
(wt%) 
fluorophore 
(wt%) 
initiator 
(wt%) 
Dh 
(nm) 
PD 
 batch 
number 
OEGMA 
2000 
OEGMA 
360 
TEGMA DEGMA MMA EMA DEAEMA EGDMA DSDMA ABMMA KPS    
1           120  1  1 400 0.06 1 
1           120 1   1 205 0.03 2 
1       120     1   1 n/a n/a 3 
1       100     1   1 n/a n/a 4 
1       50     1   1 n/a n/a 5 
1       40     1   1 n/a n/a 6 
1       30     1   1 n/a n/a 7 
1       20     1   1 n/a n/a 8 
1         120   1   1 n/a n/a 9 
1         100   1   1 n/a n/a 10 
1         50   1   1 n/a n/a 11 
  1         120 1   1 165 0.06 12 
  1         50 1   1 190 0.02 13 
    1       120 1   1 410 0.02 14 
    1       50 1   1 265 0.04 15 
 1      50 1   5 185 0.02 16 
    1       50 1   5 115 0.02 17 
    1       50 1   7 420 0.21 18 
    1       50 1   10 400 0.02 19 
      1     50 1   5 155 0.04 20 
    1       50 2   5 190 0.02 21 
    1       50 5   5 455 0.05 22 
  1    50  1  5 95 0.04 23 
  1    50  1 1 5 140 0.02 24 
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Attempts to reduce the size of the particles were first focused on the composition of 
the core of the particles. The synthesis of the particles was tested with MMA 
(particles 3-8), utilising different equivalent ratios of MMA to the shell monomer, 
OEGMA2000. Monomer ratios ranged from 120 to 20 equivalents of MMA for 1 
equivalent of OEGMA2000, with 1 wt% of cross-linker (EGDMA) and 1 wt% of 
initiator (KPS). Similarly, the synthesis of the particles was tested with EMA 
(particles 9-11) instead of MMA. The different particle batches obtained were 
analysed by dynamic light scattering (DLS), all the batches presented similar DLS 
profiles: high dispersities and multiple populations, see Figure 5.10 for examples of 
DLS data for MMA and EMA particles (3 and 9). It would have been interesting to 
measure the pH when measuring the size, in order to compare the influence of the 
variation of the core monomer nature. These results could be attributed to the 
higher hydrophobicity of PMMA and PEMA compared to PDEAEMA, which could 
promote the formation of particles aggregates.  
 
MMA particles EMA particles 
  
Figure 5.10. Example of DLS data obtained for MMA particles (3) or EMA 
particles (9) in water at ca. 0.05 mg·mL-1. 
 
Following these unsuccessful experiments, the focus was shifted to the composition 
of the shell of the particles. As previously observed in Chapter 4, the composition of 
the shell can have a drastic impact on the particles behaviour. The shell monomer 
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was changed from OEGMA2000 to OEGMA360 (12-13) or TEGMA (14-15), in order 
to test the effect of the density of the shell on the particles’ size, a denser shell would 
be obtain with OEGMA2000 than with TEGMA as a consequence of a lower number 
of ethylene oxide units. The different ratios between hydrophobic and hydrophilic 
monomer were tested to assess the effect on the particles size. Different batches of 
particles were synthesised with 120 or 50 equivalents of DEAEMA for 1 equivalent of 
OEGMA360 or TEGMA, with 1 wt% cross-linker and 1 wt% initiator. Particles 
synthesised with OEGMA360 (12-13) were of a smaller hydrodynamic diameter 
(165 nm and 190 nm) compared to the particles synthesised with TEGMA (14-15; 410 
nm and 265 nm) as revealed by DLS analysis. All the particles (12-15) showed a low 
dispersity, see Table 5.2. These experiments confirmed that the length of the shell 
monomer and therefore the shell density can have an impact on the particles’ size, 
however, the particles obtained were too large (> 100 nm). 
Table 5.2. Different ratios of DEAEMA to OEGMA360 or TEGMA, and the size of 
the particles obtained (in water at ca. 0.05 mg·mL-1). 
Shell 
monomer 
wt% 
cross-
linker 
wt% 
initiator 
Number 
of eq. of 
DEAEMA 
Hydrodynamic 
diameter (nm) 
PD 
Batch 
number 
OEGMA360 
1 eq.  
1 1 
120 165 0.06 12 
50 190 0.02 13 
TEGMA 
1 eq. 
1 1 
120 410 0.02 14 
50 265 0.04 15 
 
As shown in Chapter 4, an increase of the quantity of initiator could contribute to 
the reduction of the particles’ size, therefore, particles were synthesised with 5 wt% 
of initiator instead of 1 wt%. The particles were synthesised with 50 equivalents of 
DEAEMA for 1 equivalent of OEGMA360 or TEGMA, with 1 wt% cross-linker and 5 
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wt% initiator. The particles synthesised with OEGMA360 (16) possessed an average 
hydrodynamic diameter of 185 nm with a low dispersity (PD = 0.02), see Table 5.3. 
Meanwhile, the particles synthesised with TEGMA (17) possessed a diameter of 115 
nm with a low dispersity (PD = 0.02), see Table 5.3. This result was the closest to 
the diameter and dispersity requirements for the particles; particle diameter ≤ 100 
nm and a low dispersity (< 0.1). These results confirmed that the shell density can 
have an impact on the size of the particles. 
As an increase in the quantity of initiator reduced particle size for the PDEAEMA 
particles, higher quantities of initiator were tested: 7 wt% (18) and 10 wt% (19). 
Particles were synthesised with 50 equivalents of DEAEMA for 1 equivalent of 
TEGMA, 1 wt% cross-linker, and 7 wt% or 10 wt% initiator. However, the particles 
obtained were of diameters of 420 nm (PD = 0.21) and 400 nm (PD = 0.02) 
respectively, see Table 5.3.  
Table 5.3. Different percentages of initiator used for OEGMA360 particles or 
TEGMA particles, and the size of the particles obtained (in water at 
ca. 0.05 mg·mL-1). 
Shell 
monomer 
wt% 
cross-
linker 
Number 
of eq. of 
DEAEMA 
wt% 
initiator 
Hydrodynamic 
diameter (nm) 
PD 
Batch 
number 
OEGMA360 
1 eq.  
1 50 
1 190 0.02 13 
5 185 0.02 16 
TEGMA 
1 eq. 
1 50 
1 265 0.04 15 
5 115 0.02 17 
7 420 0.21 18 
10 400 0.02 19 
 
For comparable composition, particles synthesised with OEGMA360 (16) were 
185 nm diameter and particles synthesised with TEGMA (17) were 115 nm diameter. 
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As an improvement in the particle size was observed through the reduction of the 
number of ethylene glycol units of the shell monomer (from OEGMA2000 with 43 
units, and OEGMA360 with 9 units, to TEGMA with 3 units). The synthesis of the 
particles was tested with a shorter ethylene glycol methacrylate, DEGMA (2 ethylene 
glycol units) (20), the monomer ratios used were 50 equivalents of DEAEMA for 1 
equivalent of DEGMA, with 1 wt% cross-linker and 5 wt% initiator. The particles 
obtained were 155 nm in diameter with a low dispersity (PD = 0.04). In this case, the 
reduction of the shell monomer length did not further reduce the size of the 
particles, therefore the use of DEGMA was not further investigated. 
Different quantities of cross-linker were also tested, based on the particles 
synthesised from 50 equivalents of DEAEMA for 1 equivalent of TEGMA, with 1 wt% 
cross-linker and 5 wt% initiator (17). The cross-linking density would be expected to 
have an impact on the particles’ size as it would affect the core compactness. The 
percentage of cross-linker was increased to 2 wt% (21) and 5 wt% (22). The size of 
the particles obtained were 190 nm and 455 nm (PD = 0.05 and PD = 0.02) for 2 
wt% and 5 wt% EGDMA respectively, see Table 5.4. It appeared that increasing the 
quantity of cross-linker did not afford a reduction in the hydrodynamic diameter of 
the particles. However, the increase in particles’ diameter and the consistent low 
dispersity could indicate inter-cross-linking between particles. 
Table 5.4. Different percentages of cross-linker used in TEGMA/DEAEMA 
particles, and the size of the particles obtained (in water at ca. 0.05 mg·mL-1). 
Number 
of eq. of 
TEGMA 
Number 
of eq. of 
DEAEMA 
wt% 
initiator 
wt% 
cross-
linker 
Hydrodynamic 
diameter (nm) 
PD 
Batch 
number 
1  50 5 
1 115 0.02 17 
2 190 0.02 21 
5 455 0.05 22 
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In an attempt to improve the particles’ size, the synthesis of particles 17 was tested 
with mechanic stirring utilising an over-head stirrer, however, despite a better shear, 
the particles obtained were of a larger diameter (420 nm, PD = 0.05). 
To conclude, the results of these different tests determined the current optimal 
conditions to be the one used to obtain particles 17: 50 equivalents of DEAEMA for 
1 equivalent of TEGMA, with 1 wt% cross-linker and 5 wt% initiator, utilising 
magnetic stirring. As mentioned above, these particles were 115 nm in diameter, with 
a low dispersity (PD = 0.02) and TEM images confirmed the spherical morphology 
of the particles (see Figure 5.11 for DLS data and Figure 5.12 for TEM image).  
 
 
Figure 5.11. DLS data for the optimal DEAEMA/TEGMA/EGDMA particles (17), 
in water at ca. 0.05 mg·mL-1. 
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Figure 5.12. TEM image of DEAEMA/TEGMA/EGDMA particles (17) stained with 
uranyl acetate, and the distribution of size observed. 
 
5.3.2.2. Synthesis of DSDMA-containing particles  
Following the results of the optimisation, the same particles were synthesised with 
the glutathione-responsive cross-linker DSDMA instead of EGDMA, with 50 
equivalents of DEAEMA for 1 equivalent of TEGMA, 1 wt% DSDMA and 5 wt% 
initiator (23), see Figure 5.13.  
 
 
Figure 5.13. Schematic representation of the synthesis of the DSDMA-containing 
particles (23). 
 
These DSDMA cross-linked particles were analysed by DLS and found to have a 
hydrodynamic diameter of 95 nm with a dispersity of 0.04, and therefore met the 
particle size requirements defined earlier in this chapter (see Figure 5.14 for DLS 
data). The spherical morphology was confirmed by TEM (see Figure 5.15), however 
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the size of the particles observed by TEM appeared to be larger than the size 
obtained by light scattering, this size difference could be attributed to a drying 
effect, which could make particles look bigger as they spread upon drying on the 
TEM grid. 
 
 
Figure 5.14. DLS data for the DSDMA-containing particles (23), in water at 
ca. 0.05 mg·mL-1. 
  
  
Figure 5.15. TEM image of DSDMA-containing particles (23) stained with uranyl 
acetate, and the distribution of size observed. 
 
5.3.2.3. Synthesis of fluorescent DSDMA-containing particles 
Fluorescent DSDMA-containing particles (24) were synthesised by emulsion 
polymerisation following the same protocol as for the DSDMA-containing 
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particles (23), see Figure 5.16. To incorporate the fluorescent monomer ABMMA 
(aminobromomaleimide methacrylate) into the emulsion polymerisation, it was 
dissolved into DEAEMA before the mixture was added to the OEGMA solution in 
water to form the emulsion.  
 
 
Figure 5.16. Schematic representation of the synthesis of fluorescent DSDMA-
containing particles (24). 
 
 
The particles obtained were characterised by DLS, and found to have diameter of 
140 nm and a low dispersity (PD = 0.02), see Figure 5.17. The fluorescence emission 
and excitation spectra were recorded, the emission maximum was found at 482 nm 
for an excitation maximum at 370 nm, see Figure 5.18.  
 
 
Figure 5.17. DLS data for the fluorescent DSDMA-containing particles (24), in 
water at ca. 0.05 mg·mL-1. 
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Figure 5.18. Fluorescence emission (green line) and excitation (black line) 
spectra of the fluorescent DSDMA-containing particles (24), in water at ca. 
0.05 mg·mL-1. λex = 375 nm, λem = 485 nm. 
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5.3.3. Responsiveness experiments 
The DSDMA-containing particles (23-24) were exposed to glutathione at different 
concentrations: 1 mM and 10 µM, which respectively correspond to intra-cellular and 
extra-cellular typical concentrations. A small volume of a concentrated solution of 
glutathione was added to a solution of particles to obtain the desired final 
glutathione concentration with a minimised dilution effect on the solution of 
particles. The DSDMA-containing particles (23-24) response was monitored by DLS 
and the response of the fluorescent DSDMA-containing particles (24) was also 
monitored by fluorescence emission.  
5.3.3.1. Monitoring of the size of DSDMA-containing particles (23) 
According to the preliminary experiment, these DSDMA-containing particles (23) 
would be expected to disassemble upon exposure to 1 mM glutathione. The size of 
the particles was monitored over time after addition of glutathione. Similarly to the 
preliminary experiment, in 10 µM glutathione the particles did not exhibit any 
response, see Figure 5.19.  
 
 
Figure 5.19. DLS data for the DSDMA-containing particles (23), in water at 
ca. 0.05 mg·mL-1, with 10 µM GSH monitored over time (number distribution). 
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However, in 1 mM glutathione, the particles showed a very quick response, within 
30 second, the particles size drastically decreased, see Figure 5.20. The disassembly 
was also confirmed by the lack of scattering, indicating the absence of nanostructure 
in solution, see Figure 5.20. 
 
 
 
Figure 5.20. DLS data of the DSDMA-containing particles (23), in water at 
ca. 0.05 mg·mL-1, with 1 mM GSH monitored over time (number distribution), 
and corresponding correlation functions. 
 
5.3.3.2. Monitoring of the size and fluorescence emission of the fluorescent 
DSDMA-containing particles (24) 
The size was the fluorescent DSDMA-containing particles (24) was monitored and 
as expected, showed similar results to the non-fluorescent DSDMA-containing 
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particles (23). The DLS data showed a similar absence of response upon exposure to 
10 µM glutathione, see Figure 5.21. However, after 17 hours larger nanostructures 
appeared, which could be a consequence of particles aggregation over time.  
 
 
Figure 5.21. DLS data for the fluorescent DSDMA-containing particles (24), in 
water at ca. 0.05 mg·mL-1, with 10 µM GSH monitored over time (number 
distribution). 
 
Similarly to the non-fluorescent particles (23), a quick response of fluorescent 
particles (24) exposed to 1 mM glutathione was observed, within 30 second, and a 
decrease in scattering intensity confirmed the particles disassembly, see Figure 5.22. 
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Figure 5.22. DLS data for the fluorescent DSDMA-containing particles (24), in 
water at ca. 0.05 mg·mL-1, with 1 mM GSH monitored over time (number 
distribution) and the corresponding correlation functions. 
 
The fluorescence emission of the fluorescent DSDMA-containing particles (24) was 
monitored over time following the addition of glutathione. As introduced in Chapter 
3, the aminobromomaleimide functionality is sensitive to protic environment; the 
ABM functionality is highly emissive in aprotic environments but the emission is 
quenched in protic environments as a consequence of hydrogen bonding between 
the functionality’s carbonyls and the solvent. The fluorescent probe ABMMA being 
located in core of the particles, it is protected from the protic environment, when 
particles were disassembled upon glutathione addition, the probe would be exposed 
to the environment, therefore the fluorescence would be quenched. As expected, the 
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particles with 10 µM glutathione did not show a drastic emission intensity decrease, 
the minor decrease observed could be the result of the disassembly of a small 
number of particles, see Figure 5.23. However, particles with 1 mM glutathione 
showed a quick and drastic emission intensity decrease within 30 second, see Figure 
5.24. 
 
Figure 5.23. Fluorescence emission of fluorescent DSDMA-containing particles 
(24), in water at ca. 0.05 mg·mL-1, with 10 µM GSH monitored over time, 
λex = 375 nm. 
 
Figure 5.24. Fluorescence emission of fluorescent DSDMA-containing particles 
(24), in water at ca. 0.05 mg·mL-1, with 1 mM GSH monitored over time, 
λex = 375 nm. 
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5.3.4. Sedimentation of the particles 
The potential application for this material being drug-delivery related, it was 
important to be able to purify the particles. However, it was observed that upon 
purification of the particles via dialysis, after several days and dialysate changes, the 
particles were destabilised and started to sediment. After further investigation, it 
was found that the stability of the particles was affected by the pH of the particles 
solution. The pH of the particles solution post-synthesis was basic (pH ≈ 9), 
following purification via dialysis against water, the pH of the solution was 
progressively neutralised through several dialysate changes. DLS analysis confirmed 
the formation of aggregates with large particle diameters and a high dispersity, see 
Figure 5.25. Sedimentation of the purified particles could be observed after being 
stored on the shelf for several days, see Figure 5.26.  
 
Figure 5.25. DLS data for DSDMA-containing particles (23), in water, after 
dialysis against water (unknown concentration). 
 
  
Chapter 5 
193 
 
  
Figure 5.26. Pictures of DSDMA-containing particles (23) in water before (left) 
and after (right) dialysis. 
 
However, TEM images showed particles of a similar shape and dimension before and 
after dialysis, aggregates were observed in both samples, which could be a result of 
a drying effect, see Figure 5.27.  
 
Before 
dialysis 
   
After 
dialysis 
   
Figure 5.27. TEM images of the DSDMA-containing particles (23) before and 
after dialysis, at different magnifications. 
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The influence of pH on the stability of the particles was further confirmed through 
the increase of the pH of the dialysed particle solution to pH 9. The solution 
appeared to recover stability upon dropwise addition of a 10 mM sodium hydroxide 
solution, see Figure 5.28. It appeared that after the pH was increased to 9, the 
hydrodynamic diameter of the particles was reduced, however some aggregates 
could still be observed by DLS and the dispersity was higher (PD = 0.3) than before 
purification (PD < 0.1), see Figure 5.29. The instability of the particles could be 
related to the pH-responsive nature of the core of the particles, as all the particles 
synthesised with DEAEMA (1, 2, 12-24) exhibited a basic pH at the end of the 
synthesis, unlike particles synthesised with EMA or MMA (3-11), which were acidic. 
The pH at which particles seem to be stable (pH ≈ 9) is not suitable for living cells, 
therefore, further optimisation of particle synthesis and purification would be 
required. 
  
 
  
Figure 5.28. Pictures of DSDMA-containing particles (23), in water before (left) 
and after (right) pH increased to 9 via addition of NaOH. 
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Figure 5.29. DLS data for DSDMA-containing particles (23), in water before 
dialysis (pH 9), after dialysis (pH 7) and after addition of NaOH (pH increased 
to 9). 
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5.3.5. Control experiments 
Control experiments were performed with particles that are not GSH-responsive and 
particles that are neither GSH-responsive nor pH-responsive, in order to confirm 
that GSH only impact on particles is to cleave the particles GSH-responsive cross-
linker. The size and the fluorescence intensity of these two batches of particles were 
measured before and after the addition of GSH for a concentration of 1 mM.  
The size and the fluorescence emission of the particles that were not responsive to 
glutathione were not expected to be affected by GSH. However, it appeared that 
both fluorescence emission and particles’ size were altered by the addition of 
glutathione. 
 
  
Figure 5.30. DLS data for non-GSH-responsive particles in water at ca. 0.05 
g·mL-1 before (left) and after addition of GSH (right). 
 
When glutathione was added to these particles, an increase in diameter of structure 
and dispersity could be observed, see Figure 5.30. The fluorescence emission of this 
batch before and after addition of glutathione was measured and a drastic decrease 
in fluorescence emission intensity was observed (see Figure 5.31) when it was not 
expected to be changed.  
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Figure 5.31. Fluorescence emission for non-GSH-responsive particles in water at 
ca. 0.05 g·mL-1 before (left) and after addition of GSH (right). λex = 375 nm. 
 
In an attempt to understand the system, the same measurements were performed 
with the second batch of particles that are not responsive to GSH and pH. It was 
observed that particles’ diameter increased upon addition of GSH, from 435 nm to 
625 nm, see Figure 5.32.  
   
  
Figure 5.32. DLS data for non-GSH, non-pH-responsive particles in water at ca. 
0.05 g·mL-1 before (left) and after addition of GSH (right). 
 
The fluorescence emission of this particle batch was measured before and after the 
addition of GSH, unlike the previous batch (only non-GSH-responsive) these 
measurements exhibited a very small decrease in intensity from 320 a.u. to 305 a.u., 
see Figure 5.33.  
Chapter 5 
198 
 
  
  
Figure 5.33. Fluorescence emission for non-GSH, non-pH-responsive particles in 
water at ca. 0.05 g·mL-1 before (left) and after addition of GSH (right). 
λex = 375 nm. 
 
These control experiments highlighted the acidic properties of glutathione and 
these were contributing in the particles disassembly observed in this chapter. These 
experiments clearly showed the influence of glutathione on particles that are 
responsive or not to pH. The pH-responsiveness of the particles probably facilitate 
the penetration of GSH into the particles core through swelling to then cleave the 
cross-linker more efficiently.  
It also confirmed that the fluorescent probe is not directly affected by the addition 
of glutathione, therefore, a decrease in fluorescence can indicate a change of the 
probe’s environment. It would have been interesting to monitor the particles’ 
parameters over time.  
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5.4. Conclusions and future work 
In this chapter, the synthesis of fluorescent DSDMA-containing particles and their 
response to glutathione was presented. It has been shown that DSDMA-containing 
particles can respond to intra-cellular concentrations of glutathione. The synthesis 
of the particles was optimised to obtain the desired particles diameter and 
dispersity. Fluorescent DSDMA-containing particles exhibited a very quick response 
(30 seconds) to the intra-cellular level of glutathione (1 mM), this response was 
confirmed by light scattering and fluorescence emission measurements. The 
fluorescence emission intensity drastically decreased within 30 seconds.  
However, despite the successful response of the particles, the current limitations of 
this system were identified: the particles were only stable at a basic pH, which is not 
suitable for potential drug-delivery applications. Different parameters could be 
altered to improve the stability of particles in a neutral pH environment. The first 
parameter that could be considered is the cross-linking density of the particles, if 
increased, the core of the particles would be expected to be more compact and less 
sensitive to pH variations. Another obvious option would be to avoid the use of a 
pH-responsive monomer; however, it has been shown in the optimisation of the size 
of the particles that particles with the lowest dispersity were only obtained utilising 
DEAEMA, which could be attributed to the difference in hydrophobicity of 
DEAEMA and MMA. The synthesis of the particles could also be attempted using a 
buffer as the emulsion solvent. Another option would be to use both pH response 
and GSH-response of this system for a more efficient release.  
If stable particles at neutral pH cannot be obtained for drug-delivery applications, 
these fluorescent DSDMA-containing particles could be used for the detection of 
glutathione levels. The quenching of the fluorescence emission indicating high level 
of glutathione could be optimised to detect cancer cells high levels of glutathione.  
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5.5.  Experimental 
5.5.1. Materials and methods 
DEAEMA, EMA and MMA were filtered through a plug of alumina prior to use and 
stored at 4 °C. All other chemicals were purchased from Aldrich, Fluka or Acros and 
used as received.  
The magnetic stirrer IKA RCT basic was used to synthesise particles at 1000 rpm. 
The mechanic stirrer Stuart SS10 was tested to synthesise a batch of particles at 
∼ 100 rpm. 
The stained transmission electron microscopy (TEM) images were obtained using a 
JEOL 2000FX or a JEOL 2100 LaB6 instrument operated at 200 kV. TEM samples 
were negatively stained by an aqueous solution of uranyl acetate (UA, 2.5 wt%) on 
formvar/carbon grids (300 Mesh, Cu, Elektron Technology UK LTD). Typically, 
formvar/carbon grids were cleaned by air plasma from a glow-discharge system (2 
min, 20 mA) which also improved the hydrophilicity of the grids. 5 µL of particle 
solution was added onto the grid, which was left to dry for 1 min, then 5 µL of a 2.5 
wt% UA solution was added onto the grid to stain the particles and was blotted away 
after 1 min before air-drying.  
Dynamic Light Scattering (DLS) measurements were performed with a Malvern 
Zetasizer Nano ZS instrument and analysed with Malvern Zetasizer Software 7.03. 
All measurements were made in triplicate (with 10 measurements recorded for each 
run). 
  
Chapter 5 
201 
 
5.5.2. Synthetic procedures 
General procedure for the synthesis of particles by emulsion polymerisation  
Oligoethylene glycol methacrylate (OEGMA) was first dissolved in deionised water 
and then ethylene glycol dimethacrylate (EGDMA) or disulfide-based 
dimethacrylate (DSDMA), and N,N-(diethylaminoethyl methacrylate) (DEAEMA) 
were added dropwise to the solution. The mixture, whilst stirred, was purged with 
nitrogen for 30 min and further heated at 65 °C for 30 min. The initiator, potassium 
persulfate (KPS) was dissolved in water (2 mL) and purged with nitrogen before 
being added to the reaction mixture to initiate polymerisation. The reaction was 
stirred at 65 °C for 16 h under a nitrogen atmosphere.  
The different equivalents utilised to synthesise the particles are mentioned in the 
main text where relevant. The different combinations and ratios of monomers, 
initiator and cross-linker tested in the optimisation of particle synthesis were listed 
in Table 5.1. 
5.5.3. Glutathione addition tests 
Two solutions of glutathione in water were prepared at 200 µM and 20 mM.  
DLS micro-cuvettes were filled with 570 µL of particle solution and 30 µL of 
glutathione solution was added, 200 µM solution added to give final GSH 
concentration of 10 µM or 20 mM solution added to obtain a 1 mM final GSH 
concentration. The samples were analysed immediately after addition of the 
glutathione solution.  
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In this thesis, dithiomaleimide and aminomaleimide functionalities were presented 
as efficient fluorescent probes for responsive polymers. The previously developed 
chemistry to synthesise dithiomaleimide fluorophores was shown to efficiently 
produce amine derivatives. A library of aminomaleimides was synthesised, and the 
investigation of their fluorescent properties was shown to be highly emissive, with 
high quantum yields in aprotic solvents. Similarly to dithiomaleimides, the emission 
was found to be drastically decreased in polar protic solvents, and the conjugation 
of the aromatic substituent with maleimide resulted in a fluorescence emission 
quenching.  
The sensitivity to aromatic substituents and the ability of the dithiomaleimide 
functionality to undergo a thiol exchange were exploited to switch-off the 
fluorescence of dithiomaleimide-containing micelles. The fluorescence switch-off 
occurred as a result of substituting the dithiomaleimide polymer substituents for 
aromatic substituents, which simultaneously triggered a morphology transition 
driven by the nature of the polymer end-groups.  
It was shown that the aminobromomaleimide functionality could also be used to 
probe its environment using its sensitivity to protic environments. As the probe was 
incorporated in the hydrophobic core of the responsive particles, it was able to read-
out the behaviour of both CO2/pH-responsive particles and glutathione-responsive 
particles. For both particles, a change in their structure could be related to a 
simultaneous fluorescence emission decrease as a consequence of the modification 
of the fluorophore’s immediate environment. These systems highlight the potential 
of this functionality to be used as a self-reporting contrast agent.  
We believe that this fluorescent aminobromomaleimide probe and its versatile 
chemistry could be developed for a wide range of applications in polymer chemistry. 
Some aspects of the aminobromomaleimide chemistry could also be further 
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investigated.  For example, the synthesis of a derivative of dithiomaleimide or 
aminobromomaleimide that can emit in water would be of great interest for the 
development of fluorescent hydrogels. Moreover, a higher fluorescent quantum 
yield and a different emission wavelength range were obtained by changing the 
structure from dithiomaleimide to aminobromomaleimide, it would be interesting 
to develop a derivative of these functionalities that could allow the tuning of the 
emission wavelength.  
 
 
 
 
 
 
 
 
